ID;Term;Depth;IC Nuno;IC zhou;IC sanchez;IC resnik;IC RZ;IC Rnormalized;IC Nuno org;Annotated Genes Set number
GO:2000480;negative regulation of cAMP-dependent protein kinase activity;12.0;1.0;0.9481203125901445;9.628524252492122;1429.0529900327056;7.697632086000634;0.04782911751220199;0.8417775754447168;[PRKAR1B, PRKAR2B, PKIG, SIRT1]
GO:0034199;activation of protein kinase A activity;12.0;1.0;0.9481203125901445;9.628524252492122;1099.1709144601095;7.57984905034425;0.03678826131738048;0.835754145523778;[PRKAR1B, PRKAR2B, PRKACB]
GO:1904976;cellular response to bleomycin;7.0;1.0;0.8509193652572005;9.628524252492122;332.1079197183639;9.083926447120524;0.011115353195250678;0.8154717862087246;[TIMELESS]
GO:0002244;hematopoietic progenitor cell differentiation;4.0;0.811012628672052;0.655506314336026;8.935377071932177;21.066225782797595;5.395046993006588;7.050676185779127E-4;0.5259029541176994;[TOP2A, SPI1, TNFRSF13B, PLEK, SOX4, PDGFRA, ESCO2, TAL1, KIT, HOXB4, HOXB3, RBM47, PRKDC, PLD4, GATA3, JAM3, TGFB1, ACE, INHBA, ANLN, PTPRC, BCL2, PTPN6]
GO:0000187;activation of MAPK activity;13.0;0.811012628672052;0.8680612791036626;9.526741558182179;3706.2450018205795;4.759793790865545;0.12404468480698592;0.705971040585548;[, LRRK2, ARRB1, TNF, GHR, PROK2, TNFSF11, MAP4K1, MAP2K2, SYK, RIPK2, DUSP6, MDFIC, IL1B, KIT, TLR4, C5AR1, FPR1, CXCR4, TGFA, NOD2, IQGAP3, THBS1, NTF3, CCL19, DRD4, MAP2K6, CD74, EGF, IGF1, MAPK14, BMP2, CD40LG, CDK1, CSPG4, PKN1]
GO:0071373;cellular response to luteinizing hormone stimulus;8.0;1.0;0.875;9.628524252492122;601.1788189541068;8.67846133901236;0.020120914044583264;0.8188169164668168;[CCNA2, LHCGR]
GO:0071377;cellular response to glucagon stimulus;8.0;1.0;0.875;9.628524252492122;462.69925393661634;6.558197802812269;0.015486127626965131;0.7103865406232063;[ADCY9, PRKAR1B, PRKAR2B, ARG1, GLP2R, PRKACB]
GO:0031915;positive regulation of synaptic plasticity;8.0;0.8653626801206646;0.8076813400603323;9.446202695698167;41.65758488823441;7.57984905034425;0.0013942418768168238;0.7626338329336335;[CDC20, PTGS2, EPHB2]
GO:0000060;protein import into nucleus, translocation;9.0;1.0;0.896240625180289;9.628524252492122;93.4429707305496;6.444869117505266;0.0031274521371376313;0.7258315315665724;[TGFB1, RANBP6, PHB2, TNF, NFKBIA, POLA2, BCL6, IFNG, BCL3, AKT1, RAN]
GO:0036123;histone H3-K9 dimethylation;12.0;1.0;0.9481203125901445;9.628524252492122;1326.2992443831567;8.67846133901236;0.04439004211767886;0.8919372290569614;[SUV39H2, SUV39H1]
GO:0036124;histone H3-K9 trimethylation;12.0;1.0;0.9481203125901445;9.628524252492122;1326.076100831845;8.16763571524637;0.044382573703832605;0.8658135829017477;[SUV39H2, SUV39H1, ARID4A, ARID4B]
GO:2000373;positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity;7.0;1.0;0.8509193652572005;9.628524252492122;112.16415423977526;7.9853141584524145;0.0037540333012201187;0.7592887026755414;[PLSCR1, UHRF1, NCAPH]
GO:0036120;cellular response to platelet-derived growth factor stimulus;6.0;1.0;0.8231203125901445;9.628524252492122;97.48528473772916;6.781341354126479;0.003262744749111514;0.6699184248047958;[PDGFRB, CCNA2, PDGFD, FYN]
GO:1900264;positive regulation of DNA-directed DNA polymerase activity;10.0;1.0;0.9152410118609203;9.628524252492122;1106.254199480119;7.9853141584524145;0.03702533249245755;0.8236103492792612;[RFC5, RFC3, RFC4, RFC2, DSCC1]
GO:1905832;positive regulation of spindle assembly;10.0;1.0;0.9152410118609203;9.628524252492122;380.05421777584075;8.16763571524637;0.012720072642367639;0.8329342821725234;[GPSM2, SPAG5]
GO:0006974;cellular response to DNA damage stimulus;4.0;0.5696777571895439;0.534838878594772;7.469040003138749;28.997869804256865;3.161008442547652;9.705326059599744E-4;0.4116541187538124;[SMC3, AKT1, PRKDC, CDCA5, RAD21, HMOX1, SFN, BARD1, LYN, MCTS1, PLK2, PLK1, CDC7, CDKN1A, BTG2, CHAF1B, CHAF1A, CTLA4, ACTL6A, SIRT1, UNG, USP1, PMS1, GTF2H1, FMR1, TNF, PYCARD, RUVBL2, RUVBL1, MACROD2, MEN1, CDC25C, MSH6, MSH2, BLM, RNASEH2A, CUL5, FOXO1, RAD51AP1, MAP2K6, FANCI, FANCL, FANCG, COPS5, BCL6, CNOT3, BCL3, CDK2, CDK1, BCL2, BCL2L1, MCM7, MCM8, MCM10, FOXM1, EXO1, TLK1, RFC5, RFC3, RFC4, RFC1, RFC2, SMC1A, TNFRSF1B, TFDP1, DTL, PPP1R15A, UHRF1, CDC45, RBBP8, POLR2E, E2F1, POLR2I, POLR2J, E2F7, POLR2K, POLR2L, E2F8, DONSON, MND1, PML, RAD50, RAD51, MNDA, SMARCAL1, CCNH, CHEK1, TRIM25, SOX4, TIPIN, ESCO2, MIF, DNA2, EPHA2, BRIP1, POLA1, TOP2A, FEN1, SUV39H1, BRCA1, BRCA2, PARP9, RAD51C, SGK1, YAP1, SP100, PCNA, RAD54B, RAD54L, APBB1, GINS2, GINS4, RPA1, RPA2, MLH1, RPA3, NEDD4, TRIP13, DCLRE1A, PTTG1, LIG1, FANCD2, TIMELESS, PSMD14, CCNB1, CLSPN, HMGA1, ISG15, UBE2T, JMY, CASP2, TOPBP1, H2AFX, MASTL, IRF7, BCL2A1, TAF9, AURKA, POLD3, POLD1, MAPK14, POLE2]
GO:0006975;DNA damage induced protein phosphorylation;8.0;1.0;0.875;9.628524252492122;212.05375489921127;7.697632086000634;0.007097248340487313;0.7686572628545723;[CHEK1, MAP2K6]
GO:0060236;regulation of mitotic spindle organization;9.0;0.7980440201809971;0.7952626352707877;9.360260265897443;71.51327617590798;6.193554689224359;0.0023934849958375417;0.7129793000169707;[GPSM2, VPS4B, SMC3, GNAI1, NUP62, PLK1, SMC1A, TPX2, PSRC1, STAG2, TACC3]
GO:0006730;one-carbon metabolic process;3.0;0.8933024483968273;0.6447715367885581;9.292052015870908;26.874295102004712;6.518977089658987;8.994584717687482E-4;0.5315011041187423;[TYMS, DHFR, MTHFD1]
GO:0048012;hepatocyte growth factor receptor signaling pathway;8.0;1.0;0.875;9.628524252492122;31.002284443533863;7.292166977892469;0.0010376185600805164;0.747921758369865;[NRP1, PAK1, STMN1]
GO:0051653;spindle localization;4.0;0.7866048967936545;0.6433024483968273;9.223059144383958;22.024791997814198;5.9928839937622085;7.371499671409332E-4;0.5564763661386056;[GPSM2, CENPA, NUSAP1, SPAG5, NDC80, ASPM, ESPL1, LLGL2]
GO:0000077;DNA damage checkpoint;8.0;0.811012628672052;0.780506314336026;9.456673995565463;85.75736069739153;5.486614186532078;0.002870221685927797;0.655585704652903;[BLM, BRIP1, CHEK1, E2F1, TOPBP1, CLSPN, FANCI, TIPIN, H2AFX, DONSON, RPA2, MAPK14, MSH6, MSH2, CDK2, CDK1]
GO:0000076;DNA replication checkpoint;8.0;0.8933024483968273;0.8216512241984136;9.461470167828956;54.456905800140625;6.8867018697843045;0.0018226236290973575;0.7271862538851576;[CDT1, TIPIN, CDC45, TIMELESS, CDC6, TOPBP1, NAE1, CLSPN, DNA2]
GO:0071480;cellular response to gamma radiation;7.0;1.0;0.8509193652572005;9.628524252492122;60.39874674087868;6.444869117505266;0.0020214916980741903;0.6805102716434839;[YAP1, EGR1, CDKN1A, H2AFX, NOX4, BCL2L1]
GO:0006729;tetrahydrobiopterin biosynthetic process;8.0;1.0;0.875;9.628524252492122;752.8847007962319;7.8311634786251565;0.02519837338340958;0.7754860644832351;[DHFR, GCH1]
GO:0071363;cellular response to growth factor stimulus;5.0;0.7671156992804218;0.6737988615011312;8.935377071932177;60.394260804020476;4.247644540169047;0.0020213415578046274;0.5074657511808371;[SPARC, SPINT2, AKT1, PDGFRB, MED1, MEF2C, POSTN, RUNX2, SPINT1, COL4A2, CALCA, TWIST1, GATA3, ADAMTS12, EPB41L5, PDGFD, PLCG1, TGFB1, EGR3, VCAM1, CAV1, COL1A1, VIL1, NR4A1, BMP2, ID1, NOX4, SNAI2, FBN1, NRP1, MCM7, TMEM100, IL10, EDN1, ANXA1, ARG1, CAD, TNFRSF1B, PAX2, CCNA2, XCL1, GAS1, CX3CR1, DTYMK, HDAC2, THBS1, CCL5, E2F1, CCL2, FYN, SNCA, MAPK14, KLF4, RPS6KB1]
GO:0072332;intrinsic apoptotic signaling pathway by p53 class mediator;7.0;0.8933024483968273;0.7975705894556142;9.446202695698167;80.0523555558605;5.734022359845919;0.002679280298012042;0.64415753539903;[CDKN1A, BRCA2, PYCARD, PERP, TP53BP2, E2F1, E2F2, SIRT1, POU4F1, PML, MSH2, JMY, BCL3]
GO:0006606;protein import into nucleus;9.0;0.8933024483968273;0.8428918493787028;9.551563211355994;277.5355368998559;5.288437257948329;0.009288864654271135;0.6666915524892495;[NUP107, CSE1L, NUP62, NUP133, SYK, TSC2, MMP12, NUP54, NUP85, NUP88, RANBP2, RANBP1, NUP155, RANBP6, PML, NUP35, RAN]
GO:0046078;dUMP metabolic process;11.0;0.8933024483968273;0.8790801765280758;9.566003895510788;882.6830739380919;7.8311634786251565;0.029542608121515816;0.8329150168128974;[TYMS]
GO:0000070;mitotic sister chromatid segregation;6.0;1.0;0.8231203125901445;9.628524252492122;56.84344269090966;6.311337724880743;0.0019024988710876387;0.6458824173477649;[SPAG5, MIS12, PLK1, CDCA8, SMC1A, TUBG1, SMC4, ZWINT, NDC80, KIF18A, KIF18B, ESPL1, KIFC1, NUSAP1, NEK2, RAN, MAD2L1]
GO:2000121;regulation of removal of superoxide radicals;7.0;0.8259837884571596;0.7639112594857803;9.4949928598676;93.21217700056023;7.474488534686424;0.003119727678695759;0.7331650565203278;[DHFR, GCH1, CD36, TNF]
GO:0035023;regulation of Rho protein signal transduction;9.0;0.8436909121759173;0.8180860812682478;9.318369324188282;48.758993290020136;4.879233827729558;0.0016319196251719597;0.645764870037956;[NRP1, ARHGEF10L, ARRB1, EPS8, ARHGDIA, STMN1, ARHGDIB, PDGFRB, PLEKHG1, ARHGEF12, GPR35, F2R, ARAP3, VAV1, TIAM2, FGD3, FGD4, EPS8L1, EPS8L3, ECT2, ABCA1, COL3A1, BCL6, DLC1, F2RL1, GPR18, F2RL3]
GO:0035024;negative regulation of Rho protein signal transduction;10.0;1.0;0.9152410118609203;9.628524252492122;340.00127024396755;6.832634648514029;0.011379536533788362;0.7646622655359331;[BCL6, DLC1, STMN1, ARAP3]
GO:0070192;chromosome organization involved in meiotic cell cycle;5.0;0.7043150770688792;0.6423985503953599;8.567652291806858;44.78603005185074;5.682729065458369;0.0014989481210252074;0.5808560405423884;[BUB1B, SMC4, NCAPH, SMC2, PPP2R1A, BUB1, MLH1, RAD50, RAD51, RAD51C, CCNE2, CCNE1, FANCD2, NCAPD2, NCAPD3, TRIP13]
GO:0002455;humoral immune response mediated by circulating immunoglobulin;7.0;1.0;0.8509193652572005;9.628524252492122;48.293467131004675;8.390779266560578;0.001616338883576055;0.7800242071602487;[EXO1, BCL3, HLA-DQB1]
GO:0071392;cellular response to estradiol stimulus;6.0;1.0;0.8231203125901445;9.628524252492122;338.1710882258028;6.221725566191056;0.011318281988697268;0.6412996473849828;[IL10, ABCB4, POU4F1, CCNA2, KIF18A, RUVBL2]
GO:0071398;cellular response to fatty acid;6.0;0.7369933605727446;0.6916169928765168;9.004369943419128;203.00017448222317;5.8067817141283475;0.006794233151624104;0.6200793994936333;[PID1, PTGER2, PTAFR, TNC, P2RY6, CCNB1, E2F1, AKT1, FFAR2, PTGDR, EDN1, DGAT2, PRKCE, NR1H4, NME1, IL1B]
GO:0071277;cellular response to calcium ion;6.0;1.0;0.8231203125901445;9.628524252492122;78.50383844342444;5.433268205826786;0.0026274528238337297;0.6009779013089371;[CPNE8, NLGN1, CAMK2D, CPNE5, SERPINE1, PHB2, ECT2, JUNB, KCNH1, MEF2A, MEF2C, JUN, EDN1, FOS, TUBG1, FOSB]
GO:0051661;maintenance of centrosome location;6.0;1.0;0.8231203125901445;9.628524252492122;46.01609631687506;7.9853141584524145;0.0015401173319278046;0.7314896500084853;[ASPM, GPSM2]
GO:0000281;mitotic cytokinesis;5.0;0.9326813400603323;0.7565816818910864;9.474373572664863;28.615093046006976;5.649939242635378;9.577214123380678E-4;0.5791791674783379;[BRCA2, CENPA, RACGAP1, STMN1, NUSAP1, ECT2, MYH10, CEP55, CDT1, PLK1, CKAP2, KIF23, CIT, ANLN, ESPL1, KIF4A, KIF20A]
GO:0048146;positive regulation of fibroblast proliferation;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;63.74573076450893;5.825829909099042;0.0021335122412550348;0.6210535250702663;[CDKN1A, PRKDC, PDGFA, BMI1, AQP1, CCNB1, PDGFD, MYB, PDGFC, E2F1, PDGFRB, PDGFRA, CD74, JUN, TGFB1, FN1, CDC6, MIF, IGF1, PML, EREG, FOSL2, BTC, CCNA2, CDK6, NDUFS4]
GO:2000377;regulation of reactive oxygen species metabolic process;5.0;0.660418147677249;0.6204500856995447;8.475844742553736;26.78229071161683;4.7018998124466425;8.963791676210415E-4;0.5306963869301438;[PID1, HP, TNF, CLU, ICAM1, AKT1, CYP1B1, CD177, PDGFRB, PRKCD, AGTR1, FPR2, SLC30A10, FOXO1, KLRK1, TGFB1, AGXT2, CAV1, DHFR, BST1, BCL2, NOX4, CDKN1A, ITGAM, ITGB2, BRCA1, FOXM1, RAC2, CD36, CD34, IL10, EDN1, SYK, PAX2, DNM2, IFNG, IL1B, TLR6, TLR4, BIRC2, PTGS2, THBS1, AIF1, GNAI2, SNCA, GCH1, MAPK14, KLF4, F2RL1, PTX3]
GO:0071158;positive regulation of cell cycle arrest;7.0;0.8933024483968273;0.7975705894556142;9.461470167828956;83.12201169572153;5.395046993006588;0.002782018926502022;0.6268223193749;[CDKN1A, BTG2, BRCA1, CASP2, SOX4, CDC25C, TFDP1, PCNA, AURKA, CCNB1, E2F1, SFN, E2F7, E2F8, TGFB1, PLK2, POU4F1, PML, FAP, CNOT3, CDK2, CDK1]
GO:0051307;meiotic chromosome separation;4.0;0.8653626801206646;0.6826813400603323;9.223059144383958;35.562483153567804;8.67846133901236;0.0011902443069929621;0.6938169164668168;[BLM, ESPL1]
GO:2001224;positive regulation of neuron migration;8.0;0.8933024483968273;0.8216512241984136;9.59462270081644;536.247192550588;7.138016298065211;0.017947710943527356;0.7400384854347593;[SEMA6A, FLNA, KIF20B]
GO:2000378;negative regulation of reactive oxygen species metabolic process;6.0;0.7763722522362496;0.7113064387082693;9.253830803050711;113.12708673636307;5.905872616772578;0.003786261785297929;0.6251469128630576;[HP, BRCA1, SLC30A10, CD34, IL10, CAV1, PAX2, BCL2]
GO:1903671;negative regulation of sprouting angiogenesis;9.0;0.8653626801206646;0.8289219652406215;9.456673995565463;200.36531453095495;6.599019797332524;0.00670604676027516;0.7337148045016781;[SEMA6A, KLF4, THBS1, E2F2]
GO:0035372;protein localization to microtubule;8.0;0.7980440201809971;0.7740220100904985;9.36615998802463;35.99248463016168;7.379178354882098;0.0012046360694383546;0.7523715242355574;[KIF20B]
GO:1903438;positive regulation of mitotic cytokinetic process;9.0;0.7436939687323844;0.7680876095464813;9.223059144383958;347.7403829701856;9.083926447120524;0.011638557671985614;0.8607930461318132;[NUP62, KIF20B]
GO:0071260;cellular response to mechanical stimulus;5.0;1.0;0.7902410118609202;9.628524252492122;56.1235610070294;5.420364800990877;0.00187840507897962;0.5674387198563348;[CD40, AQP1, CHEK1, AKT1, CASP2, IL1B, TLR8, TLR7, TLR5, TLR4, ENG, PTGS2, CASP8AP2, TGFB1, TNFSF14, TNFRSF10B, NFKB1, COL1A1, LTBR, MYD88]
GO:0051310;metaphase plate congression;6.0;0.8436909121759173;0.7449657686781032;9.34084218004034;45.439948165668724;5.948432231191374;0.0015208341718066008;0.6273234135236593;[SEH1L, CDCA5, VPS4B, KIF14, CDCA8, CCNB1, NUP62, FAM83D, MLH1, GEM, NDC80, CENPE, CENPF, KIF18A, PSRC1, KIFC1, KIF2C]
GO:0033189;response to vitamin A;7.0;0.9326813400603323;0.8172600352873667;9.533214072687796;42.3983228833862;6.781341354126479;0.0014190337108936392;0.6977174774718518;[ARG1, ABCB4, RARA, TYMS]
GO:0051315;attachment of mitotic spindle microtubules to kinetochore;4.0;0.8933024483968273;0.6966512241984136;9.292052015870908;27.921945865447032;7.379178354882098;9.345223999966889E-4;0.6273715242355574;[CENPE, CDT1, SEH1L, MIS12, NUF2, KIF2C, NDC80, MAD1L1]
GO:1902990;mitotic telomere maintenance via semi-conservative replication;9.0;1.0;0.896240625180289;9.628524252492122;232.51800064843582;8.67846133901236;0.007782168229088393;0.8400575416471059;[PCNA, DNA2]
GO:0036297;interstrand cross-link repair;8.0;0.8933024483968273;0.8216512241984136;9.541512875502493;183.0506323445446;5.905872616772578;0.006126539929698291;0.6770266002729131;[DCLRE1A, RAD51AP1, FANCI, FANCL, RPA1, RPA2, FANCG, MSH6, RAD51, MSH2, FANCD2, RPA3, UBE2T]
GO:0070365;hepatocyte differentiation;5.0;1.0;0.7902410118609202;9.628524252492122;24.20171999872632;7.212124270218933;8.100097882234571E-4;0.659069382437994;[HHEX, ANXA1, HNF1B, E2F7, E2F8]
GO:0072425;signal transduction involved in G2 DNA damage checkpoint;9.0;0.9326813400603323;0.8625812952104552;9.590783924509275;196.6208089386036;7.292166977892469;0.006580721527935406;0.769162383550154;[CHEK1, PLK1, BRCA1, DTL]
GO:0016572;histone phosphorylation;8.0;0.7090535922965819;0.729526796148291;9.195660170195843;367.80445225036385;6.444869117505266;0.012310084014303157;0.7045909063862833;[PRKCB, PRKCD, VRK1, AURKB, AURKA, CCNA2, CCNB1, CHEK1, CDK2, CDK1, PKN1]
GO:0071456;cellular response to hypoxia;6.0;1.0;0.8231203125901445;9.628524252492122;103.24589989147204;5.104244793218563;0.0034555473540902374;0.5841516286869992;[SUV39H2, SUV39H1, MPL, RORA, PHB2, SLC8A1, AQP1, ICAM1, AKT1, EDN1, KCND2, PRKCE, SIRT1, CCNA2, ADAM8, TWIST1, PTGS2, CCNB1, BRIP1, E2F1, HMOX1, FABP1, BCL2]
GO:0071459;protein localization to chromosome, centromeric region;7.0;0.7980440201809971;0.7499413753476991;9.117698628726131;34.71951895434896;6.8867018697843045;0.001162031053863633;0.7031056191423581;[MIS12, CDK1, BUB1B, TTK, CENPA, AURKB]
GO:1901673;regulation of mitotic spindle assembly;10.0;1.0;0.9152410118609203;9.628524252492122;218.77880646863287;6.832634648514029;0.0073223297643623805;0.7646622655359331;[VPS4B, PLK1, SMC1A, SMC3, STAG2]
GO:1901796;regulation of signal transduction by p53 class mediator;7.0;0.7192862368539868;0.710562483684194;9.117698628726131;45.070113835906206;4.948759890378168;0.001508456149618737;0.6039991761920099;[CHEK1, AKT1, MIF, SIRT1, TAF9, TWIST1, AURKB, AURKA, TP53BP2, CD74, MAPK14, POU4F1, PML, TPX2, JMY, CDK2, SNAI2, TAF5]
GO:0002052;positive regulation of neuroblast proliferation;8.0;1.0;0.875;9.628524252492122;500.99868276789744;6.781341354126479;0.016767975042699966;0.7217981122146513;[CX3CR1, ASPM, SMARCD3]
GO:0030855;epithelial cell differentiation;4.0;0.5489353771682173;0.5244676885841086;6.961296045910167;21.066225782797595;4.034070439870987;7.050676185779127E-4;0.45630254989846264;[EHF, LGALS3, BASP1, AKT1, HOXA5, SOX4, MEN1, MED1, MEF2C, HNF1B, EREG, COL4A1, ADAM9, HOXB5, EPHA2, GATA3, PSAP, FZD1, ST14, JUN, TGFB1, JAG1, FZD2, VIL1, FA2H, BMP2, DAB2, CDK1, CD24, TGFB1I1, SLC7A11, TMEM100, HHEX, LBH, CD34, CTSB, DSP, ANXA1, PAX2, GREM1, ELF3, TST, RARA, FAM20C, YAP1, TAGLN, CEBPB, CSTA, HDAC2, PCNA, LEF1, RXRA, E2F7, E2F8, CDX2, KLF4, USH2A, GRHL2]
GO:0051973;positive regulation of telomerase activity;9.0;0.9326813400603323;0.8625812952104552;9.600353375525426;952.4250073221435;6.193554689224359;0.031876807868214944;0.7129793000169707;[AURKB, NEK2, CCT4, CCT2, NEK7, KLF4, GRHL2, GREM1, PRKCQ]
GO:0071681;cellular response to indole-3-methanol;6.0;1.0;0.8231203125901445;9.628524252492122;467.4090985487011;8.16763571524637;0.01564376188754665;0.7408135829017477;[JUP, CDH1, CTNNA1, BRCA1]
GO:0006405;RNA export from nucleus;8.0;0.7090535922965819;0.729526796148291;9.033817144745429;77.48498941580046;4.835431205071165;0.0025933528637837495;0.6222841766978864;[, NUP107, HHEX, XPO1, NUP62, MAGOH, NUP133, NCBP2, NUP54, SLBP, NUP205, SEH1L, NUP160, NUP85, NUP43, NUP88, RANBP2, RANBP1, NUP155, UPF3B, NUP35, NUPL2, RAN, NUP37]
GO:0016321;female meiosis chromosome segregation;5.0;0.9326813400603323;0.7565816818910864;9.523163736834295;64.47658740127405;8.390779266560578;0.0021579733551592936;0.7193458537639684;[PLK1, TTK, MLH1]
GO:0016202;regulation of striated muscle tissue development;6.0;0.6108066114563391;0.628523618318314;8.273978589686811;41.666489171895165;4.964889272308052;0.001394539895177614;0.5770249808669412;[ARRB2, JPH2, EPHB1, MEF2C, MYOCD, EDN1, TGFBR3, GREM1, LEF1, TWIST1, DLL1, PAK1, CCNB1, TGFB1, IGF1, MAPK14, MEIS1, BMP2, CENPF, RPS6KB1, CDK1, BCL2]
GO:0016567;protein ubiquitination;9.0;0.6913464685778243;0.7419138594692012;8.996001693748612;153.79381005389072;3.300101264790787;0.005147340417060716;0.5650079573320931;[AKT1, MED1, CDCA3, PRKDC, NEDD4L, BARD1, HACE1, PLK1, SIRT1, RNF130, RNF43, CISH, FBXW2, CUL5, UBR1, SOCS2, FANCL, MARCH3, MARCH1, BCL2, ARRB1, ARRB2, BIRC5, DTL, BIRC2, BIRC3, UHRF1, NLRC4, ZNRF1, RNF24, CCNF, CDC20, HERC5, TRIM25, SKP2, CDC34, NAIP, BRCA1, BMI1, RNF144A, RNF144B, PDZRN3, PCNA, PCNP, NEDD4, KLHL14, DTX3, UBE2C, UBE2S, UBE2T, UBE2M, TNFAIP3, UBE2Q2, HIST1H2BK, RNF6]
GO:0019934;cGMP-mediated signaling;8.0;0.9326813400603323;0.8413406700301662;9.523163736834295;28.507808342730176;7.069023426578259;9.541306898693577E-4;0.7365101867784198;[EDNRB, PRKAR1B, PRKAR2B, CD36]
GO:0035067;negative regulation of histone acetylation;11.0;0.811012628672052;0.8379352666656883;9.498471124243924;1304.334881216342;6.943860283624253;0.04365491464912905;0.7875382901567328;[SPI1, TWIST1, BRCA1, SIRT1, SNCA]
GO:0061436;establishment of skin barrier;8.0;1.0;0.875;9.628524252492122;44.874432655588755;6.781341354126479;0.0015019068766151408;0.7217981122146513;[CLDN4, STMN1, SFN, ALOX12]
GO:0000079;regulation of cyclin-dependent protein serine/threonine kinase activity;11.0;0.7866048967936545;0.8257314007264895;9.474373572664863;340.6851601099881;5.181953777545879;0.011402425712143147;0.6974343094988531;[CDKN1A, CCNT2, CCNH, CCNF, TNFAIP3, CCNC, CKS1B, HERC5, HHEX, AKT1, MEN1, MYOCD, CDC25C, CDC25A, CCNA2, PSRC1, CCNE2, CCNE1, CKS2, CEBPA, BLM, PKMYT1, CCNB2, CCNB1, SFN, CDKN2C, PLK1, GTF2H1, CDC6, NR2F2, CDK6, CDKN3]
GO:0050773;regulation of dendrite development;9.0;0.7586651285174919;0.775573189439035;9.510741216835738;86.24077544028233;4.857092701852345;0.002886401142327329;0.6446325718309276;[CYFIP1, LRRK2, FMR1, CDC20, YWHAH, MEF2C, DCC, SHANK3, NLGN1, HDAC2, SDC2, NEDD4L, RAB21, PLK2, NEDD4, ID1, CAMK1, EZH2]
GO:0006978;DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator;8.0;1.0;0.875;9.628524252492122;145.46952913610525;7.004484905440688;0.004868734226108882;0.7332096838060964;[CDKN1A, SP100, BRCA1, BRCA2, FOXM1]
GO:0051984;positive regulation of chromosome segregation;5.0;0.6634067003016617;0.6219443620117511;8.39638057119949;42.06625563378019;6.444869117505266;0.0014079197188904481;0.6198319182472036;[CDT1, FEN1, CDC6, CCNB1, ESPL1, RAD21, DLGAP5]
GO:0000086;G2/M transition of mitotic cell cycle;5.0;1.0;0.7902410118609202;9.628524252492122;43.44612409677276;4.981283082083729;0.0014541026745458175;0.5449840603320351;[CDKN1A, FOXM1, PPP2R1A, NEK2, SKP2, TUBG1, MASTL, CDC25C, CKAP5, CDC25A, CIT, DNM2, CCNA2, MELK, PLCB1, PKMYT1, AURKA, CCNB2, CCNB1, PRKAR2B, CEP72, CEP76, PLK4, CEP152, PLK1, WEE1, CDK2, CDK1, CDK14]
GO:0006977;DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest;11.0;1.0;0.9324289523296623;9.628524252492122;888.119660647831;5.75172193694532;0.0297245657860804;0.7265722796674696;[CDKN1A, BTG2, PCNA, AURKA, CCNB1, E2F1, CASP2, SFN, E2F7, SOX4, E2F8, PLK2, CDC25C, PML, TFDP1, CNOT3, CDK2, CDK1]
GO:0031938;regulation of chromatin silencing at telomere;11.0;0.8933024483968273;0.8790801765280758;9.551563211355994;304.6981139023377;9.083926447120524;0.010197971661811984;0.8969813732811862;[CDC45]
GO:0000083;regulation of transcription involved in G1/S transition of mitotic cell cycle;10.0;0.8933024483968273;0.861892236059334;9.541512875502493;264.067998117236;6.444869117505266;0.008838118251214853;0.7448319182472036;[CDT1, PCNA, RRM2, GFI1, CDC6, TYMS, DHFR, POLA1, TFDP1, CDC45, CCNE1, E2F1, FBXO5, E2F7]
GO:0000082;G1/S transition of mitotic cell cycle;5.0;1.0;0.7902410118609202;9.628524252492122;42.752976916212816;5.142344639450834;0.0014309036622044387;0.5532207558659172;[CDKN1A, MCM7, MCM8, GMNN, MCM10, SKP2, CDC25A, DBF4, CDC34, CCNE2, CCNE1, MCM3, MCM4, RHOU, MCM5, MCM6, BCAT1, MCM2, PRIM2, CUL5, PRIM1, IQGAP3, GSPT1, CDC45, RBBP8, RANBP2, RANBP1, CDT1, CDKN2C, PLK2, RPA1, RPA2, CDC7, CDC6, INHBA, POLA1, POLA2, WEE1, CDK6, NASP, RPS6KB1, POLE2, RPA3, CDK2, CDKN3]
GO:0071353;cellular response to interleukin-4;6.0;1.0;0.8231203125901445;9.628524252492122;81.6500655361772;6.599019797332524;0.0027327542132076126;0.6605944919115335;[ARG1, LEF1, TCF7, GATA3, CORO1A, PML, ALAD, IMPDH2, XCL1, MCM2]
GO:0071479;cellular response to ionizing radiation;6.0;0.8933024483968273;0.7697715367885581;9.446202695698167;48.660440229648614;5.602686357784832;0.0016286211429333208;0.6096419534788213;[YAP1, CDKN1A, BLM, RAD51AP1, FIGNL1, ECT2, EGR1, TGFB1, H2AFX, MAPK14, SIRT1, DNM2, RAD51, SFRP2, NOX4, BCL2L1]
GO:0071356;cellular response to tumor necrosis factor;6.0;1.0;0.8231203125901445;9.628524252492122;81.6500655361772;4.973052582947213;0.0027327542132076126;0.5774424529526606;[PID1, ZFAND6, RORA, BRCA1, ICAM1, PYCARD, TCL1A, AKT1, EDN1, POSTN, CHUK, SIRT1, XCL2, CHI3L1, XCL1, CCL13, CEBPA, CALCA, GATA3, ADAMTS12, THBS1, CCL8, CCL7, CCL5, CCL4, CCL2, CCL1, CD58, CCL19, CCL18, CCL23, VCAM1, CCL21, CCL20, MAPK14, NFKB1, COL1A1]
GO:0051987;positive regulation of attachment of spindle microtubules to kinetochore;7.0;0.8653626801206646;0.7836007053175329;9.485423408851448;141.20478198009135;8.16763571524637;0.004725996976820352;0.7686126355688037;[CCNB1]
GO:0051988;regulation of attachment of spindle microtubules to kinetochore;6.0;0.7763722522362496;0.7113064387082693;9.271849308553389;31.575448191934637;7.212124270218933;0.0010568018349256063;0.6919486831672181;[CCNB1, RACGAP1, SPAG5, NEK2, ECT2]
GO:0051865;protein autoubiquitination;10.0;1.0;0.9152410118609203;9.628524252492122;155.4032479663248;5.769740442447999;0.005201206855589802;0.7103058064080809;[UHRF1, BRCA1, UBE2T]
GO:0045190;isotype switching;12.0;0.8259837884571596;0.8611122068187244;9.517298617381897;267.39842152832483;6.943860283624253;0.00894958452559752;0.8032296504172152;[MLH1, HSPD1, MSH6, CD40LG, MSH2, EXO1, CCR6]
GO:0060574;intestinal epithelial cell maturation;6.0;1.0;0.8231203125901445;9.628524252492122;41.35061092186203;8.390779266560578;0.0013839677344209735;0.7522251544931926;[CDKN1A, TYMS, HOXA5]
GO:0034088;maintenance of mitotic sister chromatid cohesion;4.0;0.8653626801206646;0.6826813400603323;9.158520623246385;27.51648075733887;8.390779266560578;9.20951847723215E-4;0.6791048419030481;[DSCC1]
GO:0006633;fatty acid biosynthetic process;8.0;0.6493065804076676;0.6996532902038338;8.912904216080118;359.8485513982277;5.076593261888053;0.01204380717262807;0.6346172154986847;[TECR, ACSM2A, ACSM5, BRCA1, EDN1, ELOVL4, ELOVL6, MIF, ELOVL7, MGST1, ALOX12, PTGS2, CYP3A4, PTGS1, ALOX5, CD74, PNPLA8, FA2H, SCD, NDUFAB1, PLP1]
GO:0006513;protein monoubiquitination;10.0;0.8653626801206646;0.8479223519212526;9.574457031221845;155.4032479663248;5.649939242635378;0.005201206855589802;0.704179167478338;[UHRF1, NEDD4L, BMI1, TRIM25, FANCL, UBE2T, DTL]
GO:0034080;CENP-A containing nucleosome assembly;9.0;1.0;0.896240625180289;9.628524252492122;242.74046782674554;6.343086423195323;0.00812430500592325;0.7206263598461826;[CENPW, HJURP, CENPA, NASP, CENPH, CENPI, CENPK, RUVBL1, CENPL, CENPM, CENPN, OIP5, CENPO]
GO:0006631;fatty acid metabolic process;7.0;0.5408746917014966;0.6213567111079488;7.849668188099975;91.0232021896581;4.037280715501235;0.0030464646617242943;0.5573860888006872;[, SCARB2, ACSM5, CYP1B1, ACSL1, ACSL5, MIF, POR, SLC27A3, SLC27A2, MGST1, ALOX12, ACAT1, C3, PRKAR2B, CYP4F2, CYP4F3, CYP4F12, FA2H, TBXAS1, TECR, ACSM2A, ETFA, BRCA1, GHR, ACADM, HIBCH, EDN1, GPX1, ELOVL4, CYP4A11, ELOVL6, ELOVL7, NDUFS6, EHHADH, ACSBG1, HSD17B4, AOAH, PTGS2, CYP3A4, PTGS1, ALOX5, SNCA, CD74, PNPLA8, MAPK14, SCD, NDUFAB1, PLP1]
GO:1902426;deactivation of mitotic spindle assembly checkpoint;13.0;1.0;0.9625549647676366;9.628524252492122;1950.7008717452545;9.777073627680469;0.0652882026605069;0.9625549647676366;[CDT1]
GO:0006511;ubiquitin-dependent protein catabolic process;8.0;0.7369933605727446;0.7434966802863723;9.190269321560967;156.4521708431119;3.582668236575797;0.005236313360306564;0.5582178202295975;[, CCNF, CDC20, PSMD3, TRIM25, SKP2, CDC34, NEDD4L, HACE1, PLK1, TGFB1I1, KIF14, SIRT1, PSMA5, PSMA6, RNF144B, PSMA3, PSMA4, PSMA2, PCNP, USP1, RANBP2, RANBP1, USP9Y, PSMC6, NEDD4, PSMC2, MAD2L1, BUB1B, PTTG1, RNF43, PSMD14, CUL5, UBR1, CCNB1, WFS1, UBE2C, UBE2S, CDK1, ARRB1, ARRB2, DTL, BIRC2, UHRF1, VPS4B, RNF6, USP18, AURKB, AURKA, ZNRF1, TBX21, RNF24, PML]
GO:0070372;regulation of ERK1 and ERK2 cascade;10.0;0.8653626801206646;0.8479223519212526;9.541512875502493;158.98679164778278;4.069963362931594;0.0053211448376282704;0.623379127513894;[PHB2, TNF, CTGF, ICAM1, PYCARD, TNFSF11, EPHB2, EPHB1, PDGFRB, PDGFRA, F2R, MIF, ADCYAP1, ATF3, EPHA3, EPHA2, CSF1R, C5AR1, PDGFA, FBLN1, FPR2, TNFRSF11A, SLC30A10, PRKCZ, RASGRP1, PKHD1, PDGFD, PDGFC, FAM83D, SLAMF1, LYN, CCR1, JUN, TGFB1, LIF, FN1, MARCO, BMP2, NOX4, NRP1, PTPRR, TREM2, PTPN22, ARRB1, ARRB2, CYR61, DUSP10, TIMP3, CCR7, EMILIN1, CD36, HAVCR2, DUSP3, SYK, DUSP1, RIPK2, DUSP6, CEACAM1, IL1B, KIT, XCL2, CHI3L1, XCL1, TLR4, CCL13, NOD2, GNAI2, CCL8, GPNMB, CCL7, CCL5, CCL4, CCL2, CCL1, CSK, CCL19, CCL18, CD74, CCL23, CCL21, CCL20, TIE1, KLF4, CD4, NLRP12, F2RL1, PTPN6, TEK]
GO:0048478;replication fork protection;10.0;1.0;0.9152410118609203;9.628524252492122;1135.309178205509;7.57984905034425;0.037997776482613155;0.8028748447945538;[SMARCAL1, BLM, TIPIN, DONSON, TIMELESS, BRCA2]
GO:0048477;oogenesis;5.0;1.0;0.7902410118609202;9.628524252492122;84.68474556890583;6.481236761676141;0.002834322222868324;0.6216917612613706;[ASPM, TRIP13, MLH1]
GO:0097711;ciliary basal body-plasma membrane docking;5.0;1.0;0.7902410118609202;9.628524252492122;21.38880323109876;5.223196736079928;7.158639954716971E-4;0.5573555358475362;[PPP2R1A, NEK2, TUBG1, CKAP5, PRKAR2B, CEP72, CEP76, PLK4, CEP152, PLK1, CDK1]
GO:0070495;negative regulation of thrombin-activated receptor signaling pathway;8.0;1.0;0.875;9.628524252492122;238.42697029648212;8.67846133901236;0.007979936125481077;0.8188169164668168;[STMN1, SNCA]
GO:0006508;proteolysis;5.0;0.5517781253862416;0.5661300745540411;7.338517941704937;47.85814540089318;2.5985281439167696;0.001601769057033345;0.42312986198474045;[, PSMD3, PRSS3, UQCRC1, PRKCQ, UQCRC2, CFB, CFD, ENPEP, CFI, NEDD4L, GATA3, ADAMTS12, CFP, C2, C3, ELANE, BARD1, ST14, ACE, HACE1, PLK1, AZU1, TGFB1I1, IFIH1, MMP28, OLR1, RIPK2, ACTL6A, SIRT1, F3, MMP12, PSMA5, PSMA6, PSMA3, PSMA4, PSMA2, MMP19, FAM105A, ADAM28, USP1, USP9Y, F11, PSMC6, PSMC2, APEH, IGHG1, RUVBL1, RNF43, FBXW2, CDC25A, ADAM2, ADAM9, ADAM8, ADAM7, CUL5, AEBP1, UBR1, TMEM27, IGLV1-44, CLCA4, WFS1, DHCR24, NFKB1, COPS5, CDK1, ARRB1, ARRB2, SCPEP1, ADAMTS1, ADAMTS20, ASPH, ESPL1, MEP1A, PIK3C3, DTL, BIRC2, BIRC3, C1S, C1R, UHRF1, HM13, VPS4B, FGL2, ZNRF1, RNF24, GZMA, GZMB, PML, GZMH, GZMK, GZMM, EIF3F, CCNF, CDC20, ANPEP, TRIM25, SKP2, ASRGL1, CDC34, CFTR, CTSZ, KIF14, CTSW, BRCA1, PCSK6, PCSK5, CTSS, CTSH, CTSG, CTSD, CTSB, MME, RNF144B, C1QB, C1QA, CD5L, TMPRSS2, PCNP, IGKC, PERP, RANBP2, RANBP1, IL33, GCA, FAP, NEDD4, MAD2L1, C1QC, FCN1, IHH, BUB1B, PTTG1, PLAU, PCOLCE, ADAM12, PRTN3, PSMD14, PSEN2, HTRA1, ADRB2, TRHDE, DPP4, CCNB1, NLRP3, CLSPN, TGFB1, UBE2C, GGH, ISG15, NFKBIA, UBE2S, UBA3, IGKV3-20, TNFAIP3, CASP2, MMP1, DDX58, MMP2, MMP8, MMP9, CCNA2, LTF, RNF6, USP18, AURKB, AURKA, TBX21, NRIP3, TNIP3, CPVL, RBMX]
GO:0051754;meiotic sister chromatid cohesion, centromeric;7.0;1.0;0.8509193652572005;9.628524252492122;116.99733732322595;8.16763571524637;0.003915795589440837;0.7686126355688037;[PPP2R1A, BUB1B, BUB1]
GO:1990918;double-strand break repair involved in meiotic recombination;9.0;1.0;0.896240625180289;9.628524252492122;208.20493307654428;8.67846133901236;0.006968431737797406;0.8400575416471059;[BRIP1]
GO:0030951;establishment or maintenance of microtubule cytoskeleton polarity;6.0;0.9326813400603323;0.7894609826203107;9.533214072687796;65.29771360028688;8.390779266560578;0.002185455710074652;0.7522251544931926;[KIF2C, CKAP5]
GO:0043504;mitochondrial DNA repair;8.0;1.0;0.875;9.628524252492122;333.4790539518545;8.67846133901236;0.011161243824104912;0.8188169164668168;[DNA2]
GO:0043988;histone H3-S28 phosphorylation;11.0;1.0;0.9324289523296623;9.628524252492122;711.4828594708514;8.67846133901236;0.023812691013487215;0.8762458687964789;[AURKB]
GO:0014066;regulation of phosphatidylinositol 3-kinase signaling;7.0;0.8933024483968273;0.7975705894556142;9.427853557029971;45.070113835906206;5.202362649177086;0.001508456149618737;0.6169684330707209;[CSF3, NCF1, CEP55, IER3, PDGFRB, PPP1R16B, PDGFRA, F2R, IL18, TSC2, SIRT1, DCN, FGR, CEACAM1, KIT, HCLS1, TWIST1, PDGFA, NLRC3, RASGRP1, CCL5, PDGFD, PDGFC, FYN, PIP5K1B, TGFB2, IGF1, C3orf58, KLF4, PTK2, SELP, GH1, NEDD4, CD28, F2RL1, PTPN6, TEK]
GO:1902275;regulation of chromatin organization;7.0;0.5120792324551303;0.6069589814847657;7.270369308343265;21.750886949199476;4.641275190630208;7.279826116623381E-4;0.5882743943473984;[SPI1, FMR1, GFI1, MKI67, RUVBL2, CHEK1, MYB, PADI2, DNMT1, TWIST1, GATA3, CCNB1, TGFB1, HMGA1, LIF, BCL6, LRRK2, ARRB1, BRCA1, TLK1, MYOCD, PAX5, SIRT1, TAL1, IL1B, CAMK2D, UHRF1, CDC45, SNCA, ATAD2]
GO:0015031;protein transport;7.0;0.4793097133439409;0.590574221929171;6.989466922876863;54.45792783373929;2.578890050578526;0.0018226578356421344;0.4828039223744382;[, NUP107, TFRC, AKT1, WLS, ZFYVE16, GATA3, LYN, ABCA1, COL1A1, SRP9, MMP12, CENPF, SNX17, GOPC, NCF1, CSE1L, AP2M1, ADCYAP1, ACAP1, SLC27A2, LIN7A, EVI5, ARRB1, ARRB2, TNFSF13B, ITGB6, ARL4C, LCP2, LRP1, LRP2, SEC63, GOLPH3L, HNF1B, ACTN4, KIF20A, MSR1, EGR2, POLA2, TF, CD24, CD3G, PCSK5, AKAP12, CCR7, CD36, SYK, NAPA, HSD17B4, STX11, CD74, NEDD4, FKBP1B, RAMP1, SCARB2, ZFAND6, CARD11, ECT2, NUP155, NASP, PLEK, NUP62, YWHAH, NUP133, TBC1D8, TBC1D9, CHI3L1, NUP54, MX2, NUP35, RAN, PHB2, AP1S2, HOMER3, CUBN, PRKCB, NUP85, S100A12, NUP88, EHD3, DENND1B, ANXA1, EXOC1, CCL19, NR1H4, TNF, CLU, LAMP2, TAP1, RAB32, RAB31, CALCRL, SLC15A3, DAB2, BCL6, BCL3, CCDC22, PLEKHF2, TLK1, NLGN1, UNC93B1, VPS4B, NLRC4, NOD2, RAB21, PML, VPS41, IL1RN, IFIT1, ARFIP1, STXBP2, AHCTF1, TRAM2, XPO1, TMED6, STRADB, ZDHHC17, RAB33B, TLR6, TLR4, TLR2, RANBP2, RANBP1, LILRB1, RANBP6, CD40LG, F2RL1, NUPL2, STEAP3, GOLT1B, TSC2, ATP1B1, HGS, COPB2, SUCNR1, LTBP2, NLRP3, TGFB1, LRP1B, NFKBIA, TBCK, KIF18A, DNM2, IFNG, EHHADH, HSPD1]
GO:1903126;negative regulation of centriole-centriole cohesion;10.0;1.0;0.9152410118609203;9.628524252492122;269.77484522762467;9.777073627680469;0.009029121288170608;0.9152410118609203;[NEK2]
GO:1990001;inhibition of cysteine-type endopeptidase activity involved in apoptotic process;13.0;1.0;0.9625549647676366;9.628524252492122;2010.8653136723324;7.292166977892469;0.06730185238732382;0.8354767231375014;[BIRC5, NLRC4, NAIP, BIRC2, BIRC3]
GO:0051000;positive regulation of nitric-oxide synthase activity;7.0;1.0;0.8509193652572005;9.628524252492122;123.23454311126406;6.832634648514029;0.0041245492540456985;0.7003406189322132;[DHFR, FCER2, GCH1, AKT1]
GO:0007409;axonogenesis;8.0;0.6873818243518346;0.7186909121759173;8.667113085337498;64.60914726719044;4.956792062075433;0.0021624100145753813;0.6284905765689417;[NRP1, ADARB1, STMN1, EPHB2, EPHB1, DCC, PAX2, MAP1B, CDH11, DSCAML1, SLITRK6, APBB1, LINGO1, SEMA4A, GP5, POU4F1, PTK2, NR4A2, LRFN4, OGN, BCL2]
GO:0019886;antigen processing and presentation of exogenous peptide antigen via MHC class II;5.0;1.0;0.7902410118609202;9.628524252492122;42.20009821028515;5.192106149009898;0.0014123993094755708;0.5557655617789146;[KIF11, IFI30, CTSS, KIF15, AP1S2, HLA-DOA, HLA-DOB, CTSD, AP2M1, HLA-DPA1, LAG3, FCER1G, KIF23, DNM2, KIF2C, HLA-DQB1, HLA-DMA, HLA-DMB, RACGAP1, HLA-DQA2, HLA-DQA1, CD74, HLA-DRB4, CENPE, KIF18A, KIF26A, KIF4A, HLA-DPB1, HLA-DRA, FCGR2B, HLA-DRB1]
GO:0090502;RNA phosphodiester bond hydrolysis, endonucleolytic;8.0;0.6799073451904818;0.7149536725952409;8.878218658092228;231.13671471601307;5.395046993006588;0.007735937832006836;0.6509029541176994;[POP5, FEN1, RNASEH2A, EXO1, RNASE2]
GO:1902042;negative regulation of extrinsic apoptotic signaling pathway via death domain receptors;10.0;0.9326813400603323;0.8815816818910864;9.589303539338841;425.73912115989816;6.193554689224359;0.014249105244888325;0.731979686697602;[SERPINE1, HMGB2, TNFAIP3, FASLG, BRCA1, ICAM1, HMOX1, GPX1, DAPK1, TNFRSF10B, SFRP2, BCL2L1]
GO:0036089;cleavage furrow formation;6.0;0.9326813400603323;0.7894609826203107;9.523163736834295;34.64508192741332;7.8311634786251565;0.001159539713561072;0.7236063770733796;[AURKB]
GO:0042307;positive regulation of protein import into nucleus;9.0;0.9326813400603323;0.8625812952104552;9.592156608321247;778.7460608588023;6.063501560976162;0.02606392983099081;0.706328376990269;[LRRK2, PTGS2, CDH1, ECT2, MED1, TGFB1, JUP, PRKCD, IGF1, MAPK14, IFNG, CDK1, HCLS1]
GO:0040001;establishment of mitotic spindle localization;7.0;0.8933024483968273;0.7975705894556142;9.577230958104572;138.61878563688504;6.481236761676141;0.0046394460064588475;0.6823701146576509;[GPSM2, CENPA, NDC80, ESPL1, NUSAP1]
GO:0000902;cell morphogenesis;4.0;0.6260725219892441;0.563036260994622;7.923776160253697;43.26261951924051;4.420487353008457;0.0014479609414792109;0.47606392880653703;[CYFIP1, COL12A1, LST1, IHH, SPINT2, ANTXR1, CLU, CDH5, C1GALT1C1, CDH3, POF1B, CDH1, MED1, MEF2C, ACTN1, COL23A1, CLDN3, ADAM8, EPHA2, SLC1A3, EPB41L5, NCKAP1L, ECT2, ST14, TGFB2, BCL11B, VDR, FN1, PARVB, BCL6, ID1, NOX4, IL7R, NRP1, COL14A1, ITGB3, KIF14, LAMC1, ITGB7, ITGA4, STRADB, GP1BA, GREM1, PALLD, COL6A2, CDH11, COL6A1, COL6A3, CDH17, YAP1, LEF1, PDPN, SLITRK6, FLNA, LAMB1, MAPK14, GRHL2, TEK]
GO:0014075;response to amine;5.0;0.7980440201809971;0.6892630219514189;9.223059144383958;29.79647000066773;6.139487467954083;9.972610358403309E-4;0.6042146864874571;[HDAC2, ARG1, CAD, NME1, ICAM1, NR4A2, CDK1, DRD4]
GO:0051260;protein homooligomerization;6.0;0.8933024483968273;0.7697715367885581;9.405380701177911;42.032160359171186;4.056761851073058;0.00140677858073304;0.5305833023127396;[CDA, KCNG2, PRF1, TCL1A, TNFSF11, TGM2, MIF, OLFM4, CLDN3, KCTD12, KCTD15, BLM, MGST1, ITPR3, ACAT1, CD79B, CD79A, NACC2, HMOX1, ECT2, VASP, CAV1, EHD3, DPYS, CD3G, CD3E, CD3D, ALAD, EMILIN1, TK1, FCER1G, KCND2, VWF, ARG1, NUP54, ACPP, FBP1, COLEC12, NLGN1, HM13, KCNA5, NLRC4, SAMHD1, PLN, RXRA, GCH1, SOD2, MARCKS, RAD51, P2RX1, IMPDH2, GOPC, CD247, RBMX]
GO:0008631;intrinsic apoptotic signaling pathway in response to oxidative stress;7.0;0.8653626801206646;0.7836007053175329;9.523163736834295;52.930841574252625;6.943860283624253;0.001771547632825523;0.7060287030842711;[GPX1, PRKCD, PML, MELK, BCL2, CYP1B1]
GO:0051382;kinetochore assembly;6.0;1.0;0.8231203125901445;9.628524252492122;123.98170582545;7.212124270218933;0.004149556117686715;0.6919486831672181;[CENPE, CENPF, CENPW, CENPH, CENPK, MIS12, CENPN, CENPA]
GO:0008630;intrinsic apoptotic signaling pathway in response to DNA damage;7.0;0.9326813400603323;0.8172600352873667;9.55953138100517;84.23129647150353;5.54296712308321;0.002819145689655962;0.6343869617060081;[CDKN1A, BCL2A1, PRKDC, BRCA1, BRCA2, TNF, PYCARD, E2F1, HMOX1, CASP2, SFN, MLH1, TNFRSF1B, SIRT1, PML, MSH6, MSH2, BCL3, BCL2, EPHA2, BCL2L1]
GO:0009966;regulation of signal transduction;5.0;0.3290196849396939;0.45475085433076723;5.351858133476067;37.58855813399747;1.7469895334129066;0.0012580552132388425;0.37958213784297784;[, SLA2, AKT1, VSTM1, PRKACB, WLS, ATF3, PDGFA, GATA3, ADAMTS12, GATA1, PDGFD, PDGFC, SFN, PIP5K1B, JUN, JAG1, JUP, FN1, EIF2AK2, ARHGAP9, ARHGAP6, ARHGAP4, JAK3, DUSP2, DUSP3, DUSP1, BGN, GMIP, DUSP6, MMP12, PLSCR1, PXDN, FRZB, SPP1, BIK, COL3A1, PKN1, LGR4, SLA, EFEMP1, MAP3K8, IFNA14, CISH, IFNA16, PKP3, IFNA10, BLK, LY96, ZNF423, IFNA21, LY86, OGN, HPSE, ITGB3, TNFSF13B, HHEX, TAGAP, ADAMTS20, ACPP, E2F1, FYN, GZMB, ICAM1, LGALS3, LGALS1, TNFSF11, TRIM25, ACTN4, BTC, CDC34, TRIB1, NAIP, TGFA, PKHD1, RACGAP1, EGR1, TNFSF14, TNFSF12, TNFSF13, PPBP, IGF1, PTK2, BST1, PEX5L, NRP1, ECM1, AKAP12, RAC2, IL10, SYK, IL15, GAB1, IL18, IL1A, IL1B, KIT, YAP1, GNAI1, GNAI2, IL32, IL33, OSM, KITLG, IL18R1, GRINA, ZFAND6, PLAU, FAM3D, IL6R, TGM2, CARD11, HTRA1, CACNA1F, LPXN, ECT2, CAV2, CAV1, GH1, GNAQ, IL7R, FBN1, PLEK, TNFAIP3, GHR, MYOCD, IRAK3, GREM1, ELF3, CHI3L1, ZMYND11, FBP1, SHANK3, RNF6, RETN, CD4, TNIP3, TEK, PHB2, EPS8, PROK2, HOMER3, PRKCH, PRKCB, PRKCE, PRKCD, DEPDC1B, DAAM2, PRKCQ, SEH1L, PRKCZ, SAMSN1, FLRT2, PRDM16, HMOX1, ICOS, NDFIP2, PLK2, SNAI2, TIMP2, PBK, TIMP3, TIMP1, CEP55, ZEB1, GAS1, GRN, SGMS1, FGD3, FGD4, GPNMB, GSN, NR1H2, NR1H4, G0S2, PF4, CSF3, TNF, CLU, FGF5, TLE4, MAP2K2, UBR1, DRD4, MAP2K6, DAB2, COPS5, BCL6, BCL3, BCL2, CSPG4, CCDC22, LAT, BCL2L1, PLEKHF1, CYR61, LBH, EMILIN1, PLEKHG1, TFDP1, LCK, XCL2, XCL1, HDAC2, NLRC3, TTK, NLRC4, NOD2, PLN, TTR, CSK, PML, P2RX5, IL1RN, GFI1, PPP2R1A, IL1R1, IL1R2, FLT3LG, TIAM2, POR, IL23A, SIK1, NBL1, SH2D2A, TXK, TWIST1, APCDD1, TP53BP2, SH2D1A, LIF, TPX2, VNN1, CD320, IFNA5, IFNA4, IFNA7, IFNA2, PRL, IFNA8, RALGPS2, EDN1, STRADB, GP1BA, PARP9, ZDHHC17, VAV1, TLR1, TLR7, TLR6, TLR5, TLR4, TLR2, TYMP, SORBS1, CD40LG, F2RL1, SIPA1, F2RL3, ARHGDIA, ARHGDIB, POSTN, HGS, FANCD2, FBLN1, HRH4, NLRP3, FAM83D, SELP, KDM5D, LRRTM4, BLNK, CASP2, PLAUR, AXIN2, DCN, DNM2, ZAP70, LTA, LTB, PFDN5, LTF, CLEC12B, LEF1, THBS1, SNCA, C3orf58, RPS6KB1, PID1, UBASH3A, MEF2C, PADI2, FPR1, FPR2, THY1, SLC30A10, IQGAP3, C3, FIGNL1, LYN, ABCA1, COL1A1, NOX4, GPR18, NOX1, EZH2, SRPX, LRRC4, JPH2, GPR37, ARG1, GPR35, RIPK2, MYOF, EMP2, SIRT1, F3, LRRC19, PTGS2, NTF3, FLNA, DMD, STAT1, TMEM64, LRG1, NCF1, RORA, CXCL13, CTGF, CXCL16, SESN3, RUVBL2, RUVBL1, PPP1R16B, ADCYAP1, MAL, S100A9, S100A8, TNFRSF11A, FOXO1, SOCS2, TNFRSF10B, NFKB1, PTPRE, CXCL10, CXCL11, CXCL12, PTPRC, MYD88, ARHGAP11A, LRRK2, PIK3CD, FASLG, ARRB1, ARRB2, FOXM1, TNFSF12-TNFSF13, PVRIG, BIRC5, BIRC2, BIRC3, PPP1R15A, LRP1, LRP2, CCL8, CCL7, CCL5, CCL4, CCL2, CCL1, SH2B1, CTHRC1, PRRX1, TIE1, PTPN6, FCGR2B, DHX58, EPHB2, EPHB1, RSAD2, PAQR3, HNF1B, MIF, EREG, SFRP4, SFRP2, EPHA3, EPHA2, PIK3R5, CD19, TSPAN5, CD14, A2M, PAG1, SLAMF1, CCR1, ID1, CD28, CD27, CALM3, CD24, PTPRR, CD40, KIF14, SECTM1, BRCA1, CD3E, PCSK6, CTSH, CCR7, CD36, BANK1, PAK1, CD74, PPP1CA, NLRP12, KIF26A, NEDD4, FKBP1B, RAMP1, IL17A, SCARB2, CD86, CD80, IHH, RGS1, PDGFRB, PDGFRA, CALCA, DDX60, RASGRP1, RASGRP4, INHBA, IL6, BMP2, HMGB2, ARHGEF10L, NUP62, YWHAH, ARHGEF12, MMP9, NDUFS3, IRF7, BCL2A1, TAF9, AURKB, AURKA, EPS8L1, EPS8L3, EGF, MAPK14, SOD2, TAF5, CYFIP1, SERPINE1, STMN1, CYP1B1, IER3, MED1, DAPK1, MAML3, S100A12, ELANE, FZD1, FZD5, FZD8, PNOC, CDK14, TGFB1I1, ADM, HAVCR2, FCRL2, IFNGR1, FCRL3, NFAM1, IFNGR2, PAWR, PAX5, AES, HCLS1, PLCB1, HBEGF, ENG, CCL13, CCL19, CCL18, CCL23, CCL21, CCL20, CARD9, SULF1, POU4F1, SULF2, GUCA1C, PYCARD, CDH3, GRAP2, PHLDA2, CD177, MEN1, RNF43, IGFBP5, IGFBP3, CD180, F2R, ADAM9, ADAM8, CSF1R, RASAL2, NACC2, PSAP, WFS1, CDK2, CDK1, TREM2, PTPN22, DUSP10, PSD3, GPX1, CHUK, TRAF1, ASPM, CX3CR1, NLGN1, KLF4, CHEK1, SKP2, SOX7, SOX4, RUNX2, RRAGD, LLGL2, EBI3, INPP5D, GADD45B, MARCO, ITM2C, ESM1, MAP4K1, RHOG, RHOH, CEACAM1, MDFIC, FAM20C, RHOU, SP100, IFI6, CXCR4, LILRA2, NPY, CTNNA1, PODN, LILRB4, DLC1, GOLT1B, GHSR, TSC2, C5AR1, ARHGAP19, ADRB2, ARHGAP15, STAP1, TGFB2, TGFB1, ARHGAP25, NR4A2, NFKBIA, TBCK, LIN28A, ARHGAP30, JMY, NFKBID, CXCL6, CXCL9, CXCL1, CXCL3, CXCL2, CXCL5, TMEM100, PTGIR, PDE4D, ARAP3, ARAP1, TGFBR3, FGR, IFNG, PDE5A, CAMK2D, DLL1, USP18, CMTM8, TRAT1, CMTM2, LTBR]
GO:0006334;nucleosome assembly;7.0;0.8653626801206646;0.7836007053175329;9.474373572664863;104.51542930890014;4.99795013456894;0.0034980373611892576;0.6065147675675062;[HMGB2, HJURP, CHAF1B, CHAF1A, RUVBL1, OIP5, BRD2, H2AFX, PADI4, MCM2, ASF1B, HIST1H2BK, CENPA, H1FX, CENPW, NASP, CENPH, CENPI, CENPK, CENPL, CENPM, CENPN, CENPO]
GO:0006335;DNA replication-dependent nucleosome assembly;8.0;1.0;0.875;9.628524252492122;163.41517932017535;7.474488534686424;0.005469358987733092;0.7572456912631272;[CHAF1B, CHAF1A, NASP, ASF1B]
GO:0051497;negative regulation of stress fiber assembly;11.0;1.0;0.9324289523296623;9.628524252492122;338.83785420150645;6.781341354126479;0.01134059804585365;0.7792270645443136;[TMEFF2, DLC1, STMN1, TACSTD2, ARAP1, PFN1, ARHGAP6]
GO:0051256;mitotic spindle midzone assembly;5.0;1.0;0.7902410118609202;9.628524252492122;55.94550109770304;7.474488534686424;0.001872445574057981;0.6724867031240476;[RACGAP1, KIF4A, KIF23, AURKB]
GO:1990138;neuron projection extension;4.0;0.811012628672052;0.655506314336026;9.223059144383958;50.60479478960687;5.69953618377475;0.0016936969402496266;0.5414745454937787;[CYFIP1, NRP1, SEMA5B, NRP2, PRKCZ, AURKA, ALCAM, POSTN, MAP1B, VCL]
GO:0010826;negative regulation of centrosome duplication;10.0;0.8933024483968273;0.861892236059334;9.582004236857228;270.18031033573334;7.292166977892469;0.0090426918404441;0.7881627702307852;[CCNF, BRCA1]
GO:0010705;meiotic DNA double-strand break processing involved in reciprocal meiotic recombination;9.0;1.0;0.896240625180289;9.628524252492122;174.6664316074383;8.67846133901236;0.005845928276318126;0.8400575416471059;[BLM, BRIP1]
GO:0031508;pericentric heterochromatin assembly;7.0;1.0;0.8509193652572005;9.628524252492122;98.72405253680223;8.67846133901236;0.0033042051925278506;0.7947362817240173;[HELLS]
GO:0048096;chromatin-mediated maintenance of transcription;11.0;1.0;0.9324289523296623;9.628524252492122;1311.6223032101445;7.57984905034425;0.043898818105007634;0.8200627852632958;[CHEK1, PADI2]
GO:2001178;positive regulation of mediator complex assembly;7.0;1.0;0.8509193652572005;9.628524252492122;140.3817219977405;9.083926447120524;0.004698449899916962;0.8154717862087246;[CDT1]
GO:1904355;positive regulation of telomere capping;9.0;0.9326813400603323;0.8625812952104552;9.59462270081644;613.4505056642549;6.943860283624253;0.02053163635497091;0.7513499630073597;[NEK7, PRKCQ, NEK2, AURKB]
GO:0051272;positive regulation of cellular component movement;5.0;0.5452700253111464;0.5628760245164934;7.377232453885626;52.22589589123734;3.603287523778533;0.0017479537352249267;0.4745133033969606;[SPARC, SERPINE1, MYLK, ICAM1, LGALS3, STMN1, C3AR1, AKT1, IL1R1, PRKCE, ACTN4, IL23A, CLDN7, PFN1, KIF20B, TWIST1, PDGFA, FPR2, GATA3, THY1, PLA2G7, EPB41L5, PDGFD, PDGFC, HMOX1, NCKAP1L, S100A14, PLCG1, ELANE, LYN, CCR1, JUN, TNFSF14, PLK2, FN1, PPBP, IGF1, PTK2, COL1A1, NOX4, SNAI2, NRP1, NRP2, CD40, EPB41L4B, RAC2, CTSH, CCR7, CCR6, CCR2, EDN1, ANXA1, ANXA3, GAB1, TACR3, SIRT1, F3, IL1A, CEACAM6, IL1B, KIT, HBEGF, PTAFR, PTGS2, AIF1, GNAI2, PAK1, GPNMB, CXCR2, PDPN, NTF3, FLNA, CCL19, CD74, CCL21, CCL20, F2RL1, PF4, SEMA5B, ATP8A1, ITGA2B, CXCL13, TNF, ETS1, SLC8A1, CXCL16, PYCARD, PLAU, IL6R, PDGFRB, PDGFRA, POSTN, SEMA6A, IGFBP5, F2R, ADAM9, ADAM8, CD274, CSF1R, CD151, C5AR1, CORO1A, TGFB2, TGFB1, SELP, VIL1, CXCL10, CXCL11, IL6, BMP2, DAB2, CXCL12, PTPRC, NR4A3, BCL6, BCL2, DOCK5, CXCL6, CXCL9, DOCK4, TNFAIP6, ITGB3, PIK3CD, LAMC2, CXCL1, CXCL3, PIK3C2A, CXCL2, CXCL5, CYR61, ITGA4, MMP9, FGR, IFNG, XCL2, XCL1, LEF1, THBS1, P2RY6, CCL8, CCL7, CCL5, CCL4, CCL1, SEMA4A, EGF, SEMA4B, LAMB1, MAPK14, SOD2, RPS6KB1, TEK]
GO:1905448;positive regulation of mitochondrial ATP synthesis coupled electron transport;12.0;0.9326813400603323;0.9144609826203107;9.600353375525426;1375.5648477489242;8.390779266560578;0.04603891752616661;0.8772251544931927;[CCNB1, CDK1]
GO:1904117;cellular response to vasopressin;8.0;1.0;0.875;9.628524252492122;462.69925393661634;8.67846133901236;0.015486127626965131;0.8188169164668168;[CDC6]
GO:0006303;double-strand break repair via nonhomologous end joining;9.0;0.8933024483968273;0.8428918493787028;9.548481544818586;368.8093148901945;5.8067817141283475;0.012343715862540626;0.693199712083778;[DCLRE1A, BLM, PSMD14, PRKDC, BRCA1, BARD1, H2AFX, MLH1, POLA1, RAD50]
GO:0045944;positive regulation of transcription by RNA polymerase II;11.0;0.5461734764479651;0.7055156905536448;8.363590748376499;1463.8556817380634;2.718315475161805;0.048993932283191266;0.5714437321440341;[EHF, PID1, SPI1, SERPINE1, SPIB, MYB, HOXA3, AKT1, HOXA2, HOXA7, JUNB, HOXA5, MEF2A, MED1, MEF2C, HOXB9, HOXB4, HOXB3, HOXB2, MAML3, HOXB7, ATF3, HOXB5, PRKDC, GATA3, GATA1, RAD21, NKX2-3, JUN, JAG1, JUP, FZD5, FZD8, FOSL2, FOSL1, HOXC10, DLGAP5, RIPK2, PAX5, FOS, SIRT1, PAX2, MMP12, PLSCR1, ZEB1, TAL1, RARA, HCLS1, ENG, NR1I2, EPCAM, STAT4, STAT1, NR1H2, ATAD2, NR1H4, GTF2H1, POU4F1, PSMC6, PSMC2, FOSB, PF4, CSF3, CCNT2, PLXND1, RORA, TNF, RUVBL2, MEN1, ADCYAP1, FOXO1, SBNO2, NFKB1, NFKB2, CXCL10, COPS5, MAFB, MAFF, BCL3, CIITA, ARRB1, FOXM1, CYR61, HHEX, PPP1R12A, CHUK, PEG3, TFDP1, CEBPA, CEBPB, HDAC2, CEBPD, CEBPE, UHRF1, NOD2, ABLIM3, E2F1, E2F2, E2F5, E2F7, E2F8, PRRX1, KLF4, PML, KLF1, KLF6, KLF5, POU2AF1, CCNH, GFI1, CCNC, IKZF1, RPS6KA1, TNFSF11, DPF3, SOX4, SLC11A1, EBF1, FLT3LG, HNF1B, RUNX2, SFRP2, IL23A, BEX1, TXK, TWIST1, NHLH2, EGR1, EGR2, EGR3, BCL11B, LIF, IGF1, CD28, TOP2A, CD40, HNF4G, PRL, BRCA1, CD3D, HNF4A, IL10, EDN1, IL18, RGMA, IL1A, IL1B, TFEC, TLR4, TLR2, YAP1, SATB2, RELB, RXRA, APBB1, IL33, CDX1, OSM, LILRB1, GRHL2, F2RL1, CAMK1, FOXA3, IL17A, FOXA2, IHH, ARID4A, ARID4B, ETS1, HOXA10, EOMES, LMO2, ADRB2, NLRP3, TGFB2, TGFB1, VDR, HMGA1, INHBA, NR4A2, NFKBIA, NR4A1, IL6, BMP2, NR4A3, TCF4, HMGB2, SLC40A1, ARHGEF10L, MYBL2, MYBL1, MYOCD, KLF13, DDX58, CKAP2, ETV1, DCN, GREM1, ELF3, IRF7, IRF8, TAF9, LEF1, DLL1, LUM, MAPK14, MEIS2, MEIS1, TNIP3, RBMX]
GO:0006301;postreplication repair;8.0;0.8259837884571596;0.7879918942285797;9.500690880982237;183.0506323445446;5.8067817141283475;0.006126539929698291;0.6719590869034888;[PCNA, BRCA1, POLD3, POLD1, TRIM25, RFC5, RFC3, RFC4, RFC1, RFC2, RPA1, RPA2, ISG15, MSH2, POLE2, RPA3, DTL]
GO:0043525;positive regulation of neuron apoptotic process;8.0;0.8436909121759173;0.7968454560879586;9.392135474427892;179.36331192335928;5.885253329569843;0.0060031286335741505;0.6759721289664703;[CTSZ, FASLG, MYB, CASP2, MYBL2, JUN, TGFB2, CDC34, IL1B, UBE2M]
GO:0006302;double-strand break repair;8.0;0.7586651285174919;0.754332564258746;9.318369324188282;183.0506323445446;4.689477292448085;0.006126539929698291;0.6148200868187911;[DCLRE1A, FEN1, MCM8, BRCA1, BRCA2, H2AFX, ESCO2, PARP9, RAD51C, MSH2, BLM, PSMD14, PRKDC, CDCA5, RAD54B, RAD51AP1, BRIP1, CDC45, RAD21, RBBP8, RAD54L, APBB1, BARD1, GINS2, GINS4, RPA1, RPA2, CDC7, MND1, MLH1, POLA1, RAD50, RAD51, RPA3, TRIP13]
GO:0051026;chiasma assembly;4.0;1.0;0.75;9.628524252492122;42.501794097528276;7.697632086000634;0.0014224967993129276;0.6436572628545723;[BRIP1]
GO:0051383;kinetochore organization;5.0;0.9326813400603323;0.7565816818910864;9.4949928598676;38.75571468247735;6.8867018697843045;0.0012971188925437662;0.6424272657460779;[CDT1, CENPW, MIS12, SMC4, CENPA, NDC80, SMC2, CENPE, CENPF, CENPH, CENPK, NUF2, CENPN]
GO:0051384;response to glucocorticoid;7.0;0.7671156992804218;0.7344772148974115;9.223059144383958;62.73690238121479;4.800339885259895;0.00209974766315278;0.5964089702280253;[CDKN1A, IL1RN, SPARC, ADM, TNF, AQP1, ICAM1, ALAD, IL10, GHSR, EDN1, ANXA1, DUSP1, ANXA3, ARG1, CAD, AVPR1A, FOS, ADCYAP1, IL1B, ADAM9, ACSBG1, PCNA, FECH, ABCB4, PTAFR, PTGS2, TYMS, AIF1, FOXO1, IGFBP7, TGFB1, FOSL1, IL6, RPS6KB1, BCL2, ALPL, SDC1, FOSB]
GO:0019860;uracil metabolic process;8.0;0.8653626801206646;0.8076813400603323;9.52844079393514;250.73952180582577;8.67846133901236;0.008392026143921861;0.8188169164668168;[DPYS, DPYD, TYMS]
GO:0030521;androgen receptor signaling pathway;8.0;0.8933024483968273;0.8216512241984136;9.446202695698167;54.01143535742291;5.948432231191374;0.0018077141342769656;0.6792031009335148;[TGFB1I1, FHL2, BRCA1, MED1, CCNE1, RAN]
GO:0019985;translesion synthesis;9.0;0.8933024483968273;0.8428918493787028;9.572954401337311;760.2225735865501;6.063501560976162;0.025443965382044766;0.706328376990269;[PCNA, POLD3, POLD1, TRIM25, RFC5, RFC3, RFC4, RFC1, RFC2, RPA1, RPA2, ISG15, POLE2, RPA3, DTL]
GO:0014038;regulation of Schwann cell differentiation;9.0;0.8933024483968273;0.8428918493787028;9.485423408851448;65.83981520803086;8.67846133901236;0.0022035993630260702;0.8400575416471059;[CDK1]
GO:0016579;protein deubiquitination;9.0;0.7307253602413294;0.7616033053009538;9.151600180401813;202.59641706362558;4.174954806800768;0.0067807197541817285;0.6097480081553338;[CDC20, RUVBL1, PSMD3, SKP2, CDC25A, CFTR, PSMD14, ADRB2, GATA3, NLRP3, CLSPN, BARD1, NFKBIA, COPS5, CDK1, TNFAIP3, BRCA1, ARRB2, IFIH1, DDX58, ACTL6A, PSMA5, CCNA2, PSMA6, PSMA3, PSMA4, PSMA2, BIRC2, BIRC3, USP18, FAM105A, USP1, IL33, USP9Y, PSMC6, TNIP3, PSMC2, EIF3F]
GO:0045717;negative regulation of fatty acid biosynthetic process;8.0;0.8436909121759173;0.7968454560879586;9.480104247373848;670.1384648150137;7.138016298065211;0.022428931331895798;0.7400384854347593;[CEACAM1, BRCA1, SIRT1]
GO:0045839;negative regulation of mitotic nuclear division;8.0;0.6997970393407541;0.724898519670377;9.076455670192082;276.53900459362586;6.166155715036245;0.009255511614802463;0.6903374900225189;[PLK1, BUB1B, TTK, CENPF, PTTG1, RAD21, CHEK1, TRIP13, AURKAIP1, BUB1, MAD1L1, MAD2L1]
GO:1902065;response to L-glutamate;6.0;0.9326813400603323;0.7894609826203107;9.55953138100517;96.09026658308662;7.474488534686424;0.0032160547469104574;0.7053660038532718;[PCNA, ABCB4, FYN]
GO:0040020;regulation of meiotic nuclear division;7.0;0.609056648853049;0.655447689683725;8.529911963824013;66.11398289201945;6.280566066213989;0.002212775508674272;0.6721078059595746;[LIF, TTK, BRCA2, CDC20, MSH2, FBXO5, TRIP13, PLCB1]
GO:0045835;negative regulation of meiotic nuclear division;8.0;0.7248374789738407;0.7374187394869203;9.271849308553389;325.6023743920082;7.212124270218933;0.010897618447788233;0.7438283705770736;[MSH2, LIF, TTK, FBXO5, TRIP13, BRCA2]
GO:0007517;muscle organ development;4.0;0.7763722522362496;0.6381861261181248;8.753055515138222;27.682183388997124;5.085725745451326;9.264977656821302E-4;0.5100842511328143;[ACHE, TAGLN, LAMA2, TWIST1, AEBP1, SGCE, BASP1, DMD, MEF2A, MEF2C, EGR3, ETV1, IGF1, SIRT1, CXCL10, CENPF, ITGA7, COL6A3, HBEGF]
GO:0006309;apoptotic DNA fragmentation;9.0;1.0;0.896240625180289;9.628524252492122;682.1166149099336;7.004484905440688;0.022829829235937554;0.7544503089863854;[FEN1, HMGB2]
GO:0010800;positive regulation of peptidyl-threonine phosphorylation;10.0;1.0;0.9152410118609203;9.628524252492122;778.6672313762616;6.375876246018314;0.026061291479152104;0.7413036195908642;[TGFB1, EGF, RIPK2, PLK1, AZU1, CHI3L1, CALM3]
GO:0085020;protein K6-linked ubiquitination;11.0;1.0;0.9324289523296623;9.628524252492122;157.60047254366168;7.697632086000634;0.00527474598481953;0.8260862151842345;[BARD1, UBE2S, UBE2T, RNF6, BRCA1]
GO:0018108;peptidyl-tyrosine phosphorylation;9.0;0.811012628672052;0.801746939516315;9.414950152194063;338.33129968976414;4.530049555519983;0.011323644122215096;0.627907570118429;[IL5RA, SLA, SLA2, FGF5, EFEMP1, GRAP2, EPHB2, EPHB1, PDGFRB, PDGFRA, MAP2K2, PRKCD, MATK, EREG, BTC, MELK, BTK, EPHA3, EPHA2, BLK, CSF1R, TXK, CSF2RB, CSF2RA, MAP2K6, LYN, LIF, EIF2AK2, BMX, CLK4, PTK2, CLK1, FES, ITK, GHR, JAK3, SYK, RIPK2, IL15, FGR, ZAP70, HCK, LCK, KIT, IL3RA, HBEGF, TTK, FYN, CSK, IL12RB2, EGF, TIE1, WEE1, PTPN6, TEK]
GO:0060045;positive regulation of cardiac muscle cell proliferation;10.0;1.0;0.9152410118609203;9.628524252492122;720.414482973016;6.641579411751319;0.024111624414165377;0.7548916918429109;[TGFBR3, MEF2C, CCNB1, CDK1, MAPK14]
GO:0000819;sister chromatid segregation;5.0;0.8933024483968273;0.736892236059334;9.427853557029971;40.65143508701015;6.221725566191056;0.0013605669484458803;0.6084203466557585;[TOP2A, SPAG5, MIS12, PLK1, CDCA8, SMC1A, TUBG1, SMC4, ZWINT, NDC80, KIF18A, KIF18B, ESPL1, KIFC1, NUSAP1, NEK2, RAN, MAD2L1]
GO:0003091;renal water homeostasis;7.0;1.0;0.8509193652572005;9.628524252492122;57.14336741787613;6.311337724880743;0.0019125370817844765;0.6736814700148209;[WFS1, CYP4F2, CYP4A11, CYP4F12, AQP1, ADCY9, PRKAR1B, PRKAR2B, PRKACB]
GO:0006366;transcription by RNA polymerase II;10.0;0.6039883530135606;0.7172351883677006;8.613793447804714;583.8786478812184;3.2909128387363804;0.01954189288791682;0.5835384474769965;[EHF, SPI1, CCNH, SPIB, MYB, HOXA7, JUNB, HOXA5, SOX4, MEF2A, MED1, MEF2C, HOXB3, HOXB2, HOXB7, ATF3, HOXB5, TXK, GATA3, GATA1, NHLH2, RAD21, EGR1, EGR2, JUN, BCL11B, FOSL2, FOSL1, TGFB1I1, BRCA1, HOXC10, PAX5, FOS, SIRT1, PAX2, PLSCR1, TFEC, SATB2, FLNA, CDX2, CDX1, GTF2H1, GRHL2, POU4F1, FOSB, TRIP13, CCNT2, ARID4A, ETS1, HOXA10, PTTG1, LMO2, C5AR1, HMGA1, NFKB1, NFKB2, COPS5, MAFB, FEV, MAFF, ARRB1, ARRB2, MYBL2, MYBL1, MYOCD, KLF13, NCBP2, ETV1, TFDP1, ELF3, IRF7, CREB5, CEBPA, CEBPB, CEBPD, CEBPE, TAF9, LEF1, POLR2E, POLR2I, POLR2J, POLR2K, POLR2L, PRRX1, KLF4, MEIS2, MEIS1, KLF6, KLF5, POU2AF1, TAF5, RBMX]
GO:1904778;positive regulation of protein localization to cell cortex;8.0;0.8653626801206646;0.8076813400603323;9.474373572664863;109.22370981396446;8.16763571524637;0.003655619272516407;0.7926932703116032;[GPSM2, GNAI1]
GO:0006367;transcription initiation from RNA polymerase II promoter;9.0;1.0;0.896240625180289;9.628524252492122;477.15162764714074;4.629579150867016;0.015969835568764485;0.6329975182530758;[CCNH, RORA, CCNC, NR3C2, CTGF, MED1, NRBP1, RUNX2, MAML3, MAZ, VDR, NR4A2, NR4A1, NR4A3, TCF4, CDKN1A, HNF4G, HNF4A, MED23, RARA, YAP1, TAF9, NR1I2, RXRA, POLR2E, E2F2, POLR2I, POLR2J, POLR2K, POLR2L, NR1H2, NR1H4, GTF2H1, TAF5]
GO:0071295;cellular response to vitamin;7.0;0.7436939687323844;0.7227663496233927;9.033817144745429;139.32535531563298;6.781341354126479;0.004663094257735114;0.6977174774718518;[COL1A1, POSTN, BRIP1, IL15, TNC]
GO:0051445;regulation of meiotic cell cycle;5.0;0.5498737448241444;0.5651778842729924;7.5284634236095505;25.888472835594534;5.8650506222523235;8.664638876944386E-4;0.5901799734356507;[TTK, BRCA2, CDC20, PPP2R1A, FBXO5, PRKACB, DUSP1, LIF, CDC25C, CDC25A, ASPM, MSH2, CDK1, TRIP13, PLCB1]
GO:0072383;plus-end-directed vesicle transport along microtubule;9.0;0.9326813400603323;0.8625812952104552;9.584072489921288;265.6185688795062;7.8311634786251565;0.00889001445920495;0.7967266896635242;[KIF23]
GO:0098535;de novo centriole assembly involved in multi-ciliated epithelial cell differentiation;7.0;1.0;0.8509193652572005;9.628524252492122;68.46281579932104;8.16763571524637;0.00229138883226928;0.7686126355688037;[PLK4, CEP152]
GO:0017148;negative regulation of translation;8.0;0.6493065804076676;0.6996532902038338;9.081980546124052;1114.6737408694362;4.99795013456894;0.03730712696566269;0.6305954023103058;[BTG2, FMR1, IGFBP5, DAPK1, SRP9, BANK1, RARA, TYMS, PURA, EIF2AK2, EIF2S1, DHFR, LIN28A, CNOT3, EIF3E]
GO:0010972;negative regulation of G2/M transition of mitotic cell cycle;9.0;0.811012628672052;0.801746939516315;9.394909401310617;357.14964968422294;5.926926025970411;0.011953477361114177;0.699343897778663;[BLM, BRCA1, AURKB, AURKA, RAD21, TOPBP1, NAE1, CLSPN, FANCI, DONSON, CDC6, MSH6, CDK1]
GO:0010971;positive regulation of G2/M transition of mitotic cell cycle;9.0;0.8933024483968273;0.8428918493787028;9.52844079393514;355.9636244052406;6.481236761676141;0.011913782162380092;0.7276913745807394;[SMARCD3, VPS4B, CDC7, CDC25C, CDC25A, CCNB1, RAD51C, CDK1, DTL]
GO:1900182;positive regulation of protein localization to nucleus;7.0;0.8436909121759173;0.7727648213451592;9.36615998802463;74.62336946219564;5.446340287394138;0.0024975770192273523;0.6294454608352614;[LRRK2, CDH1, AKT1, CCT3, CCT2, MED1, PRKCD, PARP9, IFNG, HCLS1, PTGS2, FYN, CCT8, CCT7, ECT2, CCT5, CCT4, TGFB1, JUP, PLK1, LIF, IGF1, MAPK14, CCT6A, CDK1]
GO:1902480;protein localization to mitotic spindle;8.0;0.9326813400603323;0.8413406700301662;9.533214072687796;35.99248463016168;9.777073627680469;0.0012046360694383546;0.875;[FAM83D]
GO:0000707;meiotic DNA recombinase assembly;8.0;0.8259837884571596;0.7879918942285797;9.405380701177911;133.9647452985807;7.697632086000634;0.004483679464700174;0.7686572628545723;[RAD51, RAD51C]
GO:0000706;meiotic DNA double-strand break processing;8.0;0.8933024483968273;0.8216512241984136;9.533214072687796;173.9732844268755;7.9853141584524145;0.005822729263976651;0.7833693374183408;[BLM, BRIP1, EXO1]
GO:0044806;G-quadruplex DNA unwinding;7.0;1.0;0.8509193652572005;9.628524252492122;23.726073882073138;7.8311634786251565;7.940903407527885E-4;0.7514054297404357;[BLM, DNA2]
GO:0007344;pronuclear fusion;6.0;1.0;0.8231203125901445;9.628524252492122;29.37726267204044;9.777073627680469;9.832305438132773E-4;0.8231203125901445;[CDK1]
GO:1904668;positive regulation of ubiquitin protein ligase activity;12.0;1.0;0.9481203125901445;9.628524252492122;754.3373369627636;7.212124270218933;0.025246991808615726;0.8169486831672182;[CDC20, UBE2C, UBE2S, PLK1, MASTL]
GO:1904667;negative regulation of ubiquitin protein ligase activity;12.0;1.0;0.9481203125901445;9.628524252492122;755.449957599424;7.57984905034425;0.025284230220031186;0.835754145523778;[FBXO5, MAD2L1]
GO:0007100;mitotic centrosome separation;4.0;1.0;0.75;9.628524252492122;26.82333357677892;7.9853141584524145;8.977528353818361E-4;0.6583693374183408;[NUP62, KIF11, AURKA]
GO:0007221;positive regulation of transcription of Notch receptor target;12.0;1.0;0.9481203125901445;9.628524252492122;1467.8987330058965;6.8867018697843045;0.04912924957061573;0.8003065664753022;[PLXND1, STAT1, MAML3, DLGAP5]
GO:0071163;DNA replication preinitiation complex assembly;7.0;0.8653626801206646;0.7836007053175329;9.387362195675234;77.2272886234996;8.67846133901236;0.002584727850181096;0.7947362817240173;[CDT1, CDC45, GMNN]
GO:0010629;negative regulation of gene expression;6.0;0.471430776349301;0.558835700764795;6.738152494595957;59.04642522059629;2.349334787147576;0.001976230713800692;0.44326540286011196;[SPI1, EHMT2, SLA2, AKT1, MEF2A, MEF2C, ATF3, GATA3, IQGAP3, GATA1, HESX1, JUN, EIF2AK2, NR2F2, DHFR, PKIG, EZH2, SIRT1, SRP9, MMP12, BTAF1, FLNA, STAT1, CENPF, LGR4, GMNN, CTGF, FOXO1, SBNO2, ZNF423, NFKB1, NFKB2, CIITA, LRRK2, FHL2, PIK3CD, FASLG, FOXM1, HHEX, ITGB8, PEG3, BIRC5, BIRC2, BIRC3, UHRF1, E2F1, FYN, E2F7, E2F8, PRRX1, EIF3E, IKZF1, UXT, HNF1B, MIF, EREG, SFRP2, IFI27, KCNQ1, NAIP, GSPT1, BRIP1, PCBP3, A2M, CCR1, EGR1, MSR1, ID1, CD28, SUV39H2, SUV39H1, CTSZ, PTPRK, BRCA1, CD3E, BMI1, CD38, CD36, CD34, BANK1, IL1B, DEPDC1, SATB2, RELB, RXRA, NEDD4, LOXL2, EOMES, CCNE1, CALCA, TCF7, CCNB1, VDR, CAV1, HMGA1, BMP2, UBA3, MXD1, HMGB2, MYOCD, NCBP2, GREM1, ELF3, IRF7, IRF8, FBP1, AURKB, TBX21, SERPINE1, PHB2, MYB, HOXA2, HOXA7, JUNB, MED1, DAPK1, HOXB4, HOXB3, SERPING1, NEDD4L, PRDM16, ELANE, BARD1, FZD1, NDFIP2, PLK1, FZD8, UPF3B, SNAI2, CDKN1A, BTG2, HAVCR2, HELLS, PAWR, PAX5, PAX2, AES, ZEB1, TAL1, RARA, GAS1, HCLS1, PLCB1, ENG, NR1I2, ASCL2, NR1H2, NR1H4, POU4F1, FOSB, FMR1, TNF, DACH1, MEN1, TLE4, MAP2K2, IGFBP5, DNMT1, AEBP1, NACC2, WFS1, LSM5, LSM3, DAB2, BCL6, CNOT3, BCL3, CDK2, PTPN22, EMILIN1, CR1, RFC1, PTBP2, XCL1, CEBPA, CEBPB, HDAC2, NLRC4, RBBP8, ZNF503, KLF4, PML, KLF8, KLF5, DNAJA3, GFI1, ZNF608, EDNRB, PPP2R1A, MAGOH, DPF3, SOX7, SOX4, IL1R2, RUNX2, TWIST1, BCL11A, IFNA2, XPO1, HBZ, EDN1, PARP9, CBFA2T3, NME1, MDFIC, SP100, TYMS, AIF1, PURA, APBB1, CDX2, MLH1, LILRB4, ARID4A, CHCHD3, BASP1, TIMELESS, TGFB2, TGFB1, CBX4, EIF2S1, NR4A2, LIN28A, NR4A3, CREBZF, KLF12, H2AFX, IFNG, PFDN5, LEF1, THBS1, SNCA, MEIS2, RBMX]
GO:0051574;positive regulation of histone H3-K9 methylation;11.0;0.8933024483968273;0.8790801765280758;9.571365838652174;804.3299673530898;7.474488534686424;0.02692020015733362;0.8146746435927894;[MYB, BRCA1, SIRT1]
GO:0071283;cellular response to iron(III) ion;7.0;1.0;0.8509193652572005;9.628524252492122;96.28817659807011;9.083926447120524;0.003222678617004505;0.8154717862087246;[CCNB1]
GO:0070194;synaptonemal complex disassembly;6.0;1.0;0.8231203125901445;9.628524252492122;39.82835148474282;9.083926447120524;0.0013330190810051427;0.7876727335416686;[PLK1]
GO:0031427;response to methotrexate;5.0;0.9326813400603323;0.7565816818910864;9.548481544818586;103.34292003900198;8.390779266560578;0.0034587945311156006;0.7193458537639684;[DHFR]
GO:0051572;negative regulation of histone H3-K4 methylation;11.0;0.9326813400603323;0.8987696223598284;9.59953671561887;804.8473500351352;8.390779266560578;0.026937516490087493;0.8615337942327104;[BRCA1]
GO:0071168;protein localization to chromatin;7.0;0.7369933605727446;0.7194160455435727;8.935377071932177;34.71951895434896;6.832634648514029;0.001162031053863633;0.7003406189322132;[RUVBL2, RAD21, PLK1, ESCO2, EZH2]
GO:0051573;negative regulation of histone H3-K9 methylation;11.0;0.8933024483968273;0.8790801765280758;9.571365838652174;805.1350321075869;7.57984905034425;0.026947144950155395;0.8200627852632958;[DNMT1, PAX5, BRCA1, SIRT1]
GO:0010628;positive regulation of gene expression;6.0;0.4705935272257725;0.5584170762030307;6.666693530613812;58.797024432214236;2.2471302570788807;0.001967883493859682;0.43803865843940215;[PID1, SPI1, SPIB, AKT1, MEF2A, MEF2C, PADI2, ATF3, GATA3, IQGAP3, GATA1, C3, JUN, JAG1, JUP, FN1, AZU1, NR2F2, COL1A1, LRRC32, HOXC10, DLGAP5, RIPK2, FOS, SIRT1, MMP12, PLSCR1, CKS2, PTAFR, STAT4, SPP1, STAT1, ATAD2, PSMC6, PSMC2, LGR4, CCNT2, NCF1, RORA, CTGF, RUVBL2, ADCYAP1, PKP3, BLM, FOXO1, SBNO2, ZNF423, NFKB1, NFKB2, CXCL10, MYD88, CIITA, FHL2, PIK3CD, ARRB1, ARRB2, FOXM1, HHEX, ITGB8, PPP1R12A, PEG3, PPP1R15A, UHRF1, CCL5, E2F1, E2F2, E2F5, E2F7, E2F8, PRRX1, POU2AF1, EIF3E, EIF3D, CCNH, CCNC, IKZF1, TNFSF11, EPHB2, HNF1B, SFRP4, SFRP2, EGR1, EGR2, EGR3, IGF1, ID1, CD28, CD40, HNF4G, BRCA1, BRCA2, CD3E, CD3D, HNF4A, CTSH, CD38, CD36, CD34, IL10, IL18, RGMA, IL1A, IL1B, KIT, YAP1, SATB2, RELB, RXRA, CD74, IL33, OSM, FOXA3, IL17A, FOXA2, CD86, CD80, IHH, ETS1, ACTG2, EOMES, CCNE1, CCNB1, VDR, CAV1, HMGA1, INHBA, IL6, BMP2, NAT8, TCF4, IL7R, HMGB2, ARHGEF10L, LYL1, NUP62, MYBL2, MYBL1, YWHAH, MYOCD, DDX58, NCBP2, ETV1, ACTA2, CCNA2, GREM1, PSRC1, ELF3, IRF7, IRF8, CREB5, TAF9, RNF6, TBX21, RBM38, EGF, MAPK14, CD4, TNIP3, NAA15, RAN, EHF, SERPINE1, MYB, HOXA3, HOXA2, HOXA7, JUNB, HOXA5, MED1, HOXB9, HOXB4, HOXB3, HOXB2, MAML3, HOXB7, HOXB5, PRKDC, NUP85, RAD21, PRDM16, NKX2-3, FZD1, NFE2, FZD2, FZD5, FZD8, UPF3B, FOSL2, FOSL1, TGFB1I1, PAWR, SERPINB9, PAX5, PAX2, ZEB1, TAL1, RARA, HCLS1, PLCB1, ENG, NR1I2, FAM129A, EPCAM, GSN, NR1H2, NR1H4, GTF2H1, POU4F1, PLP1, FOSB, PF4, CSF3, PLXND1, FMR1, TNC, TNF, CLU, CDH3, CDH1, LAMP3, MEN1, MAP2K2, F2R, ADAM2, ADAM8, DNMT1, DAB2, COPS5, MAFB, MAFF, BCL3, CDK2, CDK1, PTPN22, CYR61, LBH, EMILIN1, RFC1, CHUK, TFDP1, CEBPA, CEBPB, HDAC2, SMARCD3, CEBPD, CEBPE, NOD2, ABLIM3, POLR2E, POLR2K, POLR2L, KLF4, PML, KLF1, KLF6, KLF5, GFI1, CHEK1, RPS6KA1, DPF3, SOX7, SOX4, SLC11A1, EBF1, FLT3LG, RUNX2, NIF3L1, IL23A, BEX1, TXK, TWIST1, NHLH2, BCL11B, LIF, TOP2A, IFNA2, PRL, EPB41L4B, EDN1, RHOG, PARP9, MDFIC, TFEC, TLR6, TLR4, TLR2, SP100, APBB1, CDX2, CDX1, LILRB1, GRHL2, CAMK4, F2RL1, CAMK1, ARID4A, ARID4B, HOXA11, HOXA10, LMO2, HGS, ADRB2, STAP1, NLRP3, TGFB2, TGFB1, NR4A2, NFKBIA, NR4A1, LIN28A, NR4A3, FEV, SLC40A1, CKS1B, KLF13, CKAP2, AXIN2, DCN, DNM2, IFNG, LEF1, DLL1, THBS1, LUM, MEIS2, MEIS1, RPS6KB1, RBMX]
GO:0051571;positive regulation of histone H3-K4 methylation;11.0;0.9326813400603323;0.8987696223598284;9.59953671561887;804.0422852806381;7.004484905440688;0.026910571697265715;0.7906386361357586;[DNMT1, MYB, BRCA1]
GO:0097338;response to clozapine;5.0;1.0;0.7902410118609202;9.628524252492122;76.04989429310582;9.083926447120524;0.002545321521528919;0.7547934328124444;[PRKAR2B, PRKACB]
GO:0032873;negative regulation of stress-activated MAPK cascade;11.0;0.8436909121759173;0.8542744084176208;9.56534535087059;1526.0559120613332;6.039404009397101;0.051075718015538125;0.7412843542312382;[PTPN22, FOXM1, FOXO1, DUSP10, PBK, AKT1, MEN1, DUSP3, SFRP2, F2RL1, ZMYND11]
GO:0018105;peptidyl-serine phosphorylation;9.0;0.7369933605727446;0.7647373054666613;9.207310787415818;338.73676479787366;4.61801832846594;0.011337214674488616;0.6324062972578516;[, AKT1, STK32B, MAP2K2, PRKCH, PRKCB, PRKCE, PRKCD, VRK1, PRKCQ, PRKDC, PRKCZ, CCNB1, CLSPN, PLK2, PLK1, CDC7, CLK1, CDK2, CDK1, BCL2, LRRK2, MAP4K1, CHUK, SYK, MASTL, SGK1, CAMK2D, TTK, AURKB, AURKA, MAPK14, MAPK13, RPS6KB1, CAMK4, PKN1, CAMK1]
GO:0032877;positive regulation of DNA endoreduplication;10.0;1.0;0.9152410118609203;9.628524252492122;1140.1023815324472;9.083926447120524;0.03815820068436285;0.8797934328124444;[E2F7, E2F8]
GO:0018107;peptidyl-threonine phosphorylation;9.0;0.7671156992804218;0.7797984748205;9.305750860229072;337.99482745314367;5.395046993006588;0.011312382699260763;0.6721435792979885;[LRRK2, CHEK1, AKT1, PRKCB, PRKCD, CAD, VRK1, CAMK2D, TTK, CLK1, CDK1, BCL2, PKN1, CAMK1]
GO:0010862;positive regulation of pathway-restricted SMAD protein phosphorylation;10.0;1.0;0.9152410118609203;9.628524252492122;1012.5567145242198;5.905872616772578;0.033889361993245395;0.7172676121338334;[TGFB2, TGFB1, TTK, INHBA, BMP2, DAB2, ENG]
GO:1900195;positive regulation of oocyte maturation;9.0;0.9326813400603323;0.8625812952104552;9.589303539338841;598.4140132004883;9.083926447120524;0.020028378484173288;0.8607930461318132;[AURKA]
GO:0000915;actomyosin contractile ring assembly;8.0;0.9326813400603323;0.8413406700301662;9.567899630675686;135.1741411845403;7.9853141584524145;0.004524156856617609;0.7833693374183408;[ANLN, RACGAP1, KIF23]
GO:0044818;mitotic G2/M transition checkpoint;10.0;0.8933024483968273;0.861892236059334;9.551563211355994;492.819650181817;6.343086423195323;0.016494230182695288;0.7396267465268138;[FANCI, BLM, DONSON, CDC6, BRCA1, MSH6, CDK1, TOPBP1, NAE1, CLSPN]
GO:0006342;chromatin silencing;11.0;0.7763722522362496;0.820615078447787;9.454170865347344;1752.5176526080036;5.433268205826786;0.058655188669300654;0.7102865410484548;[SUV39H1, BMI1, HELLS, H2AFX, SIRT1]
GO:0006468;protein phosphorylation;7.0;0.5708408884191841;0.6363398094667926;8.175090588534603;177.75756772840523;2.970244267288293;0.005949385820444992;0.5028177952168079;[, SLA2, MYLK, AKT1, PRKACB, MEF2A, MED1, MEF2C, PRKCH, DAPK1, PRKCB, PRKCE, PRKCD, PRKAR1B, PRKCQ, PRKDC, PDGFA, THY1, IQGAP3, PRKCZ, LYN, PLK4, PLK2, PLK1, EIF2AK2, CDC7, CDK14, ITK, PBK, JAK3, RIPK2, DUSP6, CIT, RARA, HBEGF, NRAS, IL12RB2, GTF2H1, PKN1, CCNT2, IL5RA, SLA, TNF, FGF5, EFEMP1, GRAP2, MAP3K8, NEK2, STK32B, KCNH1, MEN1, KCNH2, MAP2K2, IGFBP3, VRK1, NRBP1, MELK, BLK, CSF1R, RASAL2, PKMYT1, MAP2K6, NEK7, BMX, NFKB1, CDK6, CDK2, CDK1, BCL2, LAT, LRRK2, PIK3CD, TLK1, CHUK, SPTB, LCK, IL3RA, BIRC5, PIK3C3, TTK, NOD2, IL2RG, CCL8, CCL5, CCL2, FYN, CSK, TIE1, PML, IL2RB, PTPN6, CCNH, CCNC, CHEK1, RPS6KA1, TNFSF11, EPHB2, EPHB1, PAQR3, EREG, BTC, BTK, SIK1, ALPK2, TRIB1, EPHA3, EPHA2, TXK, LIF, IGF1, PTK2, CTSH, CTSG, CCR5, SPTAN1, MAP4K1, SYK, IL15, STRADB, IL18, GFRA3, HCK, IL1B, KIT, FAM20C, TLR7, SGK1, TLR4, TLR2, GUCY2C, PAK1, PRKY, KITLG, CAMK4, CAMK1, BUB1B, PDGFRB, PDGFRA, MATK, CCNE1, CSF2RB, CSF2RA, RASGRP1, RASGRP4, SPTA1, CCNB1, CLSPN, TGFB2, TGFB1, EIF2S1, CLK4, CLK1, BMP2, FES, GHR, CAD, IRAK3, MASTL, TGFBR3, FGR, CCNA2, ZAP70, SHANK3, CAMK2D, AURKB, AURKA, NCAM1, BUB1, EGF, MAPK14, MAPK13, WEE1, RPS6KB1, TEK]
GO:0009615;response to virus;5.0;0.7436939687323844;0.6620879962271125;8.801845679307654;27.267803904038782;4.174954806800768;9.126288572378991E-4;0.503748394835965;[CHRM2, IFITM1, FMR1, PRF1, ADARB1, IFIT1, TNF, CLU, IFIT3, IFIT2, PYCARD, HERC5, STMN1, DHX58, TRIM25, IFNA14, RSAD2, IFNA16, RNASE6, RNASE2, IL23A, IFNA10, GATA3, DDX60, NLRP3, IFNA21, HMGA1, EIF2AK2, ISG15, AZU1, DEFA1, FOSL1, CXCL10, IL6, CXCL12, PTPRC, CDK6, BCL3, BCL2, SERINC5, APOBEC3A, BCL2L1, APOBEC3B, IFNA5, CREBZF, IFNA4, IFNA7, CXCL9, CD40, IFNA2, IFNA8, OASL, IFIH1, CHUK, IFNGR1, DDX58, IFNGR2, IRAK3, PARP9, MMP12, ACTA2, EEF1G, FGR, PLSCR1, IFNG, OAS1, PSMA2, NPC2, OAS3, IRF7, TLR8, XCL1, TLR7, ZMYND11, EXOC1, UNC93B1, CXCR4, SAMHD1, CCL8, CCL5, TBX21, CCL4, CCL19, CCT5, IL33, STAT1, MX2, CARD9, LILRB1, MAPK14, PML, F2RL1]
GO:0006227;dUDP biosynthetic process;12.0;1.0;0.9481203125901445;9.628524252492122;6271.9915988638395;9.083926447120524;0.2099179143880009;0.9126727335416687;[DTYMK]
GO:0042754;negative regulation of circadian rhythm;4.0;0.8259837884571596;0.6629918942285797;9.040737587590003;21.64841646219066;7.069023426578259;7.245530166796041E-4;0.6115101867784198;[SUV39H2, SUV39H1]
GO:0006346;methylation-dependent chromatin silencing;12.0;1.0;0.9481203125901445;9.628524252492122;1936.9706715625437;7.212124270218933;0.06482866521676948;0.8169486831672182;[HELLS, SIRT1]
GO:0051225;spindle assembly;7.0;0.7508913569872202;0.7263650437508107;9.168991923113682;86.84099814437;5.266214121163619;0.00290649005606778;0.6202338003175094;[KIF11, AURKA, CDC20, FLNA, NEK2, MYBL2, FBXO5, CENPW, NEK7, TUBG1, ASPM, TPX2, KIFC1, BIRC5, BIRC2, BIRC3]
GO:0031536;positive regulation of exit from mitosis;9.0;1.0;0.896240625180289;9.628524252492122;562.0425168150831;8.16763571524637;0.018811057232375368;0.8139338954918922;[TGFB1, UBE2C, CDCA5, PHB2]
GO:0097421;liver regeneration;6.0;1.0;0.8231203125901445;9.628524252492122;47.21654787453615;6.250713103064308;0.0015802953652264606;0.6427820713687392;[IL10, CEBPB, PCNA, TGFB1, IHH, TYMS, SULF2, AURKA, NFKBIA, HMOX1, EZH2]
GO:0032508;DNA duplex unwinding;7.0;0.7980440201809971;0.7499413753476991;9.223059144383958;23.726073882073138;5.734022359845919;7.940903407527885E-4;0.64415753539903;[BLM, MCM7, RAD54B, PURA, BRIP1, CDC45, RUVBL2, RUVBL1, GINS1, GINS2, ANXA1, GINS4, HMGA1, RPA1, RAD50, RAD51, MCM4, MCM6, DNA2, MCM2]
GO:0099606;microtubule plus-end directed mitotic chromosome migration;6.0;1.0;0.8231203125901445;9.628524252492122;45.439948165668724;9.777073627680469;0.0015208341718066008;0.8231203125901445;[CENPE]
GO:0010951;negative regulation of endopeptidase activity;10.0;0.7671156992804218;0.7987988615011312;9.446202695698167;500.3238742612354;4.2676852910524925;0.016745389809270216;0.6334906361130068;[PROS1, SERPINE1, SPINT2, AQP1, PTTG1, LAMP3, RPS6KA1, AKT1, APLP2, POR, SFRP2, SPINT1, SLPI, SERPING1, NAIP, C3, SFN, A2M, TNFSF14, TNFRSF10C, CRIM1, TNFRSF10B, DHCR24, VIL1, CD27, TNFAIP8, SERPINA1, ARRB1, ARRB2, TIMP2, TIMP3, TIMP1, CR1, SERPINB2, GPX1, PLAUR, SERPINB9, TNFRSF1B, MMP9, PAX2, COL6A3, BIRC5, BIRC2, LTF, BIRC3, SERPINB10, CSTA, LEF1, IFI6, NLRC4, PTGS2, CST7, THBS1, CST3, SPOCK3, SNCA, KLF4, FABP1]
GO:0099607;lateral attachment of mitotic spindle microtubules to kinetochore;5.0;1.0;0.7902410118609202;9.628524252492122;28.61509304600606;9.777073627680469;9.577214123380371E-4;0.7902410118609202;[CENPE]
GO:0010833;telomere maintenance via telomere lengthening;8.0;0.9326813400603323;0.8413406700301662;9.590783924509275;185.09737597092234;6.409777797693995;0.00619504259692348;0.7027963346592216;[RFC1, RPA1, RAD50, RAD51]
GO:0051106;positive regulation of DNA ligation;8.0;0.9326813400603323;0.8413406700301662;9.57973408832269;378.6008333431687;8.16763571524637;0.012671429173367173;0.7926932703116032;[RAD51]
GO:0042769;DNA damage response, detection of DNA damage;5.0;0.7866048967936545;0.6835434602577475;9.143016436710422;39.83823472227698;6.139487467954083;0.0013333498640710748;0.6042146864874571;[PCNA, POLD3, POLD1, USP1, SOX4, RFC5, RFC3, RFC4, RFC1, RFC2, RPA1, RPA2, RPA3, DTL]
GO:1900087;positive regulation of G1/S transition of mitotic cell cycle;9.0;0.9326813400603323;0.8625812952104552;9.577230958104572;354.40743100732976;6.409777797693995;0.011861697769835146;0.7240369598395108;[ANXA1, KCNA5, CDC6, AIF1, CDC45, PLCB1]
GO:0006351;transcription, DNA-templated;9.0;0.5708408884191841;0.6816610693898811;8.449869256150476;581.393741231429;1.9872050686257638;0.019458725298619164;0.49786638480429696;[SPI1, SPIB, MNX1, MEF2A, MEF2C, PADI4, ATF3, CDCA7, GATA3, GATA1, HESX1, MCTS1, JUN, HACE1, EIF2AK2, NR2F2, EZH2, HOXC10, CHAF1B, ACTL6A, FOS, SIRT1, PLSCR1, STAT4, FLNA, ZNF467, CASP8AP2, STAT1, ATAD2, PKN1, CCNT2, RUVBL2, RUVBL1, FOXO1, SBNO2, ZNF423, NFKB1, NFKB2, CIITA, FHL2, FASLG, ARRB1, ARRB2, FOXM1, HHEX, BIRC5, BIRC2, UHRF1, ZBTB41, E2F1, E2F5, E2F7, E2F8, PRRX1, POU2AF1, CCNH, IKZF1, UXT, HNF1B, EREG, BTK, ZNF700, EGR1, EGR2, EGR3, ID1, SUV39H2, SUV39H1, BRCA1, BMI1, DEPDC1, SATB2, RELB, IL33, FOXA3, FOXA2, ETS1, LOXL2, EOMES, TCF7, LPXN, HMGA1, MXD1, PHTF2, HMGB2, AFF3, LYL1, NUP62, MYBL2, MYBL1, MYOCD, NCBP2, ETV1, ELF3, IRF7, IRF8, ZMYND11, CREB5, TAF9, TBX21, MAPK14, MAPK13, TAF5, NAA15, EHF, PHB2, HOXA9, MYB, HOXA3, HOXA2, HOXA7, JUNB, HOXA5, HOXA4, MED1, PRKCB, HOXB9, HOXB4, HOXB3, HOXB2, HOXB7, HOXB6, HOXB5, ASF1B, RAD21, PRDM16, NKX2-3, NFE2, FOSL2, FOSL1, SNAI2, BTG2, TGFB1I1, ZNF367, BRD2, HELLS, PAWR, PAX5, PAX2, AES, ZEB1, TAL1, ASCL2, GTF2H1, POU4F1, FOSB, MEN1, TLE4, DNMT1, AEBP1, NACC2, MAP2K6, HOPX, COPS5, MAFB, BCL6, CNOT3, MAFF, BCL3, LBH, RFC1, TFDP1, CEBPA, CEBPB, HDAC2, SMARCD3, CEBPD, CEBPE, ABLIM3, POLR2E, ZNF503, POLR2I, POLR2J, POLR2K, POLR2L, IRX3, KLF4, PML, KLF1, KLF8, KLF6, KLF5, MNDA, GFI1, ZNF608, DPF3, SOX7, SOX4, EBF1, TXK, TWIST1, NHLH2, BCL11B, BCL11A, CBFA2T3, MDFIC, TFEC, SP100, PURA, APBB1, CDX2, CDX1, GRHL2, TRIP13, ARID4A, ARID4B, HOXA11, HOXA10, CHCHD3, PTTG1, LMO2, COL4A2, TIMELESS, C5AR1, NLRP3, CBX4, NR4A2, FEV, CREBZF, KDM5D, KLF12, KLF13, LTF, LEF1, HLX, MEIS2, MEIS1, RBMX]
GO:1905775;negative regulation of DNA helicase activity;9.0;0.9326813400603323;0.8625812952104552;9.585964638073326;205.113589991404;9.777073627680469;0.006864967266765914;0.896240625180289;[MCM2]
GO:0006470;protein dephosphorylation;7.0;0.7586651285174919;0.7302519295159464;9.223059144383958;177.1697810635027;4.458953633836253;0.005929713129744359;0.5789504614541361;[PPP2R1A, CDC25C, CDC25A, PTPRE, PTPRC, BCL2, PTPRR, PTPN22, PTPRK, DUSP10, DLGAP5, DUSP2, PPP1R12A, DUSP3, DUSP1, DUSP6, LCK, PPP1R15A, TPTE, CPPED1, PPP1CA, PTPN6, PTPN7, PTPN4, CDKN3]
GO:0006233;dTDP biosynthetic process;12.0;1.0;0.9481203125901445;9.628524252492122;6271.9915988638395;9.083926447120524;0.2099179143880009;0.9126727335416687;[DTYMK]
GO:0000921;septin ring assembly;7.0;1.0;0.8509193652572005;9.628524252492122;107.16030555582066;7.069023426578259;0.003586558988939603;0.7124295520356204;[ANLN]
GO:0006355;regulation of transcription, DNA-templated;9.0;0.4043225613388953;0.5984019058497367;6.838723401371219;245.35026186902695;1.5478292109445575;0.008211652463856259;0.4753966830094131;[NUP107, SPI1, SLA2, SPIB, AKT1, MNX1, ATF3, CDCA7, GATA3, GATA1, JUN, JAG1, JUP, EIF2AK2, NR2F2, DHFR, PKIG, HOXC10, CHAF1B, DLGAP5, FOS, MMP12, MED23, PLSCR1, PTAFR, SPP1, ZNF467, CASP8AP2, ATAD2, NOC3L, CENPF, PKN1, LGR4, GMNN, EFEMP1, BLM, G3BP2, ZNF423, CIITA, ITGB2, HHEX, UHRF1, CDC45, E2F1, E2F2, E2F5, E2F7, E2F8, POU2AF1, SMARCAL1, IKZF1, ICAM1, TNFSF11, TRIM25, FBXO5, BTK, TRIB1, TGFA, PKHD1, BRIP1, EGR1, EGR2, EGR3, IGF1, POLA1, ECM1, IL10, SYK, IL18, IL1A, IL1B, KIT, DEPDC1, YAP1, PCNA, RELB, IL33, OSM, ETS1, NR3C2, LOXL2, CARD11, TCF7, HTRA1, LPXN, CAV1, UBA3, TCF4, MXD1, FBN1, PHTF2, PLEK, TNFAIP3, LYL1, MYBL2, MYBL1, MYOCD, NUP133, IRAK3, ETV1, GREM1, ELF3, ZMYND11, FBP1, RNF6, TBX21, RRM2, CD4, TNIP3, PHB2, PRKCH, PRKCB, PRKCQ, PRKDC, PRKCZ, NUP85, PRDM16, HMOX1, NFE2, PLK1, FOSL2, FOSL1, SNAI2, CDKN1A, BTG2, ZNF367, HELLS, ZEB1, RARA, NR1I2, ASCL2, EPCAM, NR1H2, NR1H4, ELP4, FOSB, PF4, CSF3, PLXND1, TNF, CLU, TLE4, MAP2K2, AEBP1, MAP2K6, DAB2, COPS5, BCL6, BCL3, CCDC22, SLC26A3, CYR61, LBH, EMILIN1, RFC1, TFDP1, XCL1, CEBPA, CEBPB, HDAC2, CEBPD, CEBPE, NLRC3, NLRC4, NOD2, ABLIM3, POLR2K, POLR2L, PML, DNAJA3, PPIL4, GFI1, PPP2R1A, RPS6KA1, FLT3LG, NIF3L1, IL23A, SIK1, NBL1, TXK, TWIST1, LIF, TOP2A, AHCTF1, IFNA2, PRL, XPO1, HBZ, EDN1, PARP9, CBFA2T3, VAV1, MLF2, HCK, TLR6, TLR4, TLR2, TYMS, PURA, APBB1, GRHL2, CD40LG, F2RL1, HOXA11, HOXA10, LMO2, FANCD2, TIMELESS, NLRP3, CBX4, KDM5D, SLC40A1, H2AFX, DCN, DNM2, PFDN5, LTF, LEF1, HLX, SNCA, LUM, RBMX, PID1, EHMT2, MEF2A, MEF2C, ZFYVE16, PADI2, PADI4, HESX1, MCTS1, HACE1, COL1A1, EZH2, RIPK2, ACTL6A, SIRT1, PSMA6, CKS2, FSTL1, BTAF1, STAT4, FLNA, STAT1, USP9Y, PSMC6, PSMC2, CCNT2, NCF1, RORA, RUVBL2, RUVBL1, ADCYAP1, S100A9, S100A8, MAZ, TNFRSF11A, FOXO1, SBNO2, NFKB1, NFKB2, CXCL10, MYD88, FHL2, FASLG, ARRB1, ARRB2, FOXM1, PPP1R12A, PEG3, BIRC5, BDP1, BIRC2, LRP2, ZBTB41, PRRX1, CCNH, CCNC, UXT, TMPO, HNF1B, EREG, SFRP4, SFRP2, IFI27, PCBP3, ZNF700, OR7D2, ID1, CD28, SUV39H2, CD40, SUV39H1, HNF4G, PTPRK, BRCA1, BRCA2, PCSK6, BMI1, CD3D, HNF4A, CD38, CD36, RGMA, SATB2, RXRA, CD74, NLRP12, NEDD4, FOXA3, IL17A, FOXA2, CD86, CD80, IHH, EOMES, CCNE1, CALCA, VDR, HMGA1, INHBA, IL6, BMP2, HMGB2, ARHGEF10L, AFF3, NUP62, YWHAH, DDX58, CCNA2, PSRC1, IRF7, IRF8, CREB5, TAF9, AURKB, EGF, MAPK14, SOD2, MAPK13, NUP35, TAF5, NAA15, RAN, EHF, SERPINE1, HOXA9, MYB, HOXA3, HOXA2, CYP1B1, HOXA7, JUNB, HOXA5, HOXA4, MED1, HOXB9, HOXB4, HOXB3, HOXB2, MAML3, HOXB7, HOXB6, HOXB5, ASF1B, NEDD4L, RAD21, S100A12, ELANE, NKX2-3, FZD1, FZD2, FZD5, FZD8, CDC6, TGFB1I1, HAVCR2, BRD2, ANXA3, NFAM1, PAWR, PAX5, PAX2, AES, TAL1, HCLS1, PLCB1, ENG, GTF2H1, SULF1, POU4F1, PYCARD, DACH1, CDH1, MEN1, F2R, ADAM8, DNMT1, NACC2, WFS1, HOPX, MAFB, CNOT3, MAFF, CDK2, CHUK, TRAF1, SMARCD3, RBBP8, ZNF503, IRX3, KLF4, KLF1, KLF8, KLF6, KLF5, MNDA, ZNF608, EDNRB, CHEK1, DPF3, SOX7, SOX4, SLC11A1, EBF1, RUNX2, PFN1, BEX1, SP140, NHLH2, CDT1, BCL11B, BCL11A, RHOG, RHOH, MDFIC, TFEC, SGK1, SP100, CDX2, CDX1, LILRB1, LILRB4, CAMK4, CAMK1, ARID4A, ARID4B, CHCHD3, PTTG1, BASP1, ADRB2, TGFB2, TGFB1, NR4A2, NFKBIA, NR4A1, LIN28A, NR4A3, FEV, JMY, NFKBID, CREBZF, CKS1B, TMEM100, KLF12, KLF13, CKAP2, TGFBR3, IFNG, CAMK2D, DLL1, HSPD1, MEIS2, MEIS1]
GO:0006231;dTMP biosynthetic process;12.0;0.9326813400603323;0.9144609826203107;9.610505746989444;6271.9915988638395;8.390779266560578;0.2099179143880009;0.8772251544931927;[TYMS]
GO:0007569;cell aging;3.0;0.7980440201809971;0.597142322680643;8.935377071932177;24.751975343904395;5.618190544320798;8.284263394289076E-4;0.485434838299289;[CDKN1A, SERPINE1, BRCA2, ICAM1, NUP62, CHEK1, MME, PRKCD, H2AFX, HMGA1, MIF, MAPK14, SIRT1, PML, DNAJA3, CDK1, BCL2, NOX4, ENG]
GO:0006359;regulation of transcription by RNA polymerase III;10.0;0.8436909121759173;0.837086467948879;9.52844079393514;248.56913769389934;6.481236761676141;0.008319385340914571;0.7466917612613706;[CEBPA, BRCA1, BDP1]
GO:0006235;dTTP biosynthetic process;12.0;1.0;0.9481203125901445;9.628524252492122;6270.758393425197;8.390779266560578;0.20987664011178236;0.8772251544931927;[DTYMK, TYMS]
GO:0006357;regulation of transcription by RNA polymerase II;10.0;0.43649654099988644;0.6334892823608635;7.109131426632953;248.56913769389934;1.8913682364374496;0.008319385340914571;0.5119656714299493;[PID1, SPI1, EHMT2, SLA2, SPIB, AKT1, MNX1, MEF2A, MEF2C, ZFYVE16, ATF3, GATA3, GATA1, HESX1, JUN, JAG1, JUP, NR2F2, PKIG, EZH2, HOXC10, DLGAP5, RIPK2, ACTL6A, FOS, SIRT1, MMP12, MED23, PLSCR1, CKS2, PTAFR, FSTL1, STAT4, ZNF467, STAT1, USP9Y, ATAD2, NOC3L, PSMC6, PSMC2, PKN1, CCNT2, RORA, RUVBL2, RUVBL1, ADCYAP1, MAZ, FOXO1, SBNO2, ZNF423, NFKB1, NFKB2, CXCL10, CIITA, FHL2, FASLG, ARRB1, FOXM1, HHEX, PPP1R12A, PEG3, UHRF1, LRP2, ZBTB41, E2F1, E2F2, E2F5, E2F7, E2F8, PRRX1, POU2AF1, SMARCAL1, CCNH, CCNC, IKZF1, UXT, TNFSF11, HNF1B, SFRP4, SFRP2, IFI27, TGFA, BRIP1, PCBP3, ZNF700, EGR1, EGR2, EGR3, IGF1, ID1, CD28, SUV39H2, ECM1, CD40, SUV39H1, HNF4G, BRCA1, PCSK6, BMI1, CD3D, HNF4A, CD36, IL10, IL18, RGMA, IL1A, IL1B, KIT, YAP1, SATB2, RELB, RXRA, IL33, OSM, NEDD4, FOXA3, IL17A, FOXA2, IHH, ETS1, NR3C2, LOXL2, EOMES, CCNE1, TCF7, HTRA1, VDR, CAV1, HMGA1, INHBA, IL6, BMP2, TCF4, MXD1, FBN1, PLEK, HMGB2, ARHGEF10L, LYL1, MYBL2, MYBL1, MYOCD, DDX58, ETV1, GREM1, ELF3, IRF7, IRF8, ZMYND11, FBP1, CREB5, TAF9, AURKB, TBX21, MAPK14, SOD2, TNIP3, EHF, SERPINE1, HOXA9, MYB, HOXA3, HOXA2, HOXA7, JUNB, HOXA5, HOXA4, MED1, PRKCB, HOXB9, HOXB4, HOXB3, HOXB2, MAML3, HOXB7, HOXB6, HOXB5, PRKDC, NEDD4L, RAD21, PRDM16, HMOX1, ELANE, NKX2-3, FZD1, NFE2, FZD5, PLK1, FZD8, FOSL2, FOSL1, SNAI2, CDKN1A, BTG2, ZNF367, HAVCR2, BRD2, PAWR, PAX5, PAX2, AES, ZEB1, TAL1, RARA, HCLS1, ENG, NR1I2, ASCL2, EPCAM, NR1H2, NR1H4, GTF2H1, ELP4, SULF1, POU4F1, FOSB, PF4, CSF3, PLXND1, TNF, DACH1, MEN1, TLE4, DNMT1, AEBP1, NACC2, WFS1, HOPX, COPS5, MAFB, BCL6, MAFF, BCL3, CDK2, CYR61, RFC1, CHUK, TFDP1, CEBPA, CEBPB, HDAC2, SMARCD3, CEBPD, CEBPE, NOD2, ABLIM3, RBBP8, IRX3, KLF4, PML, KLF1, KLF8, KLF6, KLF5, DNAJA3, PPIL4, GFI1, ZNF608, EDNRB, CHEK1, RPS6KA1, DPF3, SOX7, SOX4, SLC11A1, EBF1, FLT3LG, RUNX2, IL23A, PFN1, NBL1, BEX1, TXK, TWIST1, NHLH2, BCL11B, BCL11A, LIF, TOP2A, AHCTF1, PRL, XPO1, HBZ, EDN1, PARP9, TFEC, TLR4, TLR2, SP100, PURA, APBB1, CDX2, CDX1, LILRB1, GRHL2, LILRB4, F2RL1, CAMK1, ARID4A, ARID4B, HOXA11, HOXA10, CHCHD3, PTTG1, LMO2, TIMELESS, ADRB2, NLRP3, TGFB2, TGFB1, CBX4, NR4A2, NFKBIA, NR4A1, NR4A3, FEV, JMY, NFKBID, CREBZF, KDM5D, SLC40A1, TMEM100, KLF12, KLF13, CKAP2, DCN, TGFBR3, IFNG, CAMK2D, LEF1, DLL1, HSPD1, HLX, SNCA, LUM, MEIS2, MEIS1, RBMX]
GO:0051598;meiotic recombination checkpoint;9.0;1.0;0.896240625180289;9.628524252492122;404.9258988516973;8.390779266560578;0.01355250542491682;0.8253454670833372;[TRIP13, BRCA2]
GO:0006349;regulation of gene expression by genetic imprinting;7.0;0.8933024483968273;0.7975705894556142;9.577230958104572;130.9317736178294;6.8867018697843045;0.004382168632042727;0.7031056191423581;[KCNQ1, ARID4A, ARID4B, BRCA1]
GO:0051593;response to folic acid;7.0;0.8653626801206646;0.7836007053175329;9.446202695698167;113.95729645358138;7.379178354882098;0.003814048157392989;0.728290889492758;[GSN, TYMS]
GO:0006281;DNA repair;7.0;0.6281612110245125;0.6649999707694567;8.781226392104918;180.342582143442;3.582668236575797;0.006035903926554339;0.534137185486798;[SMARCAL1, CCNH, SMC3, CHEK1, TRIM25, ESCO2, DNA2, PRKDC, CDCA5, BRIP1, RAD21, BARD1, CDC7, POLA1, FEN1, BTG2, BRCA1, BRCA2, CHAF1B, CHAF1A, ACTL6A, PARP9, SIRT1, RAD51C, PCNA, UNG, RAD54B, USP1, RAD54L, APBB1, PMS1, GINS2, GINS4, RPA1, RPA2, GTF2H1, MLH1, RPA3, TRIP13, DCLRE1A, PTTG1, RUVBL2, RUVBL1, MEN1, LIG1, MSH6, MSH2, FANCD2, TIMELESS, BLM, RNASEH2A, PSMD14, RAD51AP1, CLSPN, FANCI, FANCL, HMGA1, ISG15, FANCG, COPS5, UBE2T, JMY, CDK2, CDK1, MCM8, FOXM1, EXO1, TOPBP1, RFC5, RFC3, RFC4, RFC1, RFC2, H2AFX, SMC1A, DTL, UHRF1, POLD3, CDC45, POLD1, RBBP8, POLR2E, POLR2I, POLR2J, POLR2K, POLR2L, MND1, RAD50, RAD51, POLE2]
GO:0006284;base-excision repair;8.0;0.9326813400603323;0.8413406700301662;9.584072489921288;183.0506323445446;5.69953618377475;0.006126539929698291;0.6664745454937787;[UNG, LIG1, HMGA1, RPA1, RPA2, RPA3, DNA2]
GO:0008584;male gonad development;5.0;1.0;0.7902410118609202;9.628524252492122;50.96471695749156;5.2552850506314295;0.001705743211299806;0.5589965337459591;[HMGB2, LRP2, GATA3, MEA1, GATA1, HOXA11, HOXA10, CTNNA1, PDGFRB, LHCGR, TGFB2, RRM1, BIK, INHBA, EIF2S2, ASPM, KITLG, SFRP2, NASP, MSH2, KIT, BCL2, BCL2L1]
GO:0007131;reciprocal meiotic recombination;9.0;1.0;0.896240625180289;9.628524252492122;175.07189671554147;6.343086423195323;0.005859498828591432;0.7206263598461826;[MND1, RAD54B, RAD50, RAD51, RAD51C, RAD21, TRIP13]
GO:0006283;transcription-coupled nucleotide-excision repair;9.0;1.0;0.896240625180289;9.628524252492122;184.43692670566384;5.486614186532078;0.006172937954381027;0.676826329833192;[CCNH, RFC5, RFC3, RFC4, RFC1, LIG1, RFC2, PCNA, POLD3, POLD1, POLR2E, POLR2I, POLR2J, POLR2K, POLR2L, RPA1, RPA2, GTF2H1, COPS5, RPA3]
GO:0032570;response to progesterone;6.0;0.9326813400603323;0.7894609826203107;9.548481544818586;105.99106082751567;6.166155715036245;0.0035474254201351726;0.6384578026126634;[YAP1, GABRB1, TGFB2, TGFB1, CAV1, PTGER2, FOS, TYMS, THBS1, FOSL1, CLDN4, FOSB, CD38, TLR2]
GO:0007130;synaptonemal complex assembly;6.0;1.0;0.8231203125901445;9.628524252492122;88.07517101545795;6.781341354126479;0.0029477967113796214;0.6699184248047958;[TRIP13]
GO:0006289;nucleotide-excision repair;8.0;0.8436909121759173;0.7968454560879586;9.461470167828956;183.0506323445446;5.132682728539097;0.006126539929698291;0.6374856334316459;[CCNH, BRCA2, RFC5, RFC3, RFC4, RFC1, LIG1, RFC2, SIRT1, PCNA, POLD3, BRIP1, POLD1, RBBP8, POLR2E, POLR2I, POLR2J, POLR2K, POLR2L, RPA1, RPA2, GTF2H1, COPS5, RPA3]
GO:0000733;DNA strand renaturation;7.0;0.9326813400603323;0.8172600352873667;9.584072489921288;172.76820112826425;7.57984905034425;0.005782396210476689;0.738553198190834;[SMARCAL1, BLM, RAD54L]
GO:0000731;DNA synthesis involved in DNA repair;8.0;0.7671156992804218;0.7585578496402109;9.369013057007038;574.6870345922199;5.8067817141283475;0.019234257863048946;0.6719590869034888;[BLM, PCNA, BRCA2, POLD3, POLD1, TRIM25, RFC5, RFC3, RFC4, RFC1, RFC2, RPA1, RPA2, ISG15, SIRT1, POLA1, POLE2, RPA3, DTL]
GO:0007019;microtubule depolymerization;7.0;0.811012628672052;0.7564256795932265;9.34084218004034;92.92880478075006;7.004484905440688;0.003110243465517153;0.7091290490632969;[KIF18A, KIF18B, STMN1, KIF2C, CKAP5]
GO:0044314;protein K27-linked ubiquitination;11.0;1.0;0.9324289523296623;9.628524252492122;157.60047254366168;8.16763571524637;0.00527474598481953;0.8501222226412654;[UBE2S, UBE2T, RNF6]
GO:0045769;negative regulation of asymmetric cell division;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;59.684029898698746;9.777073627680469;0.0019975707685698256;0.8231203125901445;[ASPM]
GO:0045766;positive regulation of angiogenesis;7.0;0.811012628672052;0.7564256795932265;9.303101852057495;134.49314513679974;4.7081694254602375;0.0045013645317563845;0.5916953686275062;[NRP1, ECM1, CD40, SERPINE1, ITGB2, ADM, BRCA1, PIK3C2A, ETS1, AQP1, CDH5, C3AR1, CTSH, CYP1B1, ITGB8, CD34, CCR3, IL10, PPP1R16B, GHSR, ANXA1, ANXA3, PRKCB, GAB1, CYBB, SIRT1, F3, GREM1, IL1A, SFRP2, IL1B, ADAM12, AGTR1, CHI3L1, ENG, CX3CR1, C5AR1, TWIST1, PTGS2, DLL1, THBS1, C3, CXCR2, HMOX1, PLCG1, JUP, PLK2, TNFSF12, KLF4, LRG1, TEK]
GO:0110032;positive regulation of G2/MI transition of meiotic cell cycle;9.0;1.0;0.896240625180289;9.628524252492122;414.4836470731219;8.67846133901236;0.013872394656472954;0.8400575416471059;[CDC25C, CDC25A]
GO:0051090;regulation of DNA binding transcription factor activity;10.0;0.7192862368539868;0.7748841302879137;9.223059144383958;255.33763090554476;3.793137346993279;0.00854592071745993;0.6092222321850824;[GFI1, PHB2, ICAM1, AKT1, TNFSF11, CYP1B1, TRIM25, PRKCH, PRKCB, SFRP4, BTK, SIK1, PRKCQ, TRIB1, BEX1, TWIST1, PRKCZ, PKHD1, NHLH2, S100A12, HMOX1, FZD1, JUN, FZD2, JUP, EIF2AK2, FOSL1, ID1, EZH2, CD40, CD36, HAVCR2, IL10, EDN1, SYK, ANXA3, RIPK2, NFAM1, IL18, FOS, SIRT1, PSMA6, HCK, IL1B, KIT, HCLS1, TLR6, SGK1, TLR4, TLR2, SP100, FLNA, NR1H4, POU4F1, NLRP12, CD40LG, FOXA2, CSF3, TNF, CLU, PYCARD, MEN1, FANCD2, ADAM8, S100A9, S100A8, CARD11, TNFRSF11A, G3BP2, NLRP3, TGFB1, WFS1, NFKB1, NFKB2, NFKBIA, IL6, COPS5, JMY, CCDC22, NFKBID, MYD88, CREBZF, ITGB2, TNFAIP3, ARRB1, ARRB2, MYOCD, CHUK, DDX58, IRAK3, TRAF1, GREM1, XCL1, LTF, HDAC2, NLRC3, NLRC4, NOD2, KLF4]
GO:0045892;negative regulation of transcription, DNA-templated;10.0;0.556709148698489;0.6935955862101648;8.520155788878647;1581.2569993850602;2.683669001811703;0.05292324873051003;0.5524839694169422;[SPI1, EHMT2, SLA2, PHB2, MYB, HOXA2, HOXA7, JUNB, MEF2A, MED1, MEF2C, HOXB4, HOXB3, ATF3, NEDD4L, GATA3, GATA1, PRDM16, HESX1, ELANE, FZD1, JUN, PLK1, FZD8, NR2F2, SNAI2, PKIG, EZH2, BTG2, HELLS, PAWR, PAX5, SIRT1, PAX2, AES, MMP12, ZEB1, TAL1, RARA, HCLS1, PLCB1, NR1I2, ASCL2, BTAF1, FLNA, STAT1, NR1H2, NR1H4, POU4F1, CENPF, FOSB, LGR4, GMNN, TNF, DACH1, MEN1, TLE4, DNMT1, AEBP1, FOXO1, SBNO2, NACC2, ZNF423, WFS1, NFKB1, NFKB2, DAB2, BCL6, BCL3, CDK2, CIITA, FHL2, FASLG, FOXM1, HHEX, EMILIN1, RFC1, PEG3, XCL1, BIRC5, CEBPA, CEBPB, HDAC2, UHRF1, RBBP8, E2F1, E2F7, E2F8, PRRX1, KLF4, PML, KLF8, KLF5, DNAJA3, GFI1, IKZF1, UXT, ZNF608, EDNRB, DPF3, SOX7, SOX4, HNF1B, RUNX2, EREG, SFRP2, IFI27, TWIST1, PCBP3, EGR1, BCL11A, ID1, SUV39H2, SUV39H1, IFNA2, PTPRK, BRCA1, BMI1, XPO1, CD38, CD36, HBZ, EDN1, PARP9, CBFA2T3, MDFIC, IL1B, DEPDC1, SP100, SATB2, RELB, PURA, RXRA, APBB1, CDX2, LILRB4, NEDD4, ARID4A, LOXL2, CHCHD3, BASP1, EOMES, CCNE1, TIMELESS, CALCA, TCF7, TGFB1, CBX4, VDR, CAV1, HMGA1, NR4A2, BMP2, NR4A3, UBA3, MXD1, CREBZF, HMGB2, MYOCD, KLF12, H2AFX, GREM1, IFNG, ELF3, IRF7, IRF8, FBP1, PFDN5, LEF1, AURKB, TBX21, SNCA, MEIS2]
GO:0001701;in utero embryonic development;7.0;1.0;0.8509193652572005;9.628524252492122;22.496195207419138;4.63541007117781;7.529274083310655E-4;0.5879744518658467;[IHH, EDNRA, PDGFRA, TPM1, MSH2, TWIST1, GATA3, GATA1, EPB41L5, CCNB2, CCNB1, PLCG1, MYH10, STIL, EIF2S2, FOSL1, BMP2, MAFF, BCL2L1, PTPRR, TMEM100, HHEX, EDN1, DUSP3, RXRA, TIE1]
GO:0045893;positive regulation of transcription, DNA-templated;10.0;0.5159906454948852;0.673236334608363;8.141425192250265;1208.1179641469014;2.4745772039531437;0.04043462102441837;0.5417910051506925;[PID1, SPI1, SPIB, AKT1, MEF2A, MEF2C, PADI2, ATF3, GATA3, GATA1, JUN, JAG1, JUP, NR2F2, COL1A1, HOXC10, DLGAP5, RIPK2, FOS, SIRT1, MMP12, PLSCR1, CKS2, STAT4, SPP1, STAT1, ATAD2, PSMC6, PSMC2, LGR4, CCNT2, NCF1, RORA, RUVBL2, ADCYAP1, BLM, FOXO1, SBNO2, ZNF423, NFKB1, NFKB2, CXCL10, CIITA, FHL2, ARRB1, FOXM1, HHEX, PPP1R12A, PEG3, UHRF1, E2F1, E2F2, E2F5, E2F7, E2F8, PRRX1, POU2AF1, CCNH, CCNC, IKZF1, TNFSF11, HNF1B, SFRP2, EGR1, EGR2, EGR3, IGF1, CD28, CD40, HNF4G, BRCA1, BRCA2, CD3D, HNF4A, CD38, IL10, IL18, RGMA, IL1A, IL1B, YAP1, SATB2, RELB, RXRA, CD74, IL33, OSM, FOXA3, IL17A, FOXA2, CD86, CD80, IHH, ETS1, EOMES, CCNE1, VDR, HMGA1, INHBA, IL6, BMP2, TCF4, HMGB2, ARHGEF10L, LYL1, NUP62, MYBL2, MYBL1, YWHAH, MYOCD, DDX58, ETV1, CCNA2, GREM1, PSRC1, ELF3, IRF7, IRF8, CREB5, TAF9, RNF6, TBX21, EGF, MAPK14, CD4, TNIP3, NAA15, RAN, EHF, SERPINE1, MYB, HOXA3, HOXA2, HOXA7, JUNB, HOXA5, MED1, HOXB9, HOXB4, HOXB3, HOXB2, MAML3, HOXB7, HOXB5, PRKDC, NUP85, RAD21, PRDM16, NKX2-3, FZD1, NFE2, FZD2, FZD5, FZD8, FOSL2, FOSL1, TGFB1I1, PAX5, PAX2, ZEB1, TAL1, RARA, HCLS1, PLCB1, ENG, NR1I2, EPCAM, NR1H2, NR1H4, GTF2H1, POU4F1, FOSB, PF4, CSF3, PLXND1, TNF, CDH1, MEN1, MAP2K2, F2R, DAB2, COPS5, MAFB, MAFF, BCL3, CDK2, CYR61, LBH, EMILIN1, RFC1, CHUK, TFDP1, CEBPA, CEBPB, HDAC2, SMARCD3, CEBPD, CEBPE, NOD2, ABLIM3, KLF4, PML, KLF1, KLF6, KLF5, GFI1, CHEK1, RPS6KA1, DPF3, SOX7, SOX4, SLC11A1, EBF1, FLT3LG, RUNX2, NIF3L1, IL23A, BEX1, TXK, TWIST1, NHLH2, BCL11B, LIF, TOP2A, IFNA2, PRL, EDN1, RHOG, PARP9, MDFIC, TFEC, TLR4, TLR2, SP100, APBB1, CDX2, CDX1, LILRB1, GRHL2, CAMK4, F2RL1, CAMK1, ARID4A, ARID4B, HOXA11, HOXA10, LMO2, ADRB2, NLRP3, TGFB2, TGFB1, NR4A2, NFKBIA, NR4A1, NR4A3, SLC40A1, CKS1B, KLF13, CKAP2, DCN, DNM2, LEF1, DLL1, LUM, MEIS2, MEIS1, RBMX]
GO:0044320;cellular response to leptin stimulus;6.0;1.0;0.8231203125901445;9.628524252492122;109.38485831558611;7.379178354882098;0.003661012767841448;0.7004918368257019;[CCNA2, PID1, NR4A3]
GO:0034501;protein localization to kinetochore;8.0;0.8436909121759173;0.7968454560879586;9.292052015870908;35.81813124301707;7.212124270218933;0.0011988006184784857;0.7438283705770736;[MIS12, CDK1, BUB1B, TTK, AURKB]
GO:0032201;telomere maintenance via semi-conservative replication;8.0;0.8933024483968273;0.8216512241984136;9.55953138100517;216.32599304453976;6.7325511899570465;0.0072402363064467505;0.719302980950052;[RFC5, PRIM2, RFC3, FEN1, PCNA, RFC4, RFC1, RFC2, PRIM1, RPA1, RPA2, POLD3, POLA1, POLA2, POLD1, RPA3, DNA2]
GO:0071930;negative regulation of transcription involved in G1/S transition of mitotic cell cycle;11.0;1.0;0.9324289523296623;9.628524252492122;1849.0626671205805;8.67846133901236;0.061886463420164586;0.8762458687964789;[E2F1, E2F7]
GO:0030263;apoptotic chromosome condensation;8.0;1.0;0.875;9.628524252492122;25.04782972205294;8.16763571524637;8.383283192138855E-4;0.7926932703116032;[TOP2A, ACIN1]
GO:0031110;regulation of microtubule polymerization or depolymerization;8.0;0.7248374789738407;0.7374187394869203;9.117698628726131;35.502556834779206;5.4730085344763;0.001188238627033293;0.6548899109740429;[SKA3, SKA1, PAK1, STMN1, SNCA, CKAP2, PSRC1, FES, MAP1B]
GO:1904172;positive regulation of bleb assembly;9.0;1.0;0.896240625180289;9.628524252492122;200.30665838708023;9.083926447120524;0.006704083591926775;0.8607930461318132;[ANLN]
GO:0071932;replication fork reversal;9.0;1.0;0.896240625180289;9.628524252492122;151.34471233918515;9.777073627680469;0.005065371320594365;0.896240625180289;[DNA2]
GO:0031115;negative regulation of microtubule polymerization;10.0;0.9326813400603323;0.8815816818910864;9.587702257971866;405.4514152206468;7.292166977892469;0.013570093984851534;0.7881627702307852;[STMN1, SNCA]
GO:1903096;protein localization to meiotic spindle midzone;9.0;1.0;0.896240625180289;9.628524252492122;35.99248463016168;9.777073627680469;0.0012046360694383546;0.896240625180289;[TTK]
GO:0065003;protein-containing complex assembly;4.0;0.45485133202666184;0.4774256660133309;6.058991556010752;36.471478728154885;2.4440506132939883;0.0012206675708314864;0.3749888620238313;[, NUP107, PRKACB, CLDN3, PADI4, PDGFC, ABCA1, MCTS1, JUP, FN1, COL1A1, COL1A2, HLA-DRB1, ACHE, DPYS, ARHGAP6, CHAF1B, CHAF1A, KCND2, ARG1, F5, SLC7A7, SLC7A9, KCNA5, CENPA, HLA-DMA, HLA-DMB, DMD, CENPW, CENPE, CENPF, CENPH, CENPI, CENPK, CENPL, CENPM, GOPC, CENPN, CENPO, KCNG2, NCF1, GMNN, RUVBL2, RUVBL1, OLFM4, BLM, UQCRB, LIN7A, ACAT1, G3BP2, CXCL12, DMXL2, HLA-DRA, LRRK2, ALAD, VBP1, NDUFC2, ACPP, BDP1, BIRC2, BIRC3, NDUFB7, NDUFB6, HM13, NDUFB4, NDUFB3, NDUFB2, NDUFB1, CDC45, CCL5, EIF4H, NDUFA8, NDUFA7, NDUFA6, NDUFA3, NDUFA2, IL2RB, CD247, EIF3D, CCNH, PRF1, IKZF1, TCL1A, SNRPD2, SNRPD1, TNFSF11, FBXO5, SNRPD3, HNF1B, MIF, KCTD12, KCTD15, TGFA, PTK2, ANLN, CD40, CTSZ, CD3G, CD3E, CD3D, CCT3, CCT2, FCER1G, YAP1, NAPA, MIS12, CAPG, RXRA, CCT8, CD74, GCH1, RPA1, RPA2, RPA3, NDUFAB1, TGM2, NDUFB10, NDUFB11, TCF7, RASGRP1, CCNB1, LPXN, H1FX, ECT2, CAV2, UBE2C, CAV1, HMGA1, VIL1, NASP, UBE2S, TCF4, HMGB2, TNFAIP3, LAMC1, NUP62, GREM1, NDUFS8, NDUFS7, NDUFS6, NDUFS4, NDUFS3, NUP54, FBP1, TAF9, SAMHD1, RRM1, EGF, MX2, SOD2, TTC19, TEK, CDA, BIN2, ASF1B, NUP205, PRKCZ, ACMSD, HMOX1, NCKAP1L, EHD3, SERPINA1, CLINT1, TK1, BRD2, HCLS1, GSN, GTF2H1, HJURP, TNF, CLU, DACH1, OIP5, MEN1, TLE4, SNRPG, SNRPE, SNRPF, ITPR3, NACC2, LSM3, HOPX, SYNJ1, CDK1, PIK3C2A, EMILIN1, ADSL, VWF, TRAF1, PTBP2, MCM2, NLGN1, NLRC4, NOD2, PLN, WASF3, PML, MARCKS, RAD51, P2RX1, IMPDH2, PPP2R1A, MCCC2, COX7A2L, TLN1, MGST1, CD79B, CD79A, VASP, CDT1, AHCTF1, HBZ, RAD51C, UQCR10, AIF1, CTNNA1, NDUFA11, KNTC1, CHRNB4, NCF1C, ADRB2, NLRP3, MYH11, TGFB1, EIF2S1, H2AFX, AXIN2, CKAP5, DNM2, TGFBR3, COL6A2, COL6A1, COLEC12, CAMK2D, HIST1H2BK, LEF1, HSPD1, REPS2, RBMX]
GO:0090344;negative regulation of cell aging;5.0;0.8653626801206646;0.7229223519212526;9.34084218004034;80.6841056931466;6.686031174322154;0.002700424406568797;0.6321649570480018;[PRKDC, PLK2, TWIST1, MIF, SLC30A10, FOXM1, SIRT1, CDK6, BCL6]
GO:0006296;nucleotide-excision repair, DNA incision, 5'-to lesion;8.0;1.0;0.875;9.628524252492122;115.13879119899096;6.166155715036245;0.0038535917232456105;0.6903374900225189;[PCNA, POLD3, POLD1, RFC5, RFC3, RFC4, RFC1, RFC2, RPA1, RPA2, GTF2H1, RPA3]
GO:0007140;male meiotic nuclear division;7.0;0.8933024483968273;0.7975705894556142;9.474373572664863;65.96656019186406;6.015873511986907;0.0022078414035718876;0.6585714164269392;[BRCA2, KIF18A, RAD51C, FIGNL1, TRIP13, MYBL1]
GO:0030261;chromosome condensation;7.0;0.8259837884571596;0.7639112594857803;9.223059144383958;23.949217433387346;6.343086423195323;8.01558754599117E-4;0.6753050999230941;[TOP2A, CDCA5, NCAPG2, NCAPG, SMC4, NCAPH, SMC2, CDK1, NUSAP1, ACIN1, NCAPD2, NCAPD3]
GO:0007020;microtubule nucleation;6.0;0.7980440201809971;0.722142322680643;9.0689084645567;33.1981629444775;6.686031174322154;0.0011111126373447525;0.665044257777226;[CETN3, TUBG1]
GO:0007141;male meiosis I;8.0;1.0;0.875;9.628524252492122;140.0657740590801;6.641579411751319;0.004687875406744682;0.7146506799819907;[RAD51C, TRIP13, BRCA2, MYBL1]
GO:0043111;replication fork arrest;10.0;0.8436909121759173;0.837086467948879;9.546846221477855;1135.309178205509;7.9853141584524145;0.037997776482613155;0.8236103492792612;[MSH6, TIPIN, MSH2, TIMELESS]
GO:0006297;nucleotide-excision repair, DNA gap filling;7.0;1.0;0.8509193652572005;9.628524252492122;149.0421272461911;6.641579411751319;0.0049883058697239;0.6905700452391912;[RFC5, RFC3, PCNA, RFC4, RFC1, LIG1, RFC2, RPA1, RPA2, POLD3, POLD1, RPA3]
GO:0007265;Ras protein signal transduction;7.0;0.7586651285174919;0.7302519295159464;8.935377071932177;27.526979089716047;4.2636448815154875;9.213032174599934E-4;0.5689623627776663;[CYFIP1, CELSR1, EPS8, GRAP2, ARHGDIA, ARHGDIB, RAB32, DOK2, DOK3, RAB31, AGTR1, DNMT1, IQGAP3, RASGRP1, G3BP2, JUN, HACE1, PLK2, DHCR24, IGF1, COL1A2, BCL6, CDK2, LAT, GPSM2, CDKN1A, ARHGAP6, ARHGAP4, RAC2, ARHGEF12, CHUK, RHOG, RHOH, RAB33B, CCNA2, RHOU, AIF1, RAB21, PAK1, NRAS, PDPN, EPS8L1, EPS8L3]
GO:0007144;female meiosis I;8.0;1.0;0.875;9.628524252492122;140.0657740590801;8.16763571524637;0.004687875406744682;0.7926932703116032;[TRIP13]
GO:0006298;mismatch repair;8.0;0.8259837884571596;0.7879918942285797;9.500690880982237;183.0506323445446;6.375876246018314;0.006126539929698291;0.701062607729944;[PCNA, RNASEH2A, LIG1, RPA1, RPA2, MLH1, MSH6, POLD3, MSH2, EXO1, RPA3, PMS1]
GO:0042148;strand invasion;7.0;0.8436909121759173;0.7727648213451592;9.456673995565463;149.0421272461911;7.8311634786251565;0.0049883058697239;0.7514054297404357;[RAD51, RAD51C]
GO:0070830;bicellular tight junction assembly;6.0;1.0;0.8231203125901445;9.628524252492122;56.140948375987016;6.280566066213989;0.001878987018571015;0.6443087532925187;[ACTN4, F11R, GRHL2, CLDN3, POF1B, ECT2]
GO:0001837;epithelial to mesenchymal transition;5.0;0.7508913569872202;0.6656866903545304;8.647694999480395;23.145667324477426;5.618190544320798;7.746646556020492E-4;0.5775555375700647;[LEF1, LOXL2, TMEM100, EPB41L5, FAM83D, EOMES, TGFB2, TGFB1, TGFBR3, BMP2, SNAI2, ENG]
GO:0033762;response to glucagon;7.0;0.9326813400603323;0.8172600352873667;9.541512875502493;74.03337757263446;6.166155715036245;0.0024778305216419678;0.6662568552797195;[ARG1, ABCB4, GLP2R, CCNA2, ADCY9, PRKAR1B, RPS6KB1, PRKAR2B, CYC1, PRKACB]
GO:0031100;animal organ regeneration;4.0;0.8933024483968273;0.6966512241984136;9.292052015870908;28.087648497102798;5.420364800990877;9.400683179555208E-4;0.5271977079954144;[CDKN1A, CEBPB, PCNA, C5AR1, IHH, ADM, TYMS, AURKA, ATIC, HMOX1, IL10, MED1, TGFB1, ANXA3, CAD, SULF2, TGFBR3, NFKBIA, CCNA2, CXCL12, NR4A3, CDK1, LCP1, EZH2]
GO:0032436;positive regulation of proteasomal ubiquitin-dependent protein catabolic process;11.0;0.8259837884571596;0.845420846558242;9.498471124243924;3778.5456327194074;5.334422371190153;0.12646452185682636;0.705231560468336;[LRRK2, CLU, AKT1, CBFA2T3, RNF144A, RNF144B, TRIB1, CEBPA, AURKA, IL33, PLK2, CAV1, PLK1, DAB2]
GO:0031103;axon regeneration;7.0;0.8436909121759173;0.7727648213451592;9.427853557029971;96.50678923292918;6.832634648514029;0.00322999538515464;0.7003406189322132;[DHFR, JUN, CHL1, TNC, CTNNA1, BCL2, JAM3]
GO:0071922;regulation of cohesin loading;9.0;0.7586651285174919;0.775573189439035;9.446202695698167;97.41872309218135;8.16763571524637;0.0032605169907366205;0.8139338954918922;[CDCA5]
GO:0032435;negative regulation of proteasomal ubiquitin-dependent protein catabolic process;11.0;0.8436909121759173;0.8542744084176208;9.523163736834295;3784.4609618058316;6.343086423195323;0.1266625025978984;0.7568146869955557;[TAF9, PBK]
GO:0090316;positive regulation of intracellular protein transport;8.0;0.7090535922965819;0.729526796148291;9.107227328858835;289.7860898249656;4.74012102526684;0.009698879635892712;0.6174100096703167;[, CHRM1, CDH1, MED1, PRKCD, PDZK1, KIF20B, SFN, ECT2, TGFB1, JUP, FZD5, IGF1, CDK1, ITGAM, LRRK2, ITGB2, RAC2, IFNG, IL1B, HCLS1, RHOU, PTGS2, PAK1, ABLIM3, FYN, MAPK14, CAMK1]
GO:0043009;chordate embryonic development;6.0;0.9326813400603323;0.7894609826203107;9.4949928598676;22.496195207419138;4.623782033182691;7.529274083310655E-4;0.5595807407949613;[IHH, EDNRA, PDGFRA, TPM1, MSH2, TWIST1, GATA3, GATA1, EPB41L5, CCNB2, CCNB1, PLCG1, MYH10, STIL, EIF2S2, FOSL1, BMP2, MAFF, BCL2L1, PTPRR, BRCA1, TMEM100, HHEX, EDN1, DUSP3, RXRA, TIE1]
GO:0090435;protein localization to nuclear envelope;7.0;0.8933024483968273;0.7975705894556142;9.427853557029971;34.85305034697331;7.697632086000634;0.0011665002294043187;0.7445766281117727;[NUP155, PLK1, NUP54]
GO:0070507;regulation of microtubule cytoskeleton organization;7.0;0.6073376606709605;0.6545881955926808;8.242229891372231;33.71079736555127;4.584116776790259;0.0011282700500770656;0.5853513104054853;[CEP120, CCNF, SMC3, STMN1, CHEK1, NEK2, MAP1B, EPHA3, SKA3, SKA1, PKHD1, CEP76, PLK4, STIL, PLK2, PLK1, TPX2, KIF18A, STAG2, FES, GPSM2, BRCA1, KIF11, XPO1, NUP62, CKAP2, SMC1A, PSRC1, VPS4B, GNAI1, AURKA, PAK1, SNCA, RANBP2, RANBP1, SPAG5, TACC3]
GO:0006260;DNA replication;7.0;0.7307253602413294;0.7162820453778652;9.271849308553389;254.20053156235352;4.77312732173501;0.008507863025766288;0.5950173184638491;[DSCC1, CHEK1, DNA2, SLBP, BLM, RNASEH2A, BRIP1, CLSPN, BARD1, CDT1, CDC7, CDC6, POLA1, POLA2, NASP, CDK2, CDK1, ACHE, FEN1, MCM7, MCM8, MCM10, BRCA1, CHAF1B, CHAF1A, EXO1, RFC5, RFC3, RFC4, RFC1, RFC2, RMI1, DBF4, MCM3, MCM4, MCM5, MCM6, DTL, MCM2, CDC45, POLD1, RBBP8, RRM1, RRM2, RPA1, DONSON, RPA2, RAD50, POLE2, RPA3, DNAJA3, SSBP1]
GO:0006261;DNA-dependent DNA replication;8.0;0.7586651285174919;0.754332564258746;9.318369324188282;254.89367874291247;6.250713103064308;0.008531062038107634;0.6946617587785947;[SLBP, POLD1, RFC5, RFC3, RFC4, RFC1, RFC2, RPA1, DONSON, POLE2, DNAJA3, SSBP1, DNA2]
GO:0045786;negative regulation of cell cycle;5.0;0.5089359064165209;0.5447089650691808;7.0970975870692286;42.34575940812408;3.5270983854209863;0.0014172744586806725;0.47061698731819834;[EHMT2, CCNF, SMC3, UXT, CHEK1, FBXO5, PRKACB, SOX4, TIPIN, MIF, RRAGD, DNA2, AURKAIP1, KIF20B, PRKDC, GATA3, BRIP1, RAD21, TP53BP2, SFN, BARD1, CDT1, PLK2, PLK1, LIF, CDC7, CDC6, NR2F2, ZWINT, STAG2, EZH2, TOP2A, CDKN1A, BTG2, PTPRK, BRCA1, BRCA2, BMI1, TIMP2, IL10, DUSP1, STRADB, GAS1, PCNA, PTGS2, GPNMB, APBB1, CDKN2C, RPA2, LILRB1, CENPF, FAP, TRIP13, SIPA1, MAD2L1, CDKN3, ZWILCH, GMNN, BUB1B, TNF, PTTG1, KNTC1, NEK2, MEN1, CDC25C, MSH6, ADCYAP1, MSH2, TIMELESS, MAD1L1, BLM, CUL5, CCNB1, NACC2, NAE1, CLSPN, GAS2L1, MAP2K6, FANCI, TGFB2, TGFB1, DHCR24, INHBA, NR4A1, BMP2, CDK6, BCL6, CNOT3, JMY, CDK2, CDK1, BCL2, BCL2L1, TNFAIP3, HHEX, CASP2, TOPBP1, MYOCD, H2AFX, SMC1A, TFDP1, IFNG, ESPL1, DTL, PPP1R15A, CEBPA, TTK, THBS1, AURKB, AURKA, CDC45, RBBP8, E2F1, CCL2, BUB1, E2F7, E2F8, RRM2, DONSON, MAPK14, KLF4, PML, WEE1, RAD51, EVI2B]
GO:0048812;neuron projection morphogenesis;7.0;0.6547035408479693;0.6782711356811852;8.502512989635898;62.99970935475633;4.360973225476049;0.002108543576046295;0.5739397388140403;[ADARB1, STMN1, EPHB2, EPHB1, MNX1, MEF2A, MAP1B, KIF20B, NBL1, SDC2, EPB41L3, NCKAP1L, GP5, PTK2, NR4A2, LRFN4, OGN, BCL2, NRP1, LRRK2, RAC2, DCC, STRADB, PAX2, DNM2, CDH11, SGK1, DSCAML1, SHANK3, NLGN1, LRP2, PAK1, NTF3, SLITRK6, FYN, APBB1, LINGO1, SEMA4A, POU4F1, WEE1]
GO:0043123;positive regulation of I-kappaB kinase/NF-kappaB signaling;8.0;0.8933024483968273;0.8216512241984136;9.517298617381897;239.11083947336738;4.629579150867016;0.008002824611389124;0.6117568930727868;[IL1RN, GOLT1B, TNF, LGALS1, AKT1, TNFSF11, TRIM25, WLS, TGM2, PRKCB, PRKCE, F2R, CARD11, S100A12, HMOX1, ECT2, NDFIP2, PLK2, TNFRSF10B, CCDC22, MYD88, ECM1, CD40, SECTM1, FASLG, NUP62, CCR7, CD36, CHUK, RIPK2, ZDHHC17, IL1B, TLR6, BIRC2, LTF, BIRC3, NOD2, FLNA, FYN, CCL19, CD74, CCL21, CARD9, CD4, F2RL1, LTBR]
GO:0006266;DNA ligation;7.0;0.7763722522362496;0.7391054913753253;9.35659053700848;149.0421272461911;7.004484905440688;0.0049883058697239;0.7091290490632969;[TOP2A, LIG1, HMGB2]
GO:0045665;negative regulation of neuron differentiation;8.0;0.6162540371078848;0.6831270185539424;8.732436227935485;338.1488864638422;4.401795219996305;0.011317538915704735;0.6001080122550225;[SEMA5B, GFI1, EDNRB, LGALS1, ARHGDIA, TNR, HOXA2, EPHB2, MED1, SEMA6A, PAQR3, THY1, JAG1, PLK2, PTK2, ID1, ITM2C, NRP1, LRRK2, CTSZ, ARHGAP4, CD38, YWHAH, DCC, RGMA, ASPM, IL1B, NLGN1, HDAC2, LRP1, RNF6, DLL1, SPP1, LINGO1, SEMA4A, SEMA4B, IRX3, MEIS1, PMP22]
GO:0045787;positive regulation of cell cycle;5.0;0.5265193887476639;0.5535007062347522;7.230628979693751;42.184038669436575;3.8238302933926853;0.0014118618110960173;0.4857918708913159;[, CCNH, CCNF, CCNC, PHB2, CHEK1, AKT1, SOX4, MED1, PRKCE, TAS2R13, FLT3LG, MIF, EREG, BTC, KIF20B, CDCA5, TGFA, RACGAP1, RAD21, SFN, PLK4, CDT1, PLK2, CDC7, CDC6, IGF1, FOSL1, CD28, CDKN1A, FEN1, BTG2, KIF14, BRCA1, BRCA2, DLGAP5, IL10, EDN1, ANXA1, DUSP3, KIF23, CIT, IL1A, RAD51C, TAL1, IL1B, CKS2, RARA, PLCB1, PCNA, CXCR5, KCNA5, AIF1, RANBP2, RANBP1, SVIL, POU4F1, FAP, MAD2L1, CCNT2, CEP120, CTGF, NUSAP1, PDGFRB, CDC25C, CDC25A, CCNE2, CCNE1, CCNB2, CCNB1, ECT2, FAM83D, TGFB2, TGFB1, UBE2C, NDC80, NR4A3, CNOT3, CDK2, CDK1, GPSM2, CKS1B, NUP62, CASP2, CCNA2, PSRC1, TFDP1, ESPL1, DTL, SMARCD3, VPS4B, AURKB, AURKA, CDC45, E2F1, E2F7, SH2B1, E2F8, SPAG5, EGF, MEIS2, PML, RPS6KB1, EVI2B]
GO:0045666;positive regulation of neuron differentiation;8.0;0.6181399273706679;0.684069963685334;8.712233520617966;337.32148776029015;3.9481280100702625;0.011289846625707336;0.576907450041722;[SCARB2, CYFIP1, CPNE5, PLXND1, FMR1, ARHGDIA, MEF2C, ADCYAP1, MAP1B, S100A9, NBL1, EPHA3, NEDD4L, SOCS2, ECT2, LYN, FZD1, SYT2, FN1, BMP2, CXCL12, LIN28A, BCL6, FES, BCL2, PLXNB2, TCF4, EZH2, ROBO2, NRP1, TIMP2, NME1, ZEB1, RARA, SHANK3, NLGN1, RAB21, PAK1, CNR1, FYN, APBB1, IRX3, FKBP1B, CAMK1]
GO:0000712;resolution of meiotic recombination intermediates;5.0;1.0;0.7902410118609202;9.628524252492122;26.252913020668647;6.8867018697843045;8.786613727139965E-4;0.6424272657460779;[TOP2A, BLM, MLH1]
GO:0042276;error-prone translesion synthesis;10.0;1.0;0.9152410118609203;9.628524252492122;760.9157207671086;6.7325511899570465;0.025467164394386097;0.7595439928109722;[RFC5, RFC3, PCNA, RFC4, RFC1, RFC2, RPA1, RPA2, POLE2, RPA3]
GO:0006267;pre-replicative complex assembly involved in nuclear cell cycle DNA replication;9.0;0.8933024483968273;0.8428918493787028;9.485423408851448;77.92043580405796;8.67846133901236;0.0026079268625224215;0.8400575416471059;[CDC45]
GO:0006264;mitochondrial DNA replication;9.0;1.0;0.896240625180289;9.628524252492122;406.93153826265655;7.697632086000634;0.013619632371043343;0.7898978880348613;[DNAJA3, SSBP1, DNA2]
GO:0006265;DNA topological change;7.0;1.0;0.8509193652572005;9.628524252492122;171.38190676714436;7.57984905034425;0.005735998185793931;0.738553198190834;[TOP2A, HMGB2]
GO:0006268;DNA unwinding involved in DNA replication;8.0;0.8259837884571596;0.7879918942285797;9.34084218004034;24.41922106263308;7.57984905034425;8.172893530941673E-4;0.7626338329336335;[PURA, RAD51, MCM7, HMGA1, RPA1, MCM4, MCM6, MCM2]
GO:0006269;DNA replication, synthesis of RNA primer;8.0;0.8259837884571596;0.7879918942285797;9.523163736834295;624.5843169808977;8.16763571524637;0.020904274999959296;0.7926932703116032;[POLA1, PRIM2, PRIM1]
GO:2000816;negative regulation of mitotic sister chromatid separation;10.0;0.811012628672052;0.8207473261969463;9.507163395487854;941.8965548825082;6.599019797332524;0.03152443004005238;0.7527151911823093;[PLK1, BUB1B, TTK, CENPF, PTTG1, RAD21, TRIP13, BUB1, MAD1L1, MAD2L1]
GO:0060707;trophoblast giant cell differentiation;5.0;1.0;0.7902410118609202;9.628524252492122;42.294635617598914;7.292166977892469;0.0014155633914202197;0.6631627702307852;[PLK4, LIF, NR2F2, E2F7, E2F8]
GO:0019221;cytokine-mediated signaling pathway;6.0;0.6039883530135606;0.6251144890969248;7.604142487995313;26.50247477320489;3.309374901576116;8.87013979980389E-4;0.49236189895841853;[AKT1, JUNB, PRKCD, FPR1, GATA3, FLRT2, HMOX1, HLA-DQA2, HLA-DQA1, HLA-DRB4, FN1, COL1A2, HLA-DRB1, CDKN1A, LRRC4, TIMP1, JAK3, HLA-DPA1, ANXA1, SERPINB2, IFNGR1, GPR35, RIPK2, IFNGR2, BGN, FOS, SIRT1, F3, FCER2, ZEB1, PLCB1, HLA-DQB1, CCL13, LRRC19, PTAFR, PTGS2, ALOX5, STAT4, CCL19, CCL18, IL12RB1, IL12RB2, CCL23, CCL21, CCL20, STAT1, IL10RA, HLA-DPB1, PF4, CSF3, CSF3R, F13A1, IL5RA, RORA, CXCL13, TNF, PYCARD, IGHG1, MAP3K8, IL13RA2, IL13RA1, IFNA14, CISH, IFNA16, IFNA10, CSF1R, TNFRSF11A, FOXO1, SOCS2, TNFRSF17, IFNA21, TNFRSF10C, TNFRSF10B, NFKB1, CXCL10, CXCL11, CXCL12, BCL6, LCN2, BCL2, HLA-DRA, MYD88, BCL2L1, CIITA, ITGAM, ITGB2, PIK3CD, FASLG, TNFSF13B, ITGAX, CHUK, TNFRSF1B, IL3RA, XCL2, XCL1, BIRC5, LCP1, BIRC2, BIRC3, CX3CR1, CEBPA, CEBPD, NOD2, IL2RG, CCL8, CCL7, CCL5, CCL4, IL21R, CCL2, CCL1, FYN, FCGR1A, FCGR1B, PML, KLF6, IL2RB, PTPN6, IL1RN, IFITM1, IFI30, IFIT1, IFIT3, IFIT2, ICAM1, TNFSF11, TRIM25, RSAD2, ACSL1, IL1R1, IL1R2, HLA-B, FLT3LG, HLA-C, MIF, HLA-A, HLA-F, HLA-G, EREG, HLA-E, IFI27, IL23A, EBI3, TWIST1, INPP5D, CCR10, CCR1, EGR1, TNFSF14, TNFSF12, TNFSF13, LIF, PPBP, SDC1, CD27, IFNA5, IFNA4, IFNA7, CD40, TNFRSF13B, IFNA2, IFNA8, CCR9, CCR7, CCR6, CD36, CCR5, CCR3, CCR2, IL10, SYK, IL15, IL18, GP1BA, GAB2, IL17RB, VAV1, HCK, IL1A, CEACAM1, IL1B, KIT, RHOU, SP100, CXCR5, IFI6, CXCR4, CXCR6, CXCR1, CXCR3, CXCR2, IL32, CD74, IL33, OSM, PODN, CD40LG, IL18R1, IL17A, CD86, CD80, MPL, IL18RAP, CCRL2, IL6R, PRTN3, CSF2RB, CSF2RA, TGFB1, VCAM1, ISG15, NFKBIA, IL6, IL7R, CXCL6, CXCL9, CXCL1, CXCL3, CXCL2, CXCL5, OASL, GHR, LRRTM4, MMP1, MMP2, IRAK3, MMP9, DCN, IFNG, OAS1, OAS3, LTA, IRF7, IRF8, LTB, CAMK2D, SAMHD1, NCAM1, MX2, SOD2, CD4, LTBR]
GO:1990426;mitotic recombination-dependent replication fork processing;10.0;1.0;0.9152410118609203;9.628524252492122;328.81961107458824;9.083926447120524;0.011005296464229153;0.8797934328124444;[RAD51, BRCA2]
GO:0031573;intra-S DNA damage checkpoint;10.0;1.0;0.9152410118609203;9.628524252492122;277.3883443919017;7.069023426578259;0.009283938253494562;0.7767511986393403;[TIPIN, MSH2]
GO:0010994;free ubiquitin chain polymerization;7.0;1.0;0.8509193652572005;9.628524252492122;46.126504921393284;8.16763571524637;0.0015438126085597365;0.7686126355688037;[UBE2C, UBE2S]
GO:0070987;error-free translesion synthesis;10.0;1.0;0.9152410118609203;9.628524252492122;760.9157207671086;6.781341354126479;0.025467164394386097;0.7620391240755716;[RFC5, RFC3, PCNA, RFC4, RFC1, RFC2, RPA1, RPA2, RPA3]
GO:0031577;spindle checkpoint;7.0;0.7866048967936545;0.7442218136540277;9.292052015870908;53.07061143901962;6.686031174322154;0.0017762256044145627;0.692843310444282;[PLK1, BUB1B, TTK, AURKB, CENPF, TRIP13, BUB1, MAD1L1, MAD2L1]
GO:0006270;DNA replication initiation;7.0;0.7980440201809971;0.7499413753476991;9.405380701177911;149.0421272461911;6.343086423195323;0.0049883058697239;0.6753050999230941;[GINS2, MCM7, MCM8, GINS4, MCM10, CDC7, CDC6, POLA1, PURA, POLA2, CDC34, CDC45, CCNE2, CCNE1, MCM3, MCM4, MCM5, MCM6, TOPBP1, MCM2]
GO:0070979;protein K11-linked ubiquitination;11.0;1.0;0.9324289523296623;9.628524252492122;157.60047254366168;6.375876246018314;0.00527474598481953;0.7584915600596062;[UBE2C, UBE2S, UBE2T]
GO:0000729;DNA double-strand break processing;7.0;0.811012628672052;0.7564256795932265;9.35659053700848;149.0421272461911;6.599019797332524;0.0049883058697239;0.6883935445785896;[BARD1, BLM, RAD50, BRIP1, EXO1, RBBP8, BRCA1, DNA2]
GO:0006273;lagging strand elongation;9.0;0.9326813400603323;0.8625812952104552;9.577230958104572;265.91551950056737;7.9853141584524145;0.008899953129253659;0.8046099625986299;[POLA1, LIG1]
GO:0000727;double-strand break repair via break-induced replication;10.0;1.0;0.9152410118609203;9.628524252492122;521.7226431472901;8.16763571524637;0.01746158734624478;0.8329342821725234;[GINS2, CDC45, GINS4, CDC7]
GO:0006271;DNA strand elongation involved in DNA replication;8.0;0.7763722522362496;0.7631861261181248;9.417215158824915;149.73527442675106;7.069023426578259;0.005011504882065279;0.7365101867784198;[GINS1, POLA1, GINS2, RFC3, PCNA, RFC4, LIG1, GINS4]
GO:0006272;leading strand elongation;9.0;0.9326813400603323;0.8625812952104552;9.577230958104572;265.91551950056737;8.67846133901236;0.008899953129253659;0.8400575416471059;[POLA1, PCNA]
GO:0000724;double-strand break repair via homologous recombination;9.0;0.8653626801206646;0.8289219652406215;9.515195567185119;520.6240308586224;5.299736813202263;0.01742481778162994;0.6672694122704188;[BLM, FEN1, PSMD14, MCM8, BRCA1, BRCA2, RAD54B, RAD51AP1, CDC45, RBBP8, RAD54L, GINS2, H2AFX, GINS4, RPA1, RPA2, CDC7, RAD50, RAD51, RAD51C, RPA3]
GO:0043254;regulation of protein complex assembly;5.0;0.5023590972498763;0.5414205604858584;6.876988939450173;27.318252308649967;3.6656062881777913;9.14317319939619E-4;0.4777002879064576;[CYFIP1, ICAM1, EPS8, TCL1A, STMN1, ARFIP1, PRKCE, PRKCD, HNF1B, CLDN7, PFN1, TWIST1, PRKCZ, NCKAP1L, ABCA1, VASP, CDT1, JUN, EIF2AK2, FOSL1, KIF14, CCR7, CD36, SPTAN1, HCK, TAL1, HCLS1, TLR6, TLR4, NAPA, CAPG, PAK1, GSN, CCL21, BIK, NR1H2, RPA1, RPA2, GTF2H1, PSMC6, RPA3, PSMC2, CSF3, HJURP, CXCL13, TNF, CLU, PYCARD, TMOD1, CORO1A, SPTA1, TMEM27, TGFB1, SELP, VIL1, FES, JMY, PLEK, LMOD1, MMP1, SPTB, PSRC1, IFNG, IRF8, LCP1, CDH17, BIRC2, NLRC3, EPS8L1, EPS8L3, SNCA, VPS41]
GO:0000723;telomere maintenance;7.0;0.7307253602413294;0.7162820453778652;9.292052015870908;183.01793442924338;5.266214121163619;0.006125445559899373;0.6202338003175094;[DCLRE1A, FEN1, BRCA2, RFC5, RFC3, RFC4, RFC1, RFC2, RAD51C, CCNE2, CCNE1, DNA2, PRIM2, BLM, SP100, PCNA, PRKDC, PRIM1, POLD3, POLD1, RPA1, RPA2, POLA1, POLA2, RAD50, RAD51, RPA3]
GO:0000722;telomere maintenance via recombination;9.0;0.9326813400603323;0.8625812952104552;9.593432932680852;337.7230221555657;7.212124270218933;0.011303285620559713;0.7650689957573628;[RAD50, RAD51, RAD51C, BRCA2]
GO:0007129;synapsis;6.0;1.0;0.8231203125901445;9.628524252492122;47.18392532465019;6.686031174322154;0.0015792035178401665;0.665044257777226;[CCNE2, CCNE1, FANCD2, MLH1]
GO:0043137;DNA replication, removal of RNA primer;8.0;0.9326813400603323;0.8413406700301662;9.593432932680852;683.7334329296626;8.390779266560578;0.022883942680016138;0.8041048419030481;[FEN1, RNASEH2A, DNA2]
GO:0007127;meiosis I;7.0;0.8653626801206646;0.7836007053175329;9.405380701177911;72.30745439798314;6.343086423195323;0.0024200654262164006;0.6753050999230941;[BRCA2, RAD51C, CKS2, TRIP13, MYBL1]
GO:0046651;lymphocyte proliferation;5.0;0.6873818243518346;0.6339319240368375;8.734706376470026;28.263571572696247;5.500407508664414;9.459563049751445E-4;0.571532107649126;[IFNA5, IFNA4, IFNA7, CD40, IFNA2, IFNA8, IL10, HELLS, MEF2C, CR2, IFNA14, IFNA16, RIPK2, IL15, SLC11A1, CD180, PRKCD, IL23A, DOCK2, MS4A1, CARD11, IFNA10, CD151, LEF1, EBI3, HSPD1, CD79A, FYN, IFNA21, TNFSF14, LILRB1, CD40LG, PTPRC, IMPDH2, FKBP1B, BCL2, IL7R]
GO:1990314;cellular response to insulin-like growth factor stimulus;8.0;1.0;0.875;9.628524252492122;388.66587636398185;7.57984905034425;0.013008297105323164;0.7626338329336335;[CCNA2, GHSR, TGFB1, FBN1]
GO:0001933;negative regulation of protein phosphorylation;9.0;0.6056485694559711;0.6990649099082746;8.75603614327636;664.693789818838;3.7392027077583316;0.02224670295966317;0.5874636255457587;[PID1, ADARB1, PPP2R1A, AKT1, EPHB2, PAQR3, PRKCD, SFRP2, PRKAR1B, TRIB1, ATF3, PRKDC, TWIST1, THY1, PRKCZ, SAMSN1, FLRT2, PRKAR2B, SFN, LYN, JUN, GADD45B, PLK1, LIF, NR2F2, CALM3, PKIG, CDKN1A, PTPRR, LRRC4, PBK, TIMP3, DUSP2, DUSP3, DUSP1, BGN, GP1BA, SIRT1, DUSP6, CEACAM1, IL1B, TLR4, ENG, LRRC19, FAM129A, NTF3, DMD, CDKN2C, PODN, NLRP12, F2RL1, PKN1, PYCARD, MEN1, CISH, IGFBP3, TSC2, FBLN1, FOXO1, SOCS2, CCNB1, TGFB1, CAV1, PTPRC, CDK6, GNAQ, LRRK2, TNFAIP3, PTPN22, ARRB1, ARRB2, FOXM1, HHEX, DUSP10, LRRTM4, NUP62, EMILIN1, MYOCD, PDE4D, IRAK3, DCN, GREM1, ZMYND11, CEBPA, CSK, SNCA, KLF4, PTPN6]
GO:0031442;positive regulation of mRNA 3'-end processing;10.0;0.9326813400603323;0.8815816818910864;9.590783924509275;630.6357977915417;7.57984905034425;0.021106812616712402;0.8028748447945538;[CCNB1, NCBP2]
GO:0002903;negative regulation of B cell apoptotic process;10.0;0.8436909121759173;0.837086467948879;9.466005322994347;155.02018656046687;7.292166977892469;0.00518838613506862;0.7881627702307852;[CD74, BCL6, MIF, AURKB]
GO:0010767;regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage;12.0;0.9326813400603323;0.9144609826203107;9.60185600540996;631.9844254116175;8.67846133901236;0.02115194996947028;0.8919372290569614;[NEDD4, CHEK1]
GO:0090656;t-circle formation;8.0;1.0;0.875;9.628524252492122;168.69220570471313;7.379178354882098;0.005645976311808157;0.7523715242355574;[SMARCAL1, BLM, EXO1, DNA2]
GO:0007050;cell cycle arrest;6.0;0.811012628672052;0.7286266269261705;9.292052015870908;55.61614271062087;4.7664383335842135;0.0018614222452456451;0.5668761906316916;[CDKN1A, DUSP1, STRADB, MSH2, IFNG, RRAGD, GAS1, KIF20B, PPP1R15A, CUL5, THBS1, APBB1, GAS2L1, MAP2K6, BARD1, TGFB2, TGFB1, CDKN2C, DHCR24, INHBA, PML, CDK6, FAP, JMY, CDKN3]
GO:1905342;positive regulation of protein localization to kinetochore;7.0;1.0;0.8509193652572005;9.628524252492122;73.70707873031733;8.390779266560578;0.002466909593039506;0.7800242071602487;[CDT1, NDC80]
GO:1905463;negative regulation of DNA duplex unwinding;8.0;0.8933024483968273;0.8216512241984136;9.5544162803384;116.67017030639651;9.083926447120524;0.003904845603818755;0.839552420951524;[TOP2A, MCM2]
GO:0046939;nucleotide phosphorylation;8.0;0.6729672293956388;0.7114836146978194;8.910684459341805;199.75304005510822;5.6339389012889365;0.006685554484579823;0.6631198974168686;[DTYMK, ENO2, HK3, BPGM, NME1, RAD50]
GO:0007051;spindle organization;6.0;0.6873818243518346;0.6668112247660618;8.690254613899192;44.522636097919765;4.786641040901733;0.0014901325624263064;0.5679093580234316;[GPSM2, CEP120, KIF11, CDC20, STMN1, NUF2, NEK2, MYBL2, FBXO5, TUBG1, CKAP5, ASPM, ESPL1, KIFC1, BIRC5, BIRC2, BIRC3, TTK, AURKB, AURKA, CCNB1, FLNA, CEP72, RANBP2, RANBP1, STIL, CENPW, SPAG5, PLK2, NEK7, NDC80, CENPE, TPX2, KIF4A, RAN, SPC25]
GO:1905341;negative regulation of protein localization to kinetochore;7.0;1.0;0.8509193652572005;9.628524252492122;73.78875676133134;9.777073627680469;0.0024696432832320894;0.8509193652572005;[CDT1]
GO:0030071;regulation of mitotic metaphase/anaphase transition;10.0;0.7586651285174919;0.7945735761196663;9.405380701177911;262.3324330841205;5.885253329569843;0.0087800304514636;0.7162131408273906;[BUB1B, TTK, CCNB1, RAD21, BUB1, DLGAP5, CDT1, DUSP1, UBE2C, PLK1, CDC6, NDC80, CENPE, CENPF, ESPL1, TRIP13, MAD1L1, MAD2L1]
GO:0007052;mitotic spindle organization;7.0;0.8259837884571596;0.7639112594857803;9.280217558223907;96.21539173928952;5.486614186532078;0.0032202425732832385;0.6315050699101035;[GPSM2, TTK, KIF11, AURKB, AURKA, CDC20, CCNB1, STMN1, NUF2, FLNA, NEK2, MYBL2, STIL, PLK2, TUBG1, NDC80, CENPE, TPX2, KIFC1, KIF4A, BIRC5, RAN, BIRC2, SPC25, BIRC3]
GO:1904498;protein localization to mitotic actomyosin contractile ring;9.0;1.0;0.896240625180289;9.628524252492122;102.47693557236114;8.67846133901236;0.003429810810352553;0.8400575416471059;[ANLN]
GO:0045842;positive regulation of mitotic metaphase/anaphase transition;11.0;0.9326813400603323;0.8987696223598284;9.60254876608886;1435.6381372244598;7.57984905034425;0.04804951646246229;0.8200627852632958;[CDT1, ESPL1, DLGAP5]
GO:0051294;establishment of spindle orientation;7.0;0.8653626801206646;0.7836007053175329;9.517298617381897;88.53546790794914;6.343086423195323;0.002963202434130993;0.6753050999230941;[GPSM2, SPAG5, CENPA, NDC80, LLGL2]
GO:0045840;positive regulation of mitotic nuclear division;8.0;0.7140352122741334;0.7320176061370667;9.138976027173417;276.06341799230654;5.75172193694532;0.009239594159256459;0.6691433273378073;[CDCA5, TGFA, PHB2, AURKA, NUP62, NUSAP1, DLGAP5, SH2B1, PDGFRB, RANBP2, RANBP1, CDT1, EDN1, TGFB1, EGF, UBE2C, IGF1, EREG, BTC, IL1A, ESPL1, IL1B, CD28]
GO:0007057;spindle assembly involved in female meiosis I;10.0;1.0;0.9152410118609203;9.628524252492122;179.89568969163926;9.083926447120524;0.006020946838369597;0.8797934328124444;[FBXO5, AURKA]
GO:0043547;positive regulation of GTPase activity;6.0;0.9326813400603323;0.7894609826203107;9.523163736834295;49.33745512692421;3.758480413184235;0.001651280222271285;0.5153291757075998;[F11R, ICAM1, TIAM2, DEPDC1B, RIN2, LLGL2, EPHA2, THY1, RACGAP1, NCKAP1L, A2M, JUN, EZH2, ARHGAP9, DENND1B, NRP1, CD40, ARHGAP6, ARHGAP4, CCR7, RHOG, GMIP, VAV1, DEPDC1, PLCB1, CCL13, NTF3, CCL19, CCL18, RANBP2, RANBP1, CCL23, CCL21, CCL20, DLC1, F2RL1, SIPA1, CXCL13, RGS1, ARHGDIA, ARHGDIB, F2R, TSC2, ADCYAP1, ACAP1, PRTN3, ARHGAP19, RASAL2, ARHGAP15, RASGRP1, ADAP2, ECT2, EVI5, CAV2, ARHGAP25, TBCK, ARHGAP30, GNAQ, ARHGAP11A, DOCK4, LRRK2, ARRB1, TAGAP, ARHGEF12, TBC1D8, TBC1D9, ARAP3, ARAP1, AXIN2, ALDH1A1, XCL2, XCL1, DOCK2, ASAP2, CCL8, CCL7, CCL5, CCL4, CCL2, CCL1]
GO:0044878;mitotic cytokinesis checkpoint;10.0;1.0;0.9152410118609203;9.628524252492122;492.819650181817;8.390779266560578;0.016494230182695288;0.8443458537639685;[AURKB]
GO:0035519;protein K29-linked ubiquitination;11.0;1.0;0.9324289523296623;9.628524252492122;157.60047254366168;8.16763571524637;0.00527474598481953;0.8501222226412654;[UBE2S, UBE2T]
GO:0031398;positive regulation of protein ubiquitination;10.0;0.7508913569872202;0.7906866903545304;9.372590878354922;528.4459358446122;5.113634533568402;0.01768660990225356;0.6767525197159333;[LRRK2, PTPN22, ARRB1, BRCA1, ARRB2, BMI1, CDC20, SKP2, RIPK2, MASTL, BIRC2, BIRC3, ADRB2, NOD2, FANCI, NDFIP2, WFS1, UBE2C, CAV1, PLK1, UBE2S]
GO:0035999;tetrahydrofolate interconversion;8.0;1.0;0.875;9.628524252492122;262.53585291497376;7.292166977892469;0.008786838730136297;0.747921758369865;[MTHFD1, TYMS]
GO:0034421;post-translational protein acetylation;9.0;1.0;0.896240625180289;9.628524252492122;308.12661660850654;8.67846133901236;0.010312720561935343;0.8400575416471059;[DSCC1, ESCO2]
GO:0010458;exit from mitosis;5.0;1.0;0.7902410118609202;9.628524252492122;29.819065850336454;7.379178354882098;9.980172985937987E-4;0.6676125360964777;[EPS8, UBE2C, UBE2S]
GO:0010216;maintenance of DNA methylation;7.0;1.0;0.8509193652572005;9.628524252492122;149.0421272461911;8.16763571524637;0.0049883058697239;0.7686126355688037;[HELLS, DNMT1, UHRF1]
GO:0032006;regulation of TOR signaling;7.0;0.7866048967936545;0.7442218136540277;9.260799472366804;45.070113835906206;5.244474134527214;0.001508456149618737;0.6191220163899107;[SESN3, TSC2, SIRT1, RRAGD, SIK1, SEH1L, UBR1, PKHD1, FAM83D, TBCK, LIN28A]
GO:0010575;positive regulation of vascular endothelial growth factor production;6.0;1.0;0.8231203125901445;9.628524252492122;64.54350789155374;6.481236761676141;0.002160213123744424;0.6545710619905948;[TGFB1, C5AR1, RORA, BRCA1, PTGS2, SULF1, SULF2, C3, IL1A, IL1B, C3AR1, CYP1B1, HPSE, NOX1]
GO:0008272;sulfate transport;7.0;0.8653626801206646;0.7836007053175329;9.405380701177911;30.347012514884874;6.8867018697843045;0.0010156871983350835;0.7031056191423581;[SLC13A1, RACGAP1, SLC26A8, SLC26A7, SLC26A11, SLC26A3]
GO:0045739;positive regulation of DNA repair;8.0;0.7671156992804218;0.7585578496402109;9.360260265897443;499.6181899148078;5.8650506222523235;0.01672177118926996;0.6749389615747303;[BLM, PCNA, BRCA1, FOXM1, APBB1, H2AFX, PARP9, SIRT1, TIMELESS]
GO:0090305;nucleic acid phosphodiester bond hydrolysis;6.0;0.6073376606709605;0.6267891429256247;8.355558576679234;112.24841944109592;4.100319825412187;0.0037568535816745637;0.5328108591460956;[DCLRE1A, POP5, RNASE6, RNASE3, RNASE2, DNA2, RNASEH2A, ERI2, FEN1, HMGB2, EXO1, RFC5, RFC3, RFC4, RFC1, RFC2, NCBP2, PCNA, SAMHD1, POLD3, POLD1, RBBP8, POLR2I, RPA1, RPA2, GTF2H1, RAD50, RPA3]
GO:1904385;cellular response to angiotensin;8.0;1.0;0.875;9.628524252492122;462.69925393661634;7.379178354882098;0.015486127626965131;0.7523715242355574;[BRIP1, PRKCD, CDC6, SLC30A10, NFKB1]
GO:0007062;sister chromatid cohesion;5.0;0.7508913569872202;0.6656866903545304;8.801845679307654;32.565640385727406;6.113511981550823;0.001089942676536732;0.6028862989048107;[CDCA5, PLK1, BUB1B, ESCO2, SMC1A, SMC3, PHB2, CDC20, RAD51C, STAG2, PPP2R1A, RAD21, BUB1]
GO:0045737;positive regulation of cyclin-dependent protein serine/threonine kinase activity;12.0;0.8933024483968273;0.8947715367885583;9.585964638073326;2922.0785093664276;6.193554689224359;0.09779933800857048;0.7648589874268262;[CCNT2, CCNH, CCNC, CKS1B, CCNB1, AKT1, CDC6, PSRC1, CKS2]
GO:0007186;G-protein coupled receptor signaling pathway;5.0;0.5508212674310002;0.5656516455764204;7.20077601654407;23.17027026302992;2.605416804911955;7.75488093814194E-4;0.4234821484283897;[MRGPRF, EDNRA, EDNRB, GPR171, C3AR1, AKT1, PROK2, HOMER3, PRKACB, PTGDR, TAS2R10, TAS2R13, TAAR2, TRHR, EREG, TIAM2, SFRP4, ADCY9, SFRP2, AGTR1, FPR1, FPR3, FPR2, PIK3R5, C3, GNG10, OR7D2, CCR10, CCR1, ABCA1, FZD1, GPR15, FZD2, FZD5, OR2J2, FZD8, AZU1, NMBR, PPBP, GNG11, MARCO, PNOC, CALM3, OR7C2, GPR18, GPR19, GPR25, GABRB1, GRIK3, ADM, CD3E, AKAP12, CCR9, RAC2, FFAR2, CCR7, CCR6, CCR5, CCR3, CCR2, EDN1, GPR37, ANXA1, GPR35, RHOG, GPBAR1, TACR3, AGTRAP, PTH2R, GP1BA, AVPR1A, SORCS3, VAV1, MC3R, PLCB1, CCL13, PTGER2, PTAFR, CXCR5, CXCR4, CXCR6, GNAI1, GNAI2, FGD3, FGD4, CXCR1, FRZB, NPY, CXCR3, CXCR2, FLNA, CCL19, GABRE, CCL18, GPR157, P2RY13, GABBR1, CCL23, CCL21, SORT1, GABRA5, CCL20, P2RY14, GPR6, F2RL1, RAMP1, LGR4, F2RL3, PF4, CHRM2, FCN1, CHRM1, CELSR1, CXCL13, CXCL16, RGS1, CCRL2, PDGFRB, CD97, GHSR, LHCGR, CISH, SPNS3, APLP2, F2R, NPY1R, DGKZ, PDGFRL, ADCYAP1, SPNS1, OR2C3, GNAZ, CALCA, SUCNR1, CALCRL, GPR87, C5AR1, GPR85, ITPR3, GPR84, ADRB2, GPR82, HRH4, PSAP, ECT2, DRD4, HTR1E, CAV1, GPR98, CXCL10, CXCL11, CXCL12, GNB2, GNAQ, OR7E24, TAS2R7, CXCL6, GPSM2, CXCL9, OR1G1, PLEK, CXCL1, ARRB1, ARRB2, CXCL3, CXCL2, CXCL5, LTB4R, GRM5, CA2, PDE4B, PTGIR, ARHGEF12, PDE4D, GLP2R, OR2H1, XCL2, XCL1, CX3CR1, LRP1, OR1E1, P2RY6, GNA15, CCL8, PLN, CCL7, CNR1, P2RY2, OR2W1, CCL5, CCL4, CCL2, S1PR3, OR12D3, CCL1, S1PR5, SLC12A2, TSHR, OR11A1, PTPN6]
GO:0007063;regulation of sister chromatid cohesion;8.0;0.6260725219892441;0.688036260994622;8.694215015115288;54.93577305356617;6.686031174322154;0.0018386508851169624;0.7169239451870815;[FEN1, CDCA5, AXIN2, ESPL1, RAD21, BUB1]
GO:0007064;mitotic sister chromatid cohesion;6.0;0.8653626801206646;0.7558016526504768;9.34084218004034;49.163113097731234;7.212124270218933;0.0016454451514518356;0.6919486831672181;[CDC20, CDCA5, SMC1A]
GO:0045732;positive regulation of protein catabolic process;7.0;0.7043150770688792;0.7030769037916401;9.033817144745429;231.0521549826792;4.39257856489138;0.0077331076938309705;0.5755560373415389;[FMR1, TNF, CLU, AKT1, ADAM9, ADAM8, TRIB1, NEDD4L, FOXO1, BARD1, OSBPL7, PLK2, TNFSF12, CAV1, PLK1, PTK2, DAB2, CCDC22, LRRK2, TNFAIP3, TNFRSF1B, CBFA2T3, RNF144A, RNF144B, IFNG, IL1B, DTL, CEBPA, LRP1, LRP2, AURKA, IL33, EGF, PSMC6, NEDD4, PSMC2]
GO:0008156;negative regulation of DNA replication;8.0;0.7090535922965819;0.729526796148291;9.223059144383958;828.3435142391211;6.113511981550823;0.02772391196081998;0.6876452870438905;[SMARCAL1, BLM, GMNN, BRCA2, SMC3, S100A11, TIPIN, DONSON, CDC6, SMC1A, MSH6, STAG2, MSH2, BCL6, TIMELESS]
GO:0046940;nucleoside monophosphate phosphorylation;9.0;0.8436909121759173;0.8180860812682478;9.507163395487854;900.1310122397246;8.16763571524637;0.03012657491434646;0.8139338954918922;[DTYMK]
GO:0045736;negative regulation of cyclin-dependent protein serine/threonine kinase activity;12.0;0.8933024483968273;0.8947715367885583;9.585964638073326;2927.1185870500644;6.375876246018314;0.09796802487286638;0.7741829203200885;[CEBPA, CDKN1A, MYOCD, CDKN2C, PLK1, TNFAIP3, NR2F2, HHEX, CDK6, MEN1]
GO:0051056;regulation of small GTPase mediated signal transduction;7.0;0.6799073451904818;0.6908730378524415;8.647694999480395;45.070113835906206;4.018171853803189;0.001508456149618737;0.5564088607247961;[EPS8, ARHGDIA, STMN1, ARHGDIB, EPHB2, PDGFRB, F2R, TSC2, TIAM2, DEPDC1B, ARHGAP19, RASAL2, ARHGAP15, RASGRP1, RASGRP4, RACGAP1, ECT2, A2M, ABCA1, TGFB2, IGF1, ARHGAP25, ARHGAP30, BCL6, GPR18, ARHGAP9, ARHGAP11A, NRP1, KIF14, ARHGEF10L, ARRB1, FOXM1, ARHGAP6, ARHGAP4, NUP62, PSD3, TAGAP, RAC2, TIMP2, RALGPS2, PLEKHG1, ARHGEF12, GPR35, RHOG, ARAP3, RHOH, ARAP1, GMIP, VAV1, DNM2, RHOU, FBP1, FGD3, FGD4, EPS8L1, EPS8L3, COL3A1, DLC1, F2RL1, SIPA1, F2RL3]
GO:0045860;positive regulation of protein kinase activity;10.0;0.6281612110245125;0.7293216173731766;9.003430535177193;1094.9224192180604;3.5309668621989068;0.03664606800502658;0.5958148214005239;[, IL1RN, CCNH, CCNC, TCL1A, AKT1, PROK2, TNFSF11, PRKACB, ACSL1, SLC11A1, PRKCD, MIF, EREG, PRKAR1B, IL23A, FPR1, TGFA, PDGFA, IQGAP3, PRKCZ, PIK3R5, PRKAR2B, PDGFD, PDGFC, S100A12, NCKAP1L, ELANE, EGR1, ACE, FZD5, GADD45B, FZD8, EIF2AK2, CDC6, AZU1, IGF1, PTK2, TPX2, NOX4, CALM3, CD24, EZH2, CDKN1A, CD40, KIF14, CCR7, MAP4K1, EDN1, SYK, RIPK2, STRADB, IL18, EMP2, SIRT1, DUSP6, MDFIC, IL1B, KIT, CKS2, TLR6, TLR4, CXCR4, PAK1, NTF3, CCL19, CD74, CCL21, CENPE, CD40LG, PKN1, CAMK1, CCNT2, NCF1, TNF, CLU, MAP3K8, IL6R, PDGFRB, MAP2K2, F2R, ADCYAP1, ADAM9, ADAM8, CSF1R, CALCA, C5AR1, TNFRSF11A, ADRB2, RASGRP1, CCNB1, STAP1, CLSPN, ECT2, DRD4, MAP2K6, TGFB2, TGFB1, TNFRSF10B, GH1, BMP2, PTPRC, CDK1, CSPG4, LAT, LRRK2, ITGB3, ARRB1, CYR61, CKS1B, GHR, GRM5, GREM1, PSRC1, IFNG, CHI3L1, LCP2, PDE5A, LTF, NOD2, THBS1, CCL5, FYN, CSK, SNCA, EGF, MAPK14, CD4]
GO:0031145;anaphase-promoting complex-dependent catabolic process;10.0;1.0;0.9152410118609203;9.628524252492122;350.55619955642163;6.221725566191056;0.011732800519056534;0.7334203466557586;[BUB1B, AURKB, AURKA, CDC20, CCNB1, PTTG1, UBE2C, PLK1, UBE2S, CDK1, MAD2L1]
GO:0032355;response to estradiol;5.0;0.9326813400603323;0.7565816818910864;9.523163736834295;74.25476231829794;4.940791720728991;0.0024852400698459885;0.542913330229313;[IHH, BRCA2, ETS1, CTGF, RUVBL2, CD38, PDGFRB, IL10, GHSR, POSTN, ANXA1, DUSP1, TACR3, CCNA2, IL1B, RARA, PCNA, ABCB4, PTGS2, SOCS2, CST3, RBBP8, TGFB1, NR2F2, POU4F1, COL1A1, GH1, CD4, KIF18A, EZH2]
GO:0031146;SCF-dependent proteasomal ubiquitin-dependent protein catabolic process;10.0;1.0;0.9152410118609203;9.628524252492122;350.55619955642163;6.063501560976162;0.011732800519056534;0.7253287636709003;[, CCNF, KIF14, SKP2]
GO:0090308;regulation of methylation-dependent chromatin silencing;11.0;0.8933024483968273;0.8790801765280758;9.5544162803384;378.0478930493778;7.57984905034425;0.01265292275934795;0.8200627852632958;[DNMT1, UHRF1]
GO:0090306;spindle assembly involved in meiosis;8.0;0.7866048967936545;0.7683024483968273;9.310070521373587;158.5973765159689;7.9853141584524145;0.005308111463617325;0.7833693374183408;[ASPM, FBXO5, AURKA]
GO:0090307;mitotic spindle assembly;8.0;1.0;0.875;9.628524252492122;186.05212215721153;6.193554689224359;0.006226997092562797;0.6917386748366816;[KIF11, CDC20, TPX2, KIFC1, FLNA, BIRC5, NEK2, MYBL2, BIRC2, BIRC3]
GO:0033567;DNA replication, Okazaki fragment processing;7.0;0.9326813400603323;0.8172600352873667;9.567899630675686;149.0421272461911;8.67846133901236;0.0049883058697239;0.7947362817240173;[LIG1, DNA2]
GO:0008360;regulation of cell shape;6.0;0.6763753087927167;0.6613079669865028;8.690254613899192;41.77565885716001;4.6590798152637145;0.0013981937062970905;0.5613858710120996;[CYFIP1, PLXND1, LST1, ICAM1, EPS8, TPM1, VRK1, CSF1R, EPB42, ARHGAP15, CORO1A, SPTA1, EPB41L3, MYH14, MYH10, FN1, CDC7, PARVB, PTK2, VIL1, FES, PLXNB2, ITGB2, ANXA1, RHOG, ARAP3, RHOH, ARAP1, FGR, HCK, KIT, ITGA7, RHOU, CCL13, FGD3, FGD4, CCL7, PDPN, CCL2, FYN, WASF3, SEMA4A, DLC1]
GO:0046718;viral entry into host cell;7.0;0.7671156992804218;0.7344772148974115;8.935377071932177;28.374411874040543;5.346256828837156;9.496660301113433E-4;0.6243271881103005;[SCARB2, CD86, TFRC, ITGB5, CD80, ITGB3, F11R, ICAM1, ANPEP, CLEC5A, ITGB7, ITGB6, HAVCR1, CTSB, CR2, CR1, CXADR, EPHA2, GYPA, SELPLG, DPP4, NCAM1, SLAMF1, GPR15, CDK1]
GO:0090630;activation of GTPase activity;7.0;1.0;0.8509193652572005;9.628524252492122;49.337455126924546;5.2552850506314295;0.0016512802222712962;0.6196748871422394;[CXCL13, RASGRP1, NTF3, CCR7, ECT2, EVI5, CCL21, RHOG, TBC1D8, TBC1D9, TBCK, EPHA2]
GO:0030174;regulation of DNA-dependent DNA replication initiation;9.0;0.7508913569872202;0.7716863036738992;9.326243380619188;154.23465726608282;7.9853141584524145;0.005162095176516053;0.8046099625986299;[CDT1, CDK2]
GO:0044772;mitotic cell cycle phase transition;4.0;0.8436909121759173;0.6718454560879586;9.040737587590003;28.43277148921302;4.321752512322768;9.516192739109223E-4;0.4710146244622313;[GMNN, BUB1B, EPS8, PPP2R1A, NEK2, SKP2, CDC25C, CDC25A, MELK, CDC34, CCNE2, CCNE1, CUL5, PKMYT1, IQGAP3, GSPT1, CCNB2, CCNB1, PRKAR2B, CEP72, CEP76, PLK4, CDT1, UBE2C, PLK2, PLK1, CDC7, CDC6, INHBA, POLA1, POLA2, CDK6, NASP, UBE2S, CDK2, CDK1, CDK14, CDKN1A, MCM7, MCM8, MCM10, FOXM1, TUBG1, MASTL, CKAP5, CIT, DNM2, CCNA2, DBF4, MCM3, CKS2, MCM4, RHOU, MCM5, MCM6, BCAT1, PLCB1, MCM2, PRIM2, PRIM1, AURKA, CDC45, RBBP8, RANBP2, RANBP1, CDKN2C, CEP152, RPA1, RPA2, WEE1, RPS6KB1, POLE2, RPA3, TACC3, CDKN3]
GO:0045740;positive regulation of DNA replication;8.0;0.7671156992804218;0.7585578496402109;9.427853557029971;747.3070825002359;6.166155715036245;0.025011695518573164;0.6903374900225189;[CDT1, JUN, PCNA, CDC7, EREG, CST3, DBF4, CDK2, CDK1, DNA2, E2F7, E2F8]
GO:0044774;mitotic DNA integrity checkpoint;8.0;0.8259837884571596;0.7879918942285797;9.405380701177911;188.74061193661657;5.769740442447999;0.006316978425995768;0.6700647945471605;[TOP2A, BLM, TOPBP1, NAE1, CLSPN, FANCI, TIPIN, DONSON, RPA2, CDC6, MSH6, MSH2, CDK2, CDK1]
GO:0043687;post-translational protein modification;7.0;0.6467165523344657;0.6742776414244334;8.507933057105237;151.15475272427284;3.8799197600437285;0.005059013543235805;0.5493386422205575;[CCNF, LGALS1, PSMD3, SKP2, ESCO2, MXRA8, SPARCL1, SDC2, C3, FN1, TF, SERPINA1, TIMP1, F5, PSMA5, PSMA6, PSMA3, PSMA4, PSMA2, FAM20C, FSTL1, CST3, SPP1, PSMC6, PSMC2, NUCB1, DSCC1, TNC, MEN1, IGFBP5, CISH, APLP2, IGFBP3, FBXW2, PSMD14, CUL5, SOCS2, IGFBP7, NAE1, WFS1, IL6, COPS5, UBA3, CCDC22, UBE2M, FBN1, LAMC1, CYR61, VCAN, DTL, LAMB1]
GO:2000617;positive regulation of histone H3-K9 acetylation;12.0;1.0;0.9481203125901445;9.628524252492122;1488.212472397538;7.8311634786251565;0.049809132146875434;0.8486063770733797;[GATA3, BRCA1]
GO:0045870;positive regulation of single stranded viral RNA replication via double stranded DNA intermediate;9.0;1.0;0.896240625180289;9.628524252492122;106.55819935642852;9.777073627680469;0.003566407036306347;0.896240625180289;[TOP2A]
GO:2000615;regulation of histone H3-K9 acetylation;11.0;0.8933024483968273;0.8790801765280758;9.533214072687796;182.99191619144386;7.379178354882098;0.006124574752895117;0.8098004765652196;[CHEK1, GATA3, BRCA1]
GO:0034644;cellular response to UV;7.0;0.7980440201809971;0.7499413753476991;9.223059144383958;66.19362175939281;5.420364800990877;0.0022154409498949313;0.628117073252615;[CDKN1A, FMR1, PTPRK, AQP1, RUVBL2, CHEK1, PBK, MME, SIRT1, CDC25A, PCNA, PTGS2, AURKB, POLD1, EIF2S1, MAPK13, MFAP4, NEDD4]
GO:0032465;regulation of cytokinesis;6.0;0.5930994877375815;0.6196700564589352;8.140447197062288;31.798591743249187;5.358233019883872;0.0010642702487719462;0.5971405984103235;[AHCTF1, KIF14, BRCA2, NUP62, PRKCE, TAS2R13, KIF23, CIT, PIK3C3, KIF20A, KIF20B, CXCR5, AURKB, AURKA, RACGAP1, ECT2, E2F7, E2F8, SVIL, PLK1, CDC6, PRC1, CALM3, BCL2L1]
GO:0031497;chromatin assembly;5.0;0.7586651285174919;0.6695735761196662;8.801845679307654;37.85777308927478;6.444869117505266;0.0012670655955142442;0.6198319182472036;[HELLS, HMGA1, CHAF1B, CHAF1A]
GO:0032466;negative regulation of cytokinesis;7.0;0.7140352122741334;0.7079369713942671;9.015419779605713;142.53412634803104;7.8311634786251565;0.004770488936483034;0.7514054297404357;[E2F7, AURKB, E2F8]
GO:0033316;meiotic spindle assembly checkpoint;12.0;0.9326813400603323;0.9144609826203107;9.607470843294289;1388.1064304510658;9.777073627680469;0.04645867301251565;0.9481203125901445;[TTK]
GO:0032467;positive regulation of cytokinesis;7.0;0.7043150770688792;0.7030769037916401;9.015419779605713;142.0565341908292;6.193554689224359;0.004754504356786525;0.6676580400938822;[SVIL, PRKCE, CXCR5, TAS2R13, KIF14, KIF23, CDC6, AURKB, CIT, RACGAP1, NUP62, ECT2, KIF20B]
GO:0033314;mitotic DNA replication checkpoint;11.0;1.0;0.9324289523296623;9.628524252492122;738.0966094602528;7.379178354882098;0.02470342927481251;0.8098004765652196;[CDC6, TOPBP1, NAE1, CLSPN]
GO:0070936;protein K48-linked ubiquitination;11.0;1.0;0.9324289523296623;9.628524252492122;157.60047254366168;5.8650506222523235;0.00527474598481953;0.7323679139043926;[TNFAIP3, NEDD4L, RNF6, ZNRF1, UBE2Q2, HACE1, UBE2C, CDC34, UBE2T]
GO:0010571;positive regulation of nuclear cell cycle DNA replication;10.0;0.8436909121759173;0.837086467948879;9.54628615425515;1141.0186722643214;7.9853141584524145;0.038188868110550556;0.8236103492792612;[CDC7]
GO:0007286;spermatid development;5.0;1.0;0.7902410118609202;9.628524252492122;72.7828096339012;5.370354380416217;0.0024359751381706407;0.5648811846224242;[BRIP1, JAM3, FNDC3A, FANCG, KIT, TRIP13]
GO:0090521;glomerular visceral epithelial cell migration;7.0;1.0;0.8509193652572005;9.628524252492122;24.971868181253015;8.390779266560578;8.357859548042604E-4;0.7800242071602487;[ANLN]
GO:0007284;spermatogonial cell division;3.0;1.0;0.6981203125901445;9.628524252492122;30.19503809316806;9.083926447120524;0.0010106007512083216;0.6626727335416686;[BRIP1]
GO:0045995;regulation of embryonic development;5.0;0.5017827139744404;0.5411323688481404;6.887684228566921;27.37613670804801;4.981283082083729;9.162546586948941E-4;0.5449840603320351;[IL1RN, CELSR1, HNF4A, PHLDA2, PRKACB, IL10, HNF1B, DUSP6, SFRP2, PLCB1, LAMA2, LAMA4, LAMA3, GATA3, DLL1, GATA1, RACGAP1, FZD1, FZD2, CDX2, CDX1, IGF1, KLF4, SULF1, COL5A1, COL5A2, CDK1, FOXA2]
GO:0046600;negative regulation of centriole replication;11.0;0.9326813400603323;0.8987696223598284;9.590783924509275;466.4695881312043;7.697632086000634;0.015612317319377515;0.8260862151842345;[BRCA1]
GO:0046601;positive regulation of centriole replication;11.0;0.9326813400603323;0.8987696223598284;9.592156608321247;492.4861511887348;8.67846133901236;0.016483068271526433;0.8762458687964789;[PLK4, VPS4B, NUP62]
GO:0045875;negative regulation of sister chromatid cohesion;9.0;0.7369933605727446;0.7647373054666613;9.305750860229072;314.67461185837936;8.16763571524637;0.010531876070135456;0.8139338954918922;[ESPL1]
GO:0042246;tissue regeneration;4.0;0.7586651285174919;0.629332564258746;8.935377071932177;42.88961059103013;6.039404009397101;0.0014354766683382502;0.5588554019015759;[POSTN, GSN, GPX1, TXK, CCNB1, NINJ1]
GO:0046604;positive regulation of mitotic centrosome separation;10.0;1.0;0.9152410118609203;9.628524252492122;603.270018576253;7.8311634786251565;0.020190904613979026;0.8157270763441555;[RANBP2, RANBP1]
GO:0046605;regulation of centrosome cycle;8.0;0.7192862368539868;0.7346431184269935;9.193206181234276;52.95861036100919;5.69953618377475;0.0017724770291279795;0.6664745454937787;[VPS4B, CEP120, CCNF, BRCA1, KIF11, AURKA, PKHD1, XPO1, NUP62, CHEK1, NEK2, CEP76, RANBP2, PLK4, RANBP1, STIL, PLK2]
GO:0046602;regulation of mitotic centrosome separation;9.0;0.8933024483968273;0.8428918493787028;9.503361109538115;111.3333211242262;7.212124270218933;0.003726226064543951;0.7650689957573628;[RANBP2, RANBP1, CHEK1, NEK2, KIF11]
GO:0045876;positive regulation of sister chromatid cohesion;9.0;0.7436939687323844;0.7680876095464813;9.292052015870908;259.00348872071737;7.474488534686424;0.008668613679475917;0.7784863164434164;[FEN1, RAD21]
GO:0032212;positive regulation of telomere maintenance via telomerase;10.0;1.0;0.9152410118609203;9.628524252492122;1624.1830741800397;6.250713103064308;0.054359945822938814;0.734902770639515;[AURKB, NEK2, CCT8, CCT7, CCT5, CCT4, CCT3, CCT2, NEK7, CCT6A, PRKCQ]
GO:2000620;positive regulation of histone H4-K16 acetylation;13.0;1.0;0.9625549647676366;9.628524252492122;1673.9769773112196;9.083926447120524;0.056026502949136;0.9271073857191605;[BRCA1]
GO:0010569;regulation of double-strand break repair via homologous recombination;9.0;0.8436909121759173;0.8180860812682478;9.523163736834295;184.48234756552796;6.221725566191056;0.00617445814968456;0.7144199599751273;[BLM, RPA2, RAD51AP1, RAD51, FIGNL1, CHEK1]
GO:0031122;cytoplasmic microtubule organization;6.0;0.811012628672052;0.7286266269261705;9.260799472366804;50.45034613020222;5.734022359845919;0.0016885276826141221;0.6163584827319739;[VPS4B, CEP120, FIGNL1, TUBG1]
GO:0007094;mitotic spindle assembly checkpoint;13.0;1.0;0.9625549647676366;9.628524252492122;1801.8011146821202;6.781341354126479;0.060304661792685066;0.8093530769822879;[PLK1, BUB1B, TTK, CENPF, TRIP13, BUB1, MAD1L1, MAD2L1]
GO:0007095;mitotic G2 DNA damage checkpoint;11.0;1.0;0.9324289523296623;9.628524252492122;857.7571147403349;6.7325511899570465;0.028708358699073767;0.7767319332797141;[MSH6, FANCI, BLM, DONSON, CDK1, TOPBP1, CLSPN]
GO:0035563;positive regulation of chromatin binding;5.0;0.9326813400603323;0.7565816818910864;9.4949928598676;31.32148238131123;7.292166977892469;0.0010483018277984315;0.6631627702307852;[CDT1, GMNN, PARP9]
GO:0007093;mitotic cell cycle checkpoint;7.0;0.7140352122741334;0.7079369713942671;9.0094850440859;132.2042645947957;5.142344639450834;0.0044247577598742595;0.6138991092621975;[TOP2A, ZWILCH, BUB1B, BRCA1, KNTC1, TOPBP1, TIPIN, MSH6, MSH2, MAD1L1, BLM, TTK, AURKB, NAE1, CLSPN, BUB1, FANCI, TGFB1, PLK2, PLK1, DONSON, RPA2, CDC6, ZWINT, WEE1, CENPF, CDK2, CDK1, TRIP13, MAD2L1, BCL2L1]
GO:0007098;centrosome cycle;4.0;1.0;0.75;9.628524252492122;37.692070457630365;6.088194173566533;0.0012615196775557923;0.5613505331661754;[PPP1R12A, PLK1, CETN3, CEP120, HEPACAM2, TUBE1, BRCA1, CKAP5, UXT, FES, NUP62, CDK1]
GO:0007099;centriole replication;6.0;1.0;0.8231203125901445;9.628524252492122;79.09414177220606;6.781341354126479;0.0026472097450095456;0.6699184248047958;[PLK4, CEP152, CDK2, CEP72]
GO:0007096;regulation of exit from mitosis;8.0;0.7763722522362496;0.7631861261181248;9.249034630787218;94.90422389775904;6.8867018697843045;0.0031763589656016605;0.7271862538851576;[ANLN, TGFB1, UBE2C, CDCA5, KNTC1, PHB2]
GO:0033262;regulation of nuclear cell cycle DNA replication;9.0;0.7140352122741334;0.7532582313173557;9.240758721483358;171.6907107923128;7.212124270218933;0.00574633357861074;0.7650689957573628;[CDT1, TIPIN, DACH1, BCL6, CDC7]
GO:0046578;regulation of Ras protein signal transduction;8.0;0.6954798709641801;0.72273993548209;8.712233520617966;46.45640819702609;4.388001897863968;0.0015548541743014947;0.5994026211197198;[EPS8, ARHGDIA, STMN1, ARHGDIB, EPHB2, PDGFRB, F2R, TIAM2, RASAL2, RASGRP1, RASGRP4, ECT2, ABCA1, TGFB2, IGF1, BCL6, GPR18, NRP1, KIF14, ARHGEF10L, ARRB1, FOXM1, NUP62, PSD3, TIMP2, RALGPS2, PLEKHG1, ARHGEF12, GPR35, ARAP3, VAV1, DNM2, FBP1, FGD3, FGD4, EPS8L1, EPS8L3, COL3A1, DLC1, F2RL1, F2RL3]
GO:0048754;branching morphogenesis of an epithelial tube;6.0;0.7436939687323844;0.6949672969563367;8.8813098506619;51.7127811195946;4.956792062075433;0.0017307802455913577;0.5766108891590862;[NRP1, PLXND1, CTSZ, IHH, PHB2, HOXA11, HHEX, EDNRA, HOXA5, MED1, EDN1, HNF1B, PAX2, GREM1, SFRP2, COL4A1, TIMELESS, ENG, EPHA2, LEF1, PAK1, TGFB1, EGF, VDR, PML, PPP1CA, BMP2, BCL2]
GO:0000212;meiotic spindle organization;7.0;0.7671156992804218;0.7344772148974115;9.168991923113682;69.6769368299192;7.292166977892469;0.002332024370525413;0.7238411236270654;[ASPM, ESPL1, FBXO5, TUBG1, AURKA]
GO:0045132;meiotic chromosome segregation;4.0;0.7980440201809971;0.6490220100904985;9.089527751759436;42.955130674290615;6.8867018697843045;0.001437669566560732;0.6021862538851576;[ESPL1, PTTG1, NUF2, PLK1, TTK, MLH1, SMC4, NCAPH, SMC2]
GO:0015949;nucleobase-containing small molecule interconversion;6.0;0.7671156992804218;0.7066781622303554;9.271849308553389;109.52544358977337;6.409777797693995;0.003665718030449963;0.6509166472493662;[DTYMK, TYMS, NME1]
GO:0019088;immortalization of host cell by virus;8.0;1.0;0.875;9.628524252492122;54.80099909185045;9.777073627680469;0.0018341401219070278;0.875;[TYMS]
GO:0071897;DNA biosynthetic process;7.0;0.7090535922965819;0.7054461614054914;9.249034630787218;573.3007402310989;5.058574756385375;0.01918785983836615;0.609615113546532;[BRCA2, CTGF, TRIM25, TK1, RFC5, RFC3, RFC4, RFC1, LIG1, RFC2, SIRT1, DTL, PRIM2, BLM, PCNA, TYMS, POLD3, POLD1, RPA1, RPA2, ISG15, POLA1, POLA2, RAD50, CENPF, POLE2, RPA3]
GO:0007091;metaphase/anaphase transition of mitotic cell cycle;10.0;1.0;0.9152410118609203;9.628524252492122;246.8513480975109;8.16763571524637;0.008261892469033718;0.8329342821725234;[TACC3, BUB1B]
GO:0071539;protein localization to centrosome;9.0;0.9326813400603323;0.8625812952104552;9.541512875502493;37.378778991281564;6.781341354126479;0.0012510340941211122;0.7430387373949403;[STIL, SPAG5, AURKA]
GO:0035556;intracellular signal transduction;5.0;0.5140152493238541;0.5472486365228473;6.9204740513899115;23.17027026302992;2.4005655013542495;7.75488093814194E-4;0.41300604323788886;[AKT1, MEF2A, MEF2C, PRKAR1B, AGTR1, FPR1, PDGFA, FPR2, GATA3, IQGAP3, PRKAR2B, SFN, LYN, ABCA1, JUN, HACE1, AZU1, COL1A2, ARHGAP6, ARHGAP4, JAK3, DUSP1, RIPK2, GMIP, SIRT1, DUSP6, PTAFR, NRAS, STAT4, DMD, STAT1, PKN1, LGR4, CTGF, SESN3, MAP3K8, KCNH1, KCNH2, CISH, CDC25C, MSH6, ADCYAP1, MSH2, BLK, LY96, SOCS2, G3BP2, TNFRSF10B, BMX, CORO2A, NFKB1, NFKB2, LRRK2, PIK3CD, FOXM1, TNFRSF1B, SPTB, LCP2, PIK3C3, LCP1, DTL, BIRC2, BIRC3, PPP1R15A, IL2RG, CCL5, E2F1, CCL2, E2F2, FYN, E2F7, SH2B1, E2F8, IL2RB, PTPN6, TNFSF11, PAQR3, MIF, EREG, BTC, BTK, TRIB1, RIN2, EPHA2, PIK3R5, RACGAP1, CD14, PAG1, CCR1, IGF1, PTK2, CALM3, RGL4, CD24, RGL1, CD40, CETN3, BRCA1, BRCA2, CCR9, RAC2, CTSH, CCR7, CCR6, CD36, CCR5, SPTAN1, CCR3, CCR2, IL18, GAB2, LAT2, MC3R, IL1B, KIT, DEPDC1, YAP1, PCNA, GNAI2, RELB, PAK1, PERP, KITLG, FKBP1B, RAMP1, CD80, CELSR1, CCRL2, PDGFRB, PDGFRA, DOK2, DOK3, TYROBP, CARD11, CALCA, PSEN2, RASGRP1, RASGRP4, SPTA1, CCNB1, ECT2, VCAM1, GH1, GNAQ, PLEK, TNFAIP3, GHR, GRM5, ARHGEF12, DDX58, IRAK3, MASTL, CCNA2, NDUFS4, IRF7, SHANK3, BCL2A1, AURKA, EPS8L1, EPS8L3, EGF, MAPK14, MAPK13, TEK, CYFIP1, EPS8, STMN1, CYP1B1, MED1, PRKCH, DAPK1, PRKCB, PRKCE, PRKCD, DEPDC1B, ADCY9, LGALS12, PRKCQ, PRKDC, PRKCZ, PLCG2, HMOX1, PLEK2, PLCG1, PLK2, PLK1, ITK, CDKN1A, BTG2, ADM, IFIH1, NFAM1, PAX2, CIT, HCLS1, PLCB1, HBEGF, EXOC1, GSN, CCL20, CARD9, POU4F1, IL5RA, TNF, SLC8A1, FGF5, PYCARD, GRAP2, STK32B, MEN1, LHCGR, MAP2K2, IGFBP5, DGKZ, NRBP1, RAB32, MELK, RAB31, CSF1R, DNMT1, CALCRL, CUL5, ITPR3, RASAL2, MAP2K6, DHCR24, BCL6, CNOT3, BCL3, CDK2, CDK1, BCL2, CSPG4, LAT, BCL2L1, PIK3C2A, TREM1, TLK1, GPX1, CHUK, TFDP1, IL3RA, CX3CR1, CEBPB, NLRC3, NOD2, RAB21, PLN, PML, DNAJA3, CALML4, EDNRB, PPP2R1A, CHEK1, RPS6KA1, SOX4, PTGDR, TIAM2, SIK1, INPP5D, TP53BP2, CCR10, PRL, RALGPS2, MAP4K1, EDN1, STRADB, RHOG, RHOH, AVPR1A, GFRA3, VAV1, RAB33B, TLR8, TLR7, RHOU, SGK1, TLR4, GUCY2C, SP100, PTGER2, CXCR5, CXCR4, CXCR6, AIF1, CXCR1, CXCR3, CXCR2, PDPN, MLH1, CAMK4, CAMK1, SIPA1, SIRPG, ARHGDIA, ARHGDIB, TSC2, ATP1B1, CSF2RB, ADRB2, CSF2RA, TGFB1, SELE, NFKBIA, SELP, ARHGAP30, JMY, DOCK5, GPSM2, DOCK4, MCTP1, CXCL1, TMEM100, BLNK, CASP2, PTGIR, PDE4D, TGFBR3, ZAP70, DOCK2, CAMK2D, NCAM1, TSHR, PIKFYVE, RPS6KB1]
GO:0010032;meiotic chromosome condensation;8.0;1.0;0.875;9.628524252492122;72.23175504670313;8.16763571524637;0.002417531837054052;0.7926932703116032;[NCAPD2, NCAPD3, SMC4, NCAPH, SMC2]
GO:0010390;histone monoubiquitination;11.0;0.8933024483968273;0.8790801765280758;9.589303539338841;498.95626046972137;6.375876246018314;0.016699617006440744;0.7584915600596062;[UHRF1, BMI1]
GO:0050728;negative regulation of inflammatory response;7.0;0.6729672293956388;0.6874029799550199;8.712233520617966;126.17514047852296;5.085725745451326;0.004222968401562039;0.6110036163900148;[TNFAIP6, TNFAIP3, RORA, ETS1, CDH5, DUSP10, PBK, IL10, GHSR, GPX1, IL1R2, PRKCD, TNFRSF1B, ADCYAP1, CALCRL, NLRC3, GATA3, NT5E, NLRP3, ELANE, NR1H4, KLF4, NFKB1, NLRP12, TEK, FCGR2B]
GO:0000226;microtubule cytoskeleton organization;5.0;0.579397892394798;0.5799399580583193;7.662411396119289;30.307791186580253;3.8212362582156385;0.0010143744957736317;0.4856592118117268;[CALML4, UXT, CDC20, STMN1, FBXO5, MAP1B, KIF20A, LLGL2, PRKCZ, FIGNL1, CEP72, PLK2, PLK1, PTK2, TPX2, CETN3, KIF11, NUF2, TUBG1, KIFC1, KIF2C, CENPA, FLNA, RANBP2, RANBP1, CENPW, TUBE1, CENPE, TACC3, SPC25, CEP120, NUSAP1, NEK2, GAS2L3, MAP7D1, MAP7D2, CCNB1, STIL, NEK7, NDC80, KIF18A, KIF18B, FES, KIF4A, CDK1, GPSM2, MYBL2, NAV1, CKAP5, ASPM, PSRC1, ESPL1, BIRC5, BIRC2, BIRC3, VPS4B, TTK, AURKB, AURKA, SPAG5, WEE1, PRC1, RAN]
GO:0001556;oocyte maturation;4.0;1.0;0.75;9.628524252492122;79.08984218955116;6.8867018697843045;0.0026470658418474595;0.6021862538851576;[CCNB1, FBXO5, TRIP13, BRCA2, EREG]
GO:0045143;homologous chromosome segregation;5.0;1.0;0.7902410118609202;9.628524252492122;44.56456858672447;7.697632086000634;0.00149153600508981;0.6838982747154925;[ESPL1, PTTG1, PLK1]
GO:0050727;regulation of inflammatory response;6.0;0.5272636092234699;0.5867521172018795;7.400047131651798;31.586589572713706;3.8007227183825356;0.00105717472691369;0.517489449159909;[SERPINE1, EDNRB, C3AR1, TNFSF11, IL1R1, IL1R2, PRKCD, IL23A, BTK, AGTR1, SERPING1, CFB, CFH, CFI, GATA3, ADAMTS12, CFP, PLA2G7, C2, C3, C7, CD19, S100A12, A2M, ELANE, LYN, BST1, CD28, PBK, FFAR2, CCR7, CCR2, IL10, ANXA1, FCER1G, IL15, IL18, IL17RB, PSMA6, HCK, IL1B, TLR10, TLR7, TLR6, TLR4, TLR2, C1QB, C1QA, PTGS2, NT5E, IGKC, CCL18, IL33, CCL23, NR1H4, OSM, NLRP12, ZYX, IL17A, C1QC, PROS1, RORA, TNF, CLU, ETS1, CDH5, IGHG1, TGM2, GHSR, ADCYAP1, FANCD2, ADAM8, S100A9, S100A8, SUCNR1, CALCRL, C5AR1, TNFRSF11A, SBNO2, IGLV1-44, NLRP3, SELE, NFKB1, NFKBIA, IL6, BCL6, IGKV3-20, MYD88, TNFAIP6, TNFAIP3, DUSP10, CR2, CR1, GPX1, TNFRSF1B, LTA, XCL1, BIRC2, BIRC3, C1S, C1R, NLRC3, NOD2, USP18, CNR1, CCL5, CCL4, SNCA, MAPK14, KLF4, MAPK13, CD6, TEK, FCGR2B]
GO:0035307;positive regulation of protein dephosphorylation;9.0;0.811012628672052;0.801746939516315;9.464221201200845;660.9024749708963;6.063501560976162;0.022119811063664396;0.706328376990269;[PPP1R15A, CDCA2, PDGFRB, PPP1R16B, TGFB1, PPP1R12A, FCRL3, PRKCD, LILRB2, DLC1, CALM3]
GO:0070317;negative regulation of G0 to G1 transition;7.0;1.0;0.8509193652572005;9.628524252492122;83.03241800612349;6.139487467954083;0.002779020306340262;0.6648930398837374;[EHMT2, BRCA1, BMI1, UXT, CHEK1, RBBP8, E2F1, RRM2, CDC7, RAD51, TFDP1, EZH2]
GO:0033129;positive regulation of histone phosphorylation;10.0;1.0;0.9152410118609203;9.628524252492122;1473.5624568792941;7.697632086000634;0.04931880931163779;0.8088982747154926;[CCNB1, IL1B, FMR1]
GO:0071407;cellular response to organic cyclic compound;5.0;0.5310727365277519;0.5557773801247963;7.0299582842316;63.0333181336412;3.907776714546695;0.0021096684316296343;0.4900848947730398;[IL1RN, AQP9, IFIT1, AQP1, ICAM1, LGALS1, AKT1, CYP1B1, MED1, MEF2C, KCNQ1, CFTR, ABCB4, ABCA1, EGR1, JUP, COL1A1, ID1, NOX4, EZH2, GABRB1, BRCA1, IFIH1, IL10, EDN1, ANXA1, ARG1, IL15, IL18, IL1B, PTAFR, PTGS2, AIF1, GNAI1, CTNNA1, SPP1, P2RY13, STAT1, POU4F1, TNC, RORA, TNF, SLC8A1, CDH1, RUVBL2, IGFBP5, ADCYAP1, BLM, FECH, FOXO1, CCNB1, OSBPL7, TGFB1, CAV1, INHBA, NFKB1, NFKBIA, BMP2, KIF18A, NR4A3, ALPL, SLC26A3, LRRK2, PDE4B, DDX58, PDE4D, DNM2, CCNA2, COLEC12, CEBPA, CEBPB, HDAC2, NOD2, P2RY6, CCL5, CCL2, SNCA, KLF4, RAD51, KLF5, RPS6KB1]
GO:0010389;regulation of G2/M transition of mitotic cell cycle;8.0;0.7369933605727446;0.7434966802863723;8.986670366319727;58.92720908338202;4.74012102526684;0.001972240656975688;0.6174100096703167;[PPP2R1A, NEK2, CDC25C, CDC25A, MSH6, BLM, HMMR, CCNB1, PRKAR2B, RAD21, CEP72, NAE1, CLSPN, CEP76, FANCI, PLK4, PLK1, CDC7, CDC6, TPX2, CDK6, CDK2, CDK1, KIF14, BRCA1, TOPBP1, TUBG1, CKAP5, RAD51C, DTL, SMARCD3, VPS4B, AURKB, AURKA, CEP152, DONSON, CENPF]
GO:0032270;positive regulation of cellular protein metabolic process;7.0;0.47017759384120705;0.586008162177804;7.412950536487706;288.49227156764;2.455885070940991;0.00965557670318086;0.47651344199545814;[, AKT1, PRKACB, PRKAR1B, AGTR1, CDCA2, FPR1, PDGFA, FPR2, GATA3, SLC30A10, IQGAP3, GATA1, C3, PRKAR2B, PDGFD, PDGFC, LYN, JUN, FN1, EIF2AK2, AZU1, NOX4, NOX1, EZH2, GPR37, RIPK2, EMP2, SIRT1, F3, DUSP6, CKS2, PTAFR, PTGS2, NTF3, CASP8AP2, CENPE, PSMC6, PSMC2, PKN1, CCNT2, NCF1, CTGF, RUVBL2, MAP3K8, PPP1R16B, IFNA14, IFNA16, ADCYAP1, S100A9, S100A8, IFNA10, TNFRSF11A, IFNA21, TNFRSF10B, PTPRC, LRRK2, ITGB3, FASLG, ARRB1, ARRB2, PPP1R12A, TNFRSF1B, LCP2, BIRC2, BIRC3, PPP1R15A, LRP1, UHRF1, LRP2, CCL8, CCL7, CCL5, CCL4, CCL2, CCL1, FYN, TIE1, EIF3E, FCGR2B, EIF3D, CCNH, CCNC, ICAM1, CDC20, TCL1A, TNFSF11, EPHB2, EPHB1, MIF, EREG, SFRP2, IFI27, TRIB1, EPHA3, EPHA2, TGFA, PIK3R5, SLAMF1, CCR1, EGR1, IGF1, PTK2, CD28, CD27, CALM3, CD24, NRP1, CD40, KIF14, BRCA1, CD3E, BMI1, CTSH, CCR7, CD36, SYK, IL15, IL18, RNF144A, RNF144B, BANK1, IL1B, KIT, GNAI2, PAK1, RXRA, PERP, CD74, IL33, OSM, NLRP12, RAMP1, CD80, IL6R, PDGFRB, PDGFRA, PCOLCE, CALCA, PSMD14, RASGRP1, CCNB1, ECT2, CAV2, UBE2C, CAV1, INHBA, GH1, IL6, BMP2, UBE2S, TNFAIP3, GHR, GRM5, MASTL, MMP9, GREM1, PSRC1, CHI3L1, AURKA, EGF, MAPK14, CD4, TEK, PHB2, MYB, PROK2, DAPK1, PRKCE, PRKCD, PRKCZ, S100A12, NCKAP1L, ELANE, FZD1, NDFIP2, ACE, FZD5, PLK2, PLK1, FZD8, UPF3B, CDC6, CDKN1A, TIMP2, HAVCR2, FCRL3, HCLS1, PLCB1, HBEGF, ENG, CCL13, FAM129A, GPNMB, CCL19, CCL18, CCL23, GSN, CCL21, CCL20, NR1H2, CARD9, CSF3, FMR1, TNF, CLU, PYCARD, MAP2K2, IGFBP3, F2R, ADAM9, ADAM8, CSF1R, DNMT1, PSAP, DRD4, MAP2K6, FANCI, OSBPL7, WFS1, DAB2, BCL6, BCL3, CDK1, BCL2, CSPG4, CCDC22, LAT, TREM2, PTPN22, CYR61, CR1, ASPH, LCK, XCL2, XCL1, CEBPA, HDAC2, TTK, NLRC4, NOD2, CSK, KLF4, PML, RAD50, P2RX1, IL1RN, ANTXR1, EDNRB, SKP2, SOX7, SOX4, ACSL1, SLC11A1, FLT3LG, IL23A, AURKAIP1, GADD45B, LIF, MARCO, TPX2, IFNA5, IFNA4, IFNA7, IFNA2, IFNA8, MAP4K1, EDN1, STRADB, PARP9, CBFA2T3, MDFIC, TLR6, TLR4, CXCR4, AIF1, LILRB2, CD40LG, DLC1, F2RL1, CAMK1, C5AR1, FBLN1, ADRB2, STAP1, NLRP3, CLSPN, TGFB2, TGFB1, NFKBIA, LIN28A, CKS1B, PLAUR, AXIN2, IFNG, PDE5A, LTF, THBS1, HSPD1, SNCA, HSPE1, RPS6KB1, LTBR]
GO:0007076;mitotic chromosome condensation;8.0;0.8933024483968273;0.8216512241984136;9.461470167828956;40.5466901453896;7.004484905440688;0.0013570612295141678;0.7332096838060964;[CDCA5, NCAPG, SMC4, NCAPH, SMC2, NUSAP1, NCAPD2, NCAPD3]
GO:0090399;replicative senescence;4.0;1.0;0.75;9.628524252492122;26.138269705024182;7.212124270218933;8.748243641116619E-4;0.6188283705770736;[CDKN1A, MME, CHEK1, SERPINE1]
GO:0007077;mitotic nuclear envelope disassembly;6.0;1.0;0.8231203125901445;9.628524252492122;74.08347249058063;7.292166977892469;0.002479507153463127;0.6960420709600095;[CCNB2, CCNB1, PRKCB, PLK1, CDK1, VRK1]
GO:1902850;microtubule cytoskeleton organization involved in mitosis;6.0;0.7586651285174919;0.7024528768488905;9.040737587590003;48.697023367814154;5.202362649177086;0.0016298455476450346;0.5891693804036648;[GPSM2, KIF11, CDC20, STMN1, NUF2, NUSAP1, NEK2, MYBL2, TUBG1, ESPL1, KIFC1, BIRC5, BIRC2, BIRC3, TTK, CENPA, AURKB, AURKA, CCNB1, FLNA, STIL, PLK2, NDC80, CENPE, TPX2, KIF4A, TACC3, RAN, SPC25]
GO:0008285;negative regulation of cell proliferation;5.0;0.5619039856592722;0.5711930046905564;7.31175452450612;43.614270733588945;3.2818080717434612;0.0014597303911579066;0.4580728292695636;[IFITM1, SPARC, LST1, SPINT2, ADARB1, PHB2, IFIT3, CYP1B1, EPHB1, SOX7, SOX4, MED1, MEF2C, HLA-G, EREG, SFRP4, SFRP2, SPINT1, BTK, TRIB1, GATA3, GATA1, BRIP1, INPP5D, HMOX1, SFN, S100A11, LYN, JUN, BCL11B, FZD5, LIF, EIF2AK2, CDC6, NR2F2, FOSL1, NOX4, SNAI2, SRPX, CDKN1A, BTG2, TNFRSF13B, TGFB1I1, ADM, PRL, PTPRK, BRCA2, LRRC32, HNF4A, TIMP2, CTLA4, CD33, HAVCR2, IL10, DUSP1, ARG1, IL15, PAWR, PDCD1LG2, CBFA2T3, NME1, IL1A, CEACAM1, ZEB1, IL1B, RARA, TLR2, PTGS2, ASCL2, AIF1, PAK1, GPNMB, FRZB, PDPN, CTNNA1, CCL23, CDKN2C, STAT1, OSM, LILRB1, LILRB2, PODN, SULF1, FAP, FABP7, DLC1, PKN1, CDKN3, CD86, CD80, SIRPG, IHH, TNF, ETS1, CDH5, DACH1, MEN1, IGFBP5, IGFBP3, F2R, TPM1, TSC2, ADCYAP1, HGS, MAD1L1, CD274, CSF1R, CUL5, FBLN1, CNN1, NACC2, IGFBP7, TGFB2, TGFB1, RARRES3, CAV2, VDR, CAV1, HMGA1, DHCR24, INHBA, IL6, BMP2, CDK6, BCL6, OGN, BCL2, TNFAIP3, CXCL1, DUSP10, ADAMTS1, NUP62, PTGIR, MYOCD, KLF13, AXIN2, TGFBR3, GREM1, TFDP1, IFNG, ASPH, LTA, XCL1, PDE5A, CEBPA, CEBPB, NLRC3, DLL1, THBS1, CCL8, E2F1, CCL2, ZNF503, CSK, E2F7, KLF4, SOD2, PML, MEIS1, DNAJA3, PMP22, CD9, PTPN6, MNDA, FCGR2B]
GO:0008284;positive regulation of cell proliferation;5.0;0.5587538620495764;0.5696179428857084;7.270369308343265;43.45254999490143;2.9881018846882994;0.0014543177435732513;0.44305268120482816;[PID1, TFRC, MYB, HOXA3, AKT1, PROK2, MED1, MEF2C, PRKCH, CLDN7, AGTR1, PRKCQ, ATF3, HHLA2, PRKDC, PDGFA, IQGAP3, GATA1, PRKCZ, PDGFD, PDGFC, HMOX1, NCKAP1L, PLCG1, ELANE, LYN, MCTS1, JUN, FN1, CDC7, CDC6, FOSL2, FOSL1, NOX1, CDKN1A, ADM, HOXC10, TIMP1, JAK3, HLA-DPA1, HAVCR2, ANXA1, ARG1, RIPK2, FCRL3, EMP2, SIRT1, F3, PAX2, MMP12, RARA, HCLS1, HBEGF, PTAFR, KCNA5, PTGS2, NRAS, HLA-DMB, EPCAM, NTF3, FLNA, CCL19, IL12RB1, IL12RB2, STAT1, LRG1, HLA-DPB1, CSF3, CHRM1, TNC, TNF, CTGF, FGF5, PYCARD, CDH3, PPP1R16B, IGFBP5, F2R, MSH6, ADCYAP1, CD274, CSF1R, BLM, DNMT1, CALCRL, TNFRSF11A, CORO1A, NACC2, CXCL10, CXCL12, PTPRC, CDK6, BCL6, CDK2, CDK1, BCL2, HPSE, BCL2L1, ITGB3, FASLG, ARRB1, FOXM1, CYR61, TNFSF13B, LBH, ITGA4, ASPM, XCL1, BIRC5, CX3CR1, HDAC2, SMARCD3, TTK, LRP2, NOD2, CCL5, E2F1, CTHRC1, PRRX1, PML, KLF5, PRC1, DNAJA3, PTPN6, CCNF, AQP1, CDC20, TCL1A, EDNRB, SKP2, TNS3, ICOSLG, SOX4, TIPIN, FLT3LG, MIF, RUNX2, EREG, HLA-E, BTC, SFRP2, IL23A, KIF20B, EBI3, TGFA, TWIST1, CD1D, PKHD1, SLAMF1, EGR1, EGR3, TNFSF12, TNFSF13, LIF, IGF1, PTK2, BST1, ID1, CD28, CD24, CD320, NRP1, NRP2, ECM1, CD40, CTSZ, KIF14, PRL, CD3E, BMI1, ESM1, RAC2, CTSH, CD38, CCR3, CCR2, IL10, EDN1, SYK, IL15, RHOG, IL18, PDCD1LG2, AVPR1A, GAB2, NME1, HCK, CEACAM6, IL1B, KIT, YAP1, AIF1, GNAI2, CST3, PURA, PAK1, CXCR2, CD74, CDX2, OSM, LILRB2, KITLG, CD40LG, CD86, CD80, SIRPG, MPL, IHH, ETS1, IL6R, TGM2, PDGFRB, GHSR, PDGFRA, MATK, CCNE2, CCNE1, PRTN3, CARD11, C5AR1, HTRA1, LTBP3, DPP4, CCNB2, CCNB1, TGFB2, TGFB1, VCAM1, CAV2, NR4A1, IL6, BMP2, LIN28A, NR4A3, IL7R, HMGB2, TNFAIP3, LAMC2, LAMC1, CXCL5, MYOCD, MMP2, GLP2R, TBC1D8, MMP9, TGFBR3, CCNA2, GREM1, ZAP70, IFNG, NDUFS4, LTA, LTF, LEF1, DLL1, THBS1, HLX, S1PR3, EGF, LAMB1, MAPK14, MEIS2, TSHR, CD4, CD6, RPS6KB1, TEK]
GO:0090398;cellular senescence;4.0;0.8653626801206646;0.6826813400603323;9.446202695698167;55.136139509281044;6.343086423195323;0.0018453569700716361;0.5743857346658935;[CDKN1A, PRKCD, H2AFX, HMGA1, MAPK14, SIRT1, PML]
GO:1902975;mitotic DNA replication initiation;10.0;1.0;0.9152410118609203;9.628524252492122;177.94490236465032;9.083926447120524;0.005955655742129888;0.8797934328124444;[POLA1, GINS2]
GO:0007079;mitotic chromosome movement towards spindle pole;7.0;1.0;0.8509193652572005;9.628524252492122;93.22236288778774;8.67846133901236;0.0031200685911745604;0.7947362817240173;[CENPE, DLGAP5]
GO:0001890;placenta development;4.0;1.0;0.75;9.628524252492122;49.86610466882393;6.193554689224359;0.0016689736466849693;0.5667386748366816;[ABCB4, CCNF, HTRA1, MAPK14, ASCL2, PTK2, DCN, PHLDA2, E2F7, BIRC2, E2F8]
GO:0048538;thymus development;5.0;1.0;0.7902410118609202;9.628524252492122;35.890675140737365;6.039404009397101;0.0012012285974499148;0.5990964137624962;[SLC46A2, PRKDC, GATA3, CCNB2, HOXA3, BCL11B, MAFB, BCL2, MAD1L1]
GO:1902977;mitotic DNA replication preinitiation complex assembly;8.0;1.0;0.875;9.628524252492122;93.82476133550486;9.777073627680469;0.003140230325096247;0.875;[CDC45]
GO:0072520;seminiferous tubule development;4.0;1.0;0.75;9.628524252492122;49.55861996907746;7.379178354882098;0.0016586824105027187;0.6273715242355574;[KIF18A, BRIP1]
GO:0071314;cellular response to cocaine;7.0;1.0;0.8509193652572005;9.628524252492122;537.09778937307;8.67846133901236;0.017976179653688387;0.7947362817240173;[CCNA2]
GO:0032388;positive regulation of intracellular transport;6.0;0.6073376606709605;0.6267891429256247;8.04155919591008;60.38198030770418;4.449197458890889;0.00202093054064465;0.5506524775466656;[, CHRM1, CDH3, CDH1, MED1, PRKCD, PDZK1, KIF20B, SFN, ECT2, TGFB1, JUP, FZD5, IGF1, DAB2, CDK1, ITGAM, LRRK2, ITGB2, RAC2, FCER1G, SYK, NCBP2, GAB2, FGR, IFNG, IL1B, HCLS1, RHOU, NLGN1, PTGS2, RAB21, PAK1, ABLIM3, FYN, SPAG5, MAPK14, NEDD4, CAMK1]
GO:2000775;histone H3-S10 phosphorylation involved in chromosome condensation;12.0;1.0;0.9481203125901445;9.628524252492122;711.4828594708514;9.777073627680469;0.023812691013487215;0.9481203125901445;[CCNB1]
GO:0032147;activation of protein kinase activity;11.0;0.6799073451904818;0.7723826249249031;9.164951513576677;1096.8683293671154;4.034070439870987;0.03671119586651001;0.6387315022281249;[, TNF, AKT1, PROK2, TNFSF11, MAP3K8, PRKACB, MAP2K2, SLC11A1, F2R, PRKCD, PRKAR1B, ADAM9, CALCA, C5AR1, FPR1, TGFA, ADRB2, IQGAP3, PRKCZ, PRKAR2B, PDGFC, NCKAP1L, CLSPN, ECT2, DRD4, MAP2K6, TGFB2, GADD45B, TNFRSF10B, EIF2AK2, IGF1, TPX2, BMP2, CDK1, CSPG4, LRRK2, ITGB3, KIF14, ARRB1, GHR, MAP4K1, SYK, RIPK2, STRADB, IL18, EMP2, DUSP6, GREM1, MDFIC, IL1B, KIT, CHI3L1, TLR6, TLR4, CXCR4, NOD2, THBS1, PAK1, NTF3, CCL19, CD74, EGF, MAPK14, CD40LG, PKN1]
GO:0031297;replication fork processing;8.0;0.8933024483968273;0.8216512241984136;9.517298617381897;150.6515651586252;6.375876246018314;0.005042172308252987;0.701062607729944;[SMARCAL1, BLM, PCNA, BRCA2, RAD51, DNA2]
GO:0031291;Ran protein signal transduction;8.0;0.9326813400603323;0.8413406700301662;9.523163736834295;29.60642063139588;8.67846133901236;9.9090025448413E-4;0.8188169164668168;[GPSM2]
GO:1902981;synthesis of RNA primer involved in mitotic DNA replication;11.0;1.0;0.9324289523296623;9.628524252492122;652.7939449187966;9.777073627680469;0.021848425860023894;0.9324289523296623;[POLA1]
GO:0007088;regulation of mitotic nuclear division;7.0;0.5860072649471136;0.6439229977307573;8.169909229792605;54.97351338155213;4.573066940603674;0.0018399140199305624;0.5847862212690335;[CCNF, BUB1B, SMC3, MKI67, PHB2, PTTG1, CHEK1, NUSAP1, KNTC1, NEK2, FBXO5, PDGFRB, CDC25C, EREG, BTC, CCNE2, CCNE1, AURKAIP1, KIF20B, MAD1L1, CDCA5, TGFA, PKMYT1, CCNB2, CCNB1, RAD21, CDT1, TGFB1, CAV2, UBE2C, PLK1, CDC6, IGF1, NDC80, ANLN, STAG2, CD28, KIF11, NUP62, DLGAP5, EDN1, DUSP1, SMC1A, CCNA2, IL1A, ESPL1, IL1B, VPS4B, TTK, AURKA, BUB1, SH2B1, RANBP2, RANBP1, EGF, CENPE, CENPF, TACC3, TRIP13, MAD2L1]
GO:0000209;protein polyubiquitination;10.0;0.7671156992804218;0.7987988615011312;9.223059144383958;155.4032479663248;4.243684138952949;0.005201206855589802;0.6322632160784685;[CCNF, HERC5, SKP2, FBXW2, CDC34, NEDD4L, BARD1, HACE1, UBE2C, MARCH1, UBE2S, UBE2T, BCL2, TNFAIP3, BRCA1, UBE2Q2, RNF144A, RNF144B, DTL, BIRC2, RNF6, ZNRF1, RNF24, NEDD4]
GO:0090166;Golgi disassembly;5.0;1.0;0.7902410118609202;9.628524252492122;58.9131161342151;7.9853141584524145;0.001971768978649902;0.6986103492792611;[CDK1, VRK1]
GO:0009263;deoxyribonucleotide biosynthetic process;9.0;0.6913464685778243;0.7419138594692012;9.253830803050711;956.1008338098185;6.943860283624253;0.03199983447272836;0.7513499630073597;[DTYMK, RRM1, RRM2, TYMS]
GO:0007089;traversing start control point of mitotic cell cycle;10.0;1.0;0.9152410118609203;9.628524252492122;354.407431007331;8.390779266560578;0.01186169776983519;0.8443458537639685;[CDC6]
GO:1902983;DNA strand elongation involved in mitotic DNA replication;11.0;0.8933024483968273;0.8790801765280758;9.541512875502493;179.04351465331663;9.777073627680469;0.005992425306744681;0.9324289523296623;[GINS1]
GO:1903827;regulation of cellular protein localization;5.0;0.4816167172285496;0.5310493704751951;6.85593553025234;25.722958397114;3.605373030269554;8.609242683918189E-4;0.47461995629589737;[, PID1, AKT1, EPHB2, MED1, PRKCH, PRKCE, PRKCD, PDZK1, IFI27, KIF20B, EPHA3, EPHA2, CDCA5, NEDD4L, TP53BP2, CEP72, SFN, BARD1, CDT1, JUP, FZD5, PLK1, LIF, IGF1, CCT6A, PKIG, CDKN1A, XPO1, RAC2, CD36, CCT3, CCT2, FCER1G, RHOG, PARP9, SIRT1, MDFIC, IL1B, HCLS1, RHOU, SP100, PTGS2, GNAI1, PAK1, CCT8, CCT7, CCT5, CCT4, GSN, SORBS1, LILRB4, NUCB1, GOPC, CAMK1, CHRM1, TNF, CDH1, AP2M1, PLS1, CCNE2, CCNE1, ECT2, TGFB1, NDC80, VIL1, DAB2, CDK1, BCL2, BCL2L1, GPSM2, ITGAM, LRRK2, ITGB2, TREM2, NUP62, YWHAH, TFDP1, IFNG, NUP54, LCP1, LRP1, ABLIM3, E2F1, FYN, CSK, EGF, GZMB, MAPK14, CD247]
GO:1990830;cellular response to leukemia inhibitory factor;6.0;1.0;0.8231203125901445;9.628524252492122;81.6500655361772;5.266214121163619;0.0027327542132076126;0.5924347476504533;[TFRC, ICAM1, TNFSF11, TRIM25, MYBL2, TLE4, PCOLCE, SIRT1, PADI2, SBNO2, LAPTM5, KLF4, PML, BSPRY, KLF5]
GO:0035404;histone-serine phosphorylation;10.0;0.7866048967936545;0.8085434602577476;9.405380701177911;709.5369493217947;7.292166977892469;0.023747563152003725;0.7881627702307852;[CCNB1, VRK1, AURKB, AURKA]
GO:0035407;histone H3-T11 phosphorylation;11.0;1.0;0.9324289523296623;9.628524252492122;710.1813063381824;9.083926447120524;0.02376912920145855;0.8969813732811862;[CHEK1, PKN1]
GO:2000781;positive regulation of double-strand break repair;9.0;0.8933024483968273;0.8428918493787028;9.55953138100517;610.2987732095577;6.943860283624253;0.020426150706087248;0.7513499630073597;[BLM, TIMELESS, PARP9, FOXM1]
GO:0007080;mitotic metaphase plate congression;7.0;1.0;0.8509193652572005;9.628524252492122;61.63195576956532;6.193554689224359;0.002062766094448262;0.6676580400938822;[SEH1L, CDCA5, VPS4B, KIF14, CDCA8, CCNB1, NUP62, CENPE, KIF18A, PSRC1, KIFC1, KIF2C]
GO:0071548;response to dexamethasone;8.0;0.9326813400603323;0.8413406700301662;9.567899630675686;124.89021324540595;6.015873511986907;0.004179963043429046;0.6826520511697386;[PCNA, FECH, ABCB4, PTAFR, FOXO1, AQP1, ICAM1, GHSR, EDN1, TGFB1, ARG1, RPS6KB1, IL1B]
GO:0072757;cellular response to camptothecin;7.0;1.0;0.8509193652572005;9.628524252492122;502.88914831670934;8.390779266560578;0.016831247223310163;0.7800242071602487;[BLM, RAD51]
GO:0072708;response to sorbitol;5.0;0.9326813400603323;0.7565816818910864;9.474373572664863;29.400638164542393;8.16763571524637;9.840129005107402E-4;0.7079342821725234;[CDT1, MAP2K6, MAPK13]
GO:0042176;regulation of protein catabolic process;6.0;0.5945822691631375;0.6204114471717133;8.214830917184116;56.791667214012804;3.8826707934156186;0.001900765992470805;0.5216802775280761;[PSMD3, AKT1, TRIB1, NEDD4L, BARD1, PLK2, TNFSF12, PLK1, PTK2, XPO1, TIMP2, PBK, TIMP3, TIMP1, IL10, CBFA2T3, RNF144A, RNF144B, IL1B, CST3, FLNA, IL33, PSMC6, NEDD4, PSMC2, MAD2L1, FMR1, TNF, CLU, LAMP3, HGS, ADAM9, ADAM8, PSMD14, FOXO1, FAM83D, OSBPL7, CAV1, DAB2, CCDC22, LRRK2, TNFAIP3, ALAD, GPX1, IRAK3, TNFRSF1B, IFNG, DTL, CEBPA, LRP1, TAF9, LRP2, AURKA, FYN, SNCA, EGF, PML]
GO:0046655;folic acid metabolic process;7.0;0.8933024483968273;0.7975705894556142;9.551563211355994;318.75190525379287;6.7325511899570465;0.010668339410754122;0.6952223462072524;[DHFR, MTHFD1]
GO:0045445;myoblast differentiation;4.0;0.8933024483968273;0.6966512241984136;9.292052015870908;21.066225782797595;6.599019797332524;7.050676185779127E-4;0.587474179321389;[DTYMK, JAG1, LGALS1, IGF1, MAPK14]
GO:0046777;protein autophosphorylation;8.0;0.7763722522362496;0.7631861261181248;9.31486669363708;180.75330000196035;4.488806596985934;0.006049650283656873;0.604557778120715;[SLA, SLA2, GRAP2, AKT1, NEK2, EPHB1, PDGFRB, PDGFRA, MAP2K2, DAPK1, MATK, VRK1, MELK, BTK, SIK1, BLK, CSF1R, TXK, THY1, LYN, EIF2AK2, BMX, EIF2S1, CLK4, PTK2, CLK1, FES, ITK, LRRK2, JAK3, MAP4K1, SYK, CAD, IRAK3, FGR, ZAP70, HCK, LCK, KIT, CAMK2D, TTK, AURKB, AURKA, PAK1, FYN, CSK, CAMK4, TEK]
GO:0042177;negative regulation of protein catabolic process;7.0;0.7140352122741334;0.7079369713942671;9.105276108727574;231.8232476428224;5.040875179285974;0.007758915471227624;0.6087099563505541;[ALAD, LAMP3, TIMP2, PBK, TIMP3, TIMP1, IL10, IRAK3, TAF9, CST3, FLNA, FYN, SNCA, PML, MAD2L1]
GO:0046654;tetrahydrofolate biosynthetic process;8.0;0.9326813400603323;0.8413406700301662;9.603206444507832;1227.4757260734505;7.697632086000634;0.04108250789524529;0.7686572628545723;[DHFR, ATIC, GCH1, MTHFD1, GART]
GO:0032091;negative regulation of protein binding;5.0;0.6997970393407541;0.6401395315312973;8.48339194818912;32.716075545242866;5.171903441692378;0.0010949776059428606;0.5547323943871747;[LRRK2, CTSZ, ARRB2, IFIT1, IFIT2, RUVBL2, STMN1, AKT1, IL10, ITGA4, PRKCD, AES, SLPI, LEF1, ADRB2, AURKB, AURKA, EPB41L5, CCL23, CAV1, EIF2S1, PPP1CA, DAB2, ID1, CAMK1]
GO:0043029;T cell homeostasis;7.0;1.0;0.8509193652572005;9.628524252492122;22.00128503895464;6.444869117505266;7.363632103827933E-4;0.6805102716434839;[TGFB1, SLC46A2, TNFSF14, RIPK2, CACNA1F, CORO1A, CCNB2, SIT1, BCL2, NCKAP1L, JAK3]
GO:0000022;mitotic spindle elongation;4.0;1.0;0.75;9.628524252492122;36.9885698197415;9.083926447120524;0.001237974144315121;0.714552420951524;[PRC1, KIF23]
GO:0043392;negative regulation of DNA binding;5.0;0.7586651285174919;0.6695735761196662;8.866384200445225;32.533753988449135;5.788089581116195;0.0010888754675157227;0.5862441822128946;[SP100, HDAC2, LEF1, GATA1, E2F1, HMOX1, NEK2, JUN, GZMA, NFKBIA, ID1]
GO:0071732;cellular response to nitric oxide;6.0;1.0;0.8231203125901445;9.628524252492122;346.50110413771324;7.004484905440688;0.011597080124741305;0.6813299963962409;[CCNA2, CDK2, FOXO1, DNM2, AQP1]
GO:0090267;positive regulation of mitotic cell cycle spindle assembly checkpoint;13.0;0.9326813400603323;0.9288956347978027;9.597752593825367;471.1536740716433;7.8311634786251565;0.015769089460400346;0.8630410292508717;[NDC80, MAD2L1]
GO:0090266;regulation of mitotic cell cycle spindle assembly checkpoint;12.0;0.8653626801206646;0.8808016526504769;9.548481544818586;280.44081179639056;7.138016298065211;0.009386101590480495;0.8131587980249038;[CDT1, CCNB1, DUSP1, NDC80, MAD2L1]
GO:0090263;positive regulation of canonical Wnt signaling pathway;8.0;0.8259837884571596;0.7879918942285797;9.417215158824915;236.52854047757646;5.244474134527214;0.007916397387918217;0.6432026511327102;[YAP1, LRRK2, RUVBL1, SOX4, WLS, JUP, EGF, CAV1, AXIN2, NFKB1, SULF2, COL1A1, SFRP4, ASPM, SFRP2, DAAM2, LGR4, NAIP]
GO:0046785;microtubule polymerization;7.0;1.0;0.8509193652572005;9.628524252492122;97.26999823215544;7.292166977892469;0.0032555393035152377;0.7238411236270654;[FBXO5, CKAP5]
GO:0060718;chorionic trophoblast cell differentiation;4.0;1.0;0.75;9.628524252492122;21.066225782797595;8.16763571524637;7.050676185779127E-4;0.6676932703116032;[FZD5, HTRA1, E2F7, E2F8]
GO:0070512;positive regulation of histone H4-K20 methylation;11.0;1.0;0.9324289523296623;9.628524252492122;803.63682017253;9.777073627680469;0.02689700114499224;0.9324289523296623;[BRCA1]
GO:0055015;ventricular cardiac muscle cell development;7.0;1.0;0.8509193652572005;9.628524252492122;69.56390858866273;7.379178354882098;0.002328241417009372;0.728290889492758;[CCNB1, CDK1, FHL2, MYH10]
GO:0033160;positive regulation of protein import into nucleus, translocation;10.0;1.0;0.9152410118609203;9.628524252492122;970.0189350156829;7.292166977892469;0.03246566079461078;0.7881627702307852;[MED1, IFNG, LRRK2, CDK1, IGF1]
GO:0032077;positive regulation of deoxyribonuclease activity;8.0;0.8933024483968273;0.8216512241984136;9.55953138100517;813.6405734422207;8.16763571524637;0.027231817764135358;0.7926932703116032;[PCNA, PRKCD, AKT1]
GO:0090235;regulation of metaphase plate congression;6.0;0.8259837884571596;0.7361122068187242;9.427853557029971;45.24164634670696;7.8311634786251565;0.001514197188386001;0.7236063770733796;[SPAG5, MAD1L1]
GO:0045589;regulation of regulatory T cell differentiation;9.0;0.7866048967936545;0.7895430735771163;9.517298617381897;133.46855707074621;6.518977089658987;0.004467072491254967;0.7296214167088868;[TGFB1, CR1, LILRB2, HLA-G, LILRB4, DUSP10, BCL6, IFNG, FANCD2, CD28, CTLA4]
GO:0060623;regulation of chromosome condensation;7.0;0.8259837884571596;0.7639112594857803;9.377209824211215;21.750886949199476;8.390779266560578;7.279826116623381E-4;0.7800242071602487;[CCNB1]
GO:0000122;negative regulation of transcription by RNA polymerase II;11.0;0.6073376606709605;0.7360977826651425;8.793202583151634;1836.9481969605868;3.0544438328250214;0.0614810030062249;0.5886333519864981;[SPI1, EHMT2, SLA2, MYB, HOXA2, HOXA7, JUNB, MEF2A, MED1, MEF2C, HOXB4, HOXB3, ATF3, NEDD4L, GATA3, GATA1, PRDM16, HESX1, ELANE, JUN, PLK1, FZD8, NR2F2, SNAI2, PKIG, EZH2, BTG2, PAWR, PAX5, SIRT1, AES, MMP12, ZEB1, TAL1, RARA, HCLS1, ASCL2, STAT1, NR1H2, NR1H4, POU4F1, FOSB, TNF, DACH1, MEN1, TLE4, DNMT1, AEBP1, FOXO1, NACC2, WFS1, NFKB1, NFKB2, BCL6, CDK2, CIITA, FHL2, FASLG, FOXM1, HHEX, RFC1, PEG3, CEBPA, CEBPB, HDAC2, UHRF1, RBBP8, E2F1, E2F7, E2F8, PRRX1, KLF4, KLF8, KLF5, DNAJA3, GFI1, UXT, ZNF608, EDNRB, SOX7, SOX4, HNF1B, IFI27, TWIST1, PCBP3, EGR1, BCL11A, ID1, SUV39H2, SUV39H1, BMI1, XPO1, CD36, HBZ, EDN1, PARP9, IL1B, SP100, SATB2, RELB, RXRA, APBB1, CDX2, LILRB4, NEDD4, LOXL2, CHCHD3, EOMES, CCNE1, TIMELESS, TCF7, TGFB1, CBX4, VDR, CAV1, NR4A2, BMP2, NR4A3, MXD1, MYOCD, KLF12, IFNG, IRF7, IRF8, FBP1, LEF1, AURKB, TBX21, SNCA, MEIS2]
GO:0046680;response to DDT;5.0;1.0;0.7902410118609202;9.628524252492122;46.407574972267774;9.777073627680469;0.0015532197702158826;0.7902410118609202;[CCNB1]
GO:0045471;response to ethanol;5.0;0.9326813400603323;0.7565816818910864;9.523163736834295;69.73224034292265;5.006389003214805;0.0023338753293357085;0.5462679783062231;[CSF3, SPI1, SPARC, TNC, ICAM1, EEF1B2, ALAD, PRKCE, CYBB, ADCYAP1, CLDN3, IL1B, CLDN7, RARA, S100A8, BIRC2, PSMD14, FECH, GATA3, TYMS, CCL7, CNR1, FYN, CD14, GSN, VCAM1, GGH, RPS6KB1, CDK1, CD27]
GO:1902808;positive regulation of cell cycle G1/S phase transition;8.0;0.8933024483968273;0.8216512241984136;9.5544162803384;106.07932343249502;6.113511981550823;0.003550379490092644;0.6876452870438905;[, ANXA1, KCNA5, CDC6, PHB2, AIF1, CDC45, PLCB1, FAM83D]
GO:0070301;cellular response to hydrogen peroxide;6.0;1.0;0.8231203125901445;9.628524252492122;361.02555909653125;5.682729065458369;0.012083200561052132;0.6137353412716126;[HDAC2, PCNA, TNFAIP3, ETS1, FOXO1, AQP1, CST3, IL18RAP, PDGFD, MYB, CYP1B1, ECT2, ANXA1, ARG1, PRKCD, KLF4, SIRT1, PAX2, MAPK13, FABP1, IL6, CDK1, EZH2]
GO:0035335;peptidyl-tyrosine dephosphorylation;8.0;0.8933024483968273;0.8216512241984136;9.52844079393514;179.24922260518233;5.181953777545879;0.005999310166768488;0.6400053571691908;[PTPRR, PTPN22, PTPRK, DUSP10, DUSP2, DUSP3, DUSP1, CDC25C, DUSP6, CDC25A, TPTE, PTPRE, PTPRC, PTPN6, PTPN7, PTPN4, CDKN3]
GO:0090129;positive regulation of synapse maturation;7.0;0.9326813400603323;0.8172600352873667;9.571365838652174;185.50285720788708;7.57984905034425;0.006208613689015268;0.738553198190834;[CDC20]
GO:0072719;cellular response to cisplatin;6.0;1.0;0.8231203125901445;9.628524252492122;120.46332589257861;8.16763571524637;0.004031799107669873;0.7408135829017477;[TIMELESS, HMOX1]
GO:1905098;negative regulation of guanyl-nucleotide exchange factor activity;6.0;0.9326813400603323;0.7894609826203107;9.55953138100517;99.11376152007192;8.16763571524637;0.003317248401482572;0.7408135829017477;[STMN1, EIF2S1]
GO:0000132;establishment of mitotic spindle orientation;8.0;0.9326813400603323;0.8413406700301662;9.582004236857228;227.84740072539455;6.641579411751319;0.007625847452931234;0.7146506799819907;[GPSM2, CENPA, NDC80]
GO:0044030;regulation of DNA methylation;7.0;0.7980440201809971;0.7499413753476991;9.253830803050711;73.34977914704017;6.7325511899570465;0.0024549510975359675;0.6952223462072524;[SPI1, BRCA1, GRHL2]
GO:0001578;microtubule bundle formation;6.0;0.8436909121759173;0.7449657686781032;9.310070521373587;33.1981629444775;5.8067817141283475;0.0011111126373447525;0.6200793994936333;[PLK1, NAV1, PSRC1, FES, PRC1, MAP1B, KIF20A]
GO:0043066;negative regulation of apoptotic process;7.0;0.5640623033008358;0.6329505169076184;7.792313020693233;81.07407142393629;2.9735683700721314;0.0027134762086319553;0.5029877899877601;[SERPINE1, PHB2, AKT1, PROK2, IER3, MED1, MEF2C, PRKCH, DAPK1, PRKCD, CLDN7, PRKCQ, PRKDC, GATA3, SLC30A10, GATA1, PRKCZ, FIGNL1, HMOX1, SFN, NCKAP1L, BARD1, JUN, PLK2, PLK1, EIF2AK2, AZU1, SNAI2, CDKN1A, BTG2, CHL1, TIMP1, JAK3, ANXA1, SERPINB2, DUSP1, RIPK2, ANXA5, SERPINB9, SIRT1, PAX2, RARA, HCLS1, PTGS2, UNG, NTF3, FLNA, CCL19, CCL21, GABRA5, NR1H4, POU4F1, FABP1, PF4, TNF, CLU, LAMP3, CLEC5A, F2R, ADCYAP1, MSH2, ADAM8, CSF1R, BLM, DNMT1, CORO1A, FOXO1, SOCS2, WFS1, TNFRSF10C, TNFRSF10B, DHCR24, NFKB1, DAB2, CXCL12, COPS5, BCL6, BCL3, CDK1, BCL2, MYD88, BCL2L1, LRRK2, FHL2, FASLG, ARRB1, ARRB2, CYR61, GPX1, TNFRSF1B, ADAMTS20, BIRC5, BIRC2, BIRC3, CX3CR1, CEBPB, HDAC2, LRP1, NLRC4, NOD2, CCL5, CCL2, FYN, TIE1, KLF4, IL2RB, EVI2B, IL1RN, SLC46A2, IFIT3, AQP1, ICAM1, LGALS3, TCL1A, EDNRB, RPS6KA1, EPHB2, EPHB1, FLT3LG, HNF1B, MIF, BTC, POR, SFRP2, EPHA3, NAIP, EPHA2, TWIST1, PKHD1, EGR3, BCL11B, TNFSF14, IGF1, PTK2, VNN1, ID1, CD28, CD27, NRP1, KIF14, BRCA1, CTSH, CD38, CCR7, CCR5, IL10, EDN1, FCER1G, STRADB, HCK, RNF144B, IL1A, CEACAM6, IL1B, CEACAM5, KIT, YAP1, IFI6, AIF1, GNAI2, CXCR2, PDPN, CTNNA1, CD74, LILRB1, CD40LG, GRINA, MAD2L1, ZFAND6, IHH, MPO, COMP, ARHGDIA, PDGFRB, GHSR, PDGFRA, C5AR1, PSEN2, ALOX12, STIL, CBX4, CAV1, NR4A2, NFKBIA, VIL1, IL6, NR4A3, NAT8, IL7R, TNFAIP8, HMGB2, SLC40A1, TNFAIP3, NUP62, CASP2, MYOCD, PLAUR, MMP9, GREM1, NDUFS3, IRF7, ZMYND11, LTF, BCL2A1, TAF9, LEF1, DLL1, THBS1, AURKB, HSPD1, AURKA, SNCA, SOD2, RPS6KB1, TEK, NAA15]
GO:0043065;positive regulation of apoptotic process;7.0;0.5587538620495764;0.6302962962819887;7.806911820114386;80.91235068524658;3.3969510907807043;0.0027080635610472266;0.5246396020141064;[MYB, AKT1, CYP1B1, HOXA5, MEF2C, DAPK1, PRKCD, ATF3, PRKDC, HMOX1, SFN, PLCG1, BARD1, LYN, JUN, FOSL1, NOX4, NOX1, SRPX, ADM, CTLA4, TIMP3, ANXA1, DUSP1, RIPK2, PAWR, SIRT1, F3, DUSP6, AES, PTGS2, FGD3, FGD4, FRZB, CASP8AP2, GSN, BIK, G0S2, POU4F1, TNF, CTGF, PYCARD, IGFBP3, F2R, MELK, MAL, ADAM8, S100A9, S100A8, CD274, FOXO1, NACC2, MAP2K6, TNFRSF10B, BCL6, BCL2, BCL2L1, PLEKHF1, PIK3CD, FASLG, ARRB1, ARRB2, CYR61, ITGA4, TFDP1, LCK, NLRC4, CCL5, E2F1, CCL2, GZMA, GZMB, PML, P2RX1, MNDA, IFIT2, PPP2R1A, SOX7, SOX4, TIAM2, SFRP4, SFRP2, CDC34, IFI27, SIK1, INPP5D, TP53BP2, GADD45B, TNFSF12, ITM2C, TOP2A, CD40, CTSZ, CTSH, IL10, VAV1, IL1B, CXCR2, CTNNA1, APBB1, SORT1, LILRB1, PPP1CA, NLRP12, CD40LG, FAP, DLC1, TGM2, PDGFRB, NLRP3, ECT2, TGFB2, TGFB1, VDR, CAV1, INHBA, EIF2S1, IL6, BMP2, NR4A3, JMY, NFKBID, UBE2M, TNFAIP8, CASP2, MYBL2, YWHAH, ARHGEF12, PLAUR, MMP9, DNM2, IFNG, LTA, CAMK2D, BCL2A1, THBS1, HSPD1, CNR1, SNCA, HSPE1, SOD2, LTBR]
GO:0046452;dihydrofolate metabolic process;7.0;0.9326813400603323;0.8172600352873667;9.584072489921288;283.0980526959044;8.390779266560578;0.009475037052025674;0.7800242071602487;[DHFR, ATIC]
GO:0006909;phagocytosis;6.0;0.9326813400603323;0.7894609826203107;9.4949928598676;28.437470009997963;5.618190544320798;9.517765291732001E-4;0.610434838299289;[NCF2, ITGB3, NCF4, ICAM3, ITGAL, CD36, TGM2, ANXA1, CD93, ANXA3, SLC11A1, DNM2, PECAM1, RARA, IRF8, PRTN3, CD302, LRP1, CEBPE, PLD4, CORO1A, CD14, ELANE, SLAMF1, CDC7, MARCO]
GO:0034599;cellular response to oxidative stress;4.0;0.7248374789738407;0.6124187394869203;8.935377071932177;68.67201153720991;4.519578255652688;0.0022983904253524798;0.48113144217596127;[NCF1, ETS1, AQP1, IL18RAP, MYB, AKT1, CYP1B1, PDGFRA, DAPK1, TPM1, PRKCD, CYBB, FANCD2, BTK, MGST1, FOXO1, PDGFD, ECT2, JUN, EIF2S1, NR4A2, IL6, CDK2, CDK1, NOX4, EZH2, LRRK2, TNFAIP3, PTPRK, CD36, GPX2, ANXA1, GPX1, CHUK, ARG1, FOS, MMP9, SIRT1, PAX2, DNM2, CCNA2, HDAC2, PCNA, AIF1, CST3, SNCA, KLF4, SOD2, MAPK13, FABP1]
GO:0072711;cellular response to hydroxyurea;6.0;1.0;0.8231203125901445;9.628524252492122;186.99437101104425;7.8311634786251565;0.006258533313731664;0.7236063770733796;[BLM, FMR1, TIMELESS]
GO:0070534;protein K63-linked ubiquitination;11.0;0.9326813400603323;0.8987696223598284;9.577230958104572;157.60047254366168;6.166155715036245;0.00527474598481953;0.747766442352181;[UBE2S, NEDD4, UBE2T]
GO:0033147;negative regulation of intracellular estrogen receptor signaling pathway;8.0;1.0;0.875;9.628524252492122;234.23542340630428;7.138016298065211;0.007839648823214116;0.7400384854347593;[LBH, BRCA1, PHB2]
GO:2000348;regulation of CD40 signaling pathway;6.0;0.8933024483968273;0.7697715367885581;9.405380701177911;41.8512380110395;7.9853141584524145;0.0014007232725606145;0.7314896500084853;[FANCD2, TNFAIP3, TREM2, SLAMF1]
GO:2000105;positive regulation of DNA-dependent DNA replication;9.0;0.7763722522362496;0.7844267512984139;9.440472020989182;901.5417397663175;7.379178354882098;0.03017379069508918;0.7736121494158466;[CDT1, CDK2, CDC7, E2F7, E2F8]
GO:2000104;negative regulation of DNA-dependent DNA replication;9.0;0.7140352122741334;0.7532582313173557;9.245532000236016;982.5781715052054;6.558197802812269;0.03288600713733608;0.7316271658034954;[SMARCAL1, BLM, TIPIN, GMNN, DONSON, SMC1A, BRCA2, SMC3, MSH6, STAG2, MSH2, BCL6, TIMELESS]
